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Eukaryote DNA is organised into the more compact nucleosome by wrapping 147bp of DNA 
around a histone octamer core.  The N-terminal tails of the histones protrude through the 
DNA and can be modified by a variety of enzymes.  Acetylation of Histone 4 Lysine 16 
(H4K16ac) is an important modification associated with an increase in transcription, and in 
flies is an important component of the doseage compensation system.  It is also unique 
amongst histone modifications in that it has been directly associated with chromatin 
decompaction.  H4K16ac has been linked to development through its Histone 
Acetyltransferase, MOF.  Deletion of MOF in mice leads to mass chromatin defects, and 
embryonic lethality prior to the blastocyst stage. 
I set out to understand the role of H4K16ac in differentiating Embryonic Stem cells (ES 
cells) and chromatin compaction in vivo.  I generated a ChIP-seq profile for H4K16ac in 
undifferentiated ES cells, and after 3 days of retinoic acid (RA) differentiation.  This 
revealed an association of H4K16ac with the promoters of transcribed genes in pluripotent 
ES cells, followed by loss H4K16ac on ES cell specific genes and gain of the modification 
on differentiation specific genes.  There were some silent genes in ES cells, however, which 
were acetylated on their promoters.  Through this study I also found that H4K16ac and MOF 
mark active enhancers in ES cells, along with H3K4me1 and H3K27Ac and p300.  H4K16ac 
did not mark a known regulatory region in limb cells, and it is possible that it marks active 
enhancers only of ES cells. 
Furthermore, I looked at the compaction state large regions (>100kb) which lost H4K16ac 
upon differentiation by FISH, to determine if loss of H4K16ac could predict compaction.  
The regions selected showed no change in compaction state between UD and D3 cells, 
meaning that loss of H4K16ac does not directly lead to chromatin compaction in vivo.  
However loss of H4K16ac may be necessary for any subsequent compaction, or the change 
in compaction may take place at nucleosomal level. 
Finally, I attempted both to overexpress and reduce the level of MOF in ES cells.  I was 
unable to manipulate the level of MOF in this cell type in either direction; expression of 
endogenous MOF was silenced after very little time, and stable MOF shRNA cell lines 
showed no reduction in levels of MOF.  Therefore, potentially, dosage of MOF/H4K16ac in 
this cell type is critical. 
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Chapter 1:  Introduction 
1.1 Chromatin Structure and Transcription 
Chromatin structure is intrinsically linked to control of gene expression.  For example; 
broadly speaking, open regions of the chromatin (euchromatin) are conducive to active 
transcription, whilst closed chromatin (heterochromatin) provides a more repressive 
environment and genes which reside here are transcriptionally silenced (Li et al., 2007).  The 
differences between heterochromatin and euchromatin are not only revealed in regulation of 
transcription, but also DNA repair and replication.  For example, experiments have indicated 
that chromatin remodellers may be of particular importance for replication of DNA through 
densely packed heterochromatin (Collins et al., 2002).  
Although broadly, heterochromatin is silenced, transcription still occurs on some level in 
these regions (Grewal and Elgin, 2007), and by no means all are genes within euchromatin 
are transcriptionally active.  DNA derived from more open/disordered fragments of the 
genome (separated by sucrose gradient) hybridize to more gene rich regions of the genome 
than do more closed fragments, though here the relationship to transcription is less clear 
(Gilbert et al., 2004).   On a gene by gene level, changes in chromatin compaction state have 
been shown to correlate with transcription; at different stages of differentiation, globin genes 
are more accessible both to RNA polymerase II and DNAse I in chromatin isolated from cell 
types in which they are active (red blood cells) than cell types in which they are not 
expressed (liver cells) (Weintraub and Groudine, 1976).  Additionally, binding of a potent 
transcriptional activator, VP16, leads to decompaction of heterochromatin (Belmont et al., 
1999).   
In eukaryotes, the nucleosome is the fundamental subunit of chromatin, and consists 
approximately 165bp of DNA wrapped around a histone octamer core (Kornberg, 1974; 
Kornberg and Thomas, 1974; Luger et al., 1997) (Fig1.1A).  Inclusion of the linker histone 
(e.g. H1) forms the chromatosome.  The DNA is wound in nearly two superhelical turns 
around the core; from free DNA, this results in a structure five to ten times more compact.  
This primary 10nm fibre structure may then be compacted further into a secondary 30nm 
structure via internucleosome interactions, and beyond, intro tertiary structures which are 
potentially formed through long distance interactions of secondary structures. There is 
considerable work to be done before the specifics of these higher order structures are fully 




Figure 1.1 Models of chromatin structure  
A: Crystal structure of the nucleosome core particle (Luger et al., 1997).  Green and 
orange ribbon traces represent DNA, histones represented by colours as in key.  
Histone tails protrude from the core particle, beyond the DNA.  B: A model showing 
potential levels of genome compaction from free DNA through to highly compacted 
mitotic chromosomes.  Adapted from (Baylin and Schuebel, 2007). 
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The nucleosome structure, in and of itself, is not conducive to transcription.  It provides a 
barrier to the transcriptional machinery; assembled nucleosomes in vitro do not support 
transcription initiation, and have a negative effect on elongation (Williamson and Felsenfeld, 
1978; Knezetic and Luse, 1986).  However, though the presence of nucleosomes over the 
promoter or transcription factor binding sites can obstruct the initiation of transcription in 
vitro, once initiation has taken place, the polymerase can continue through the nucleosome, 
displacing it (Lorch et al., 1987; O’Neill et al., 1992).  Promoters in vivo are generally 
sensitive to nuclease digestion (Elgin, 1981; Sabo et al., 2004), and genes usually contain a 
nucleosome free region at the start (with two well positioned nucleosomes either side) 
(reviewed in (Jiang and Pugh, 2009)). 
Chromatin packaging has a profound effect on transcription (and other DNA dependent 
processes).  Therefore, systems exist both to encourage compaction of chromatin in areas of 
the genome which are required to be silenced, and to encourage decompaction in areas which 
are to be transcribed. 
One set of targets for manipulation of the chromatin fibre are the core histone tails, which 
protrude through the DNA and provide a substrate for a variety of modifications, such as 
methylation, ubiquitination, phosphorylation, and most importantly for this work, 
acetylation.  The histone core may also be modified, but these Post Translational 
Modifications (PTMs) have not been as widely studied as those on the N-terminal tails 
(Mersfelder and Parthun, 2006). 
1.2 Histone Modifications 
 
Soon after the discovery of histone tail modifications, it was postulated that they might have 
some effect on transcription.  It was soon determined that acetylation of histones relieves the 
inhibition of RNA synthesis by nucleosomes (Allfrey et al., 1964).  Broadly, post 
translational histone modifications fall into one of two categories; those which are associated 
with open, transcriptionally active chromatin, and those which are associated with more 




Figure 1.2 Histone tail modifications. 
Known histone tail post translational modifications; for a selection of relevant modification, the association with active or inactive genes is 
indicated with a green or red box respectively.  Modified from (Andy Bannister, 2012), using data from (Wang et al., 2008).
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Hypoacetylation, and trimethylation of histone 3 lysine 27 (H3K27me3), H4K20me3, H3K9 
methylation are all associated with silenced heterochromatin, whilst acetylation, H3K4me3, 
and H3K36me3 are examples of histone PTMs associated with active genes (Wang et al., 
2008).  The associations of the specific histone modifications with different types of 
chromatin are conserved across species.  Indeed, the locations of specific histone 
modifications which are conserved between cell types in the same organism are conserved 
between species (in mammals) (Woo and Li, 2012).  
There are two possible modes of action through which a particular histone modification can 
influence transcription.  They may have an intrinsic effect, that is, the presence of the histone 
modification in and of itself produces an effect on nucleosome structure.  Alternatively, a 
PTM may affect how a nucleosome interacts with its near (or potentially far) neighbours, 
since formation of a more compacted structure requires that a nucleosome come into closer 
contact with others nearby.  The histone tails have been shown to have an effect on 
nucleosome oligomerisation in vitro (Gordon et al., 2005).   
In vitro, H4K16ac is an example of a single histone PTM which has an intrinsic effect on 
chromatin structure (to be discussed later – section 1.3).  More broadly, histone acetylation 
and phosphorylation both reduce the net positive electrostatic charge of the core histone.  
Acetylation has this effect by neutralising a positively charged lysine residue, and 
phosphorylation by addition of a negatively charged phosphate group.  This theoretically 
reduces the attraction of the histone core to negatively charged DNA, causing chromatin 
decompaction.  An increase in chromatin decompaction is a demonstrated effect of a global 
increase in histone acetylation induced by incubation with the Histone Deacetylase (HDAC) 
inhibitor TSA (Tóth et al., 2004; Eskeland et al., 2010).  The effect of histone 
phosphorylation on chromatin condensation is less well studied, but phosphorylation of H1 is 
proposed to decondense chromatin at the replication fork in S phase (Alexandrow and 
Hamlin, 2005). 
Histone modifications can provide a binding site for proteins such as transcription factors or 
recruiters of chromatin remodelling complexes.  For example, the chromodomain of HP1 is 
known to recognise and bind to methylated H3K9 (Bannister et al., 2001).  PWWP domains  
can recognise and bind to H3K36me3 (Dhayalan et al., 2010) and a variety of chromatin 
domains can bind acetyl lysine, such as bromodomains (reviewed in (Zeng and Zhou, 
2002)), and PHD fingers (Lange et al., 2008).  PHD fingers are also capable of binding to 
methylated lysine (Wysocka et al., 2006). 
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Histone PTMs can also block protein binding, as in the example of the INHAT (inhibitor of 
acetyl transferases) protein, which binds to the unmodified histone H3 tail, but whose 
binding can be abrogated by a variety of histone modifications, including histone acetylation 
or another overall charge reducing modification, phosphorylation  (Schneider et al., 2004). 
Downstream effects of binding proteins to histone PTMs can be further complicated by the 
fact that they are not always direct.  For example, serum stimulation leads to increased 
transcription of the FOSL1 gene in human cell lines through the following pathway; initially, 
PIM1 kinase phosphorylates H3S10 on the gene’s enhancer.  This generates a binding 
platform for the 14-3-3 protein, which then recruits MOF (the specific histone acetyl 
transferase, or HAT, for H4K16ac), leading to H4K16ac, and then binding of the 
bromodomain protein BRD4, which subsequently recruits P-TEFb, a transcription elongation 
factor which facilitates release of the promoter-proximal paused polymerase and finally, 
transcription of the gene (Zippo et al., 2009).  This system is also an example of a 
combinatorial pattern of histone modifications providing a binding platform for a single 
protein; in vitro, nucleosomes containing H3K9Ac (which is already acetylated prior to 
serum stimulation in the in vivo example), H3S10ph, and H4K16ac induced binding of P-
TEFb/BRD4.  There is also the example of the negative effect had by H3S10ph on binding 
of HP1 to H3K9me3 peptides.  In vivo, loss of H3S10ph allows HP1 to remain bound to 
mitotic chromosomes, from where it is usually removed (Fischle et al., 2005).  A genome 
wide study of a variety of histone acetylations and methylations showed that there are a 
group of 17 modifications which tend to coexist, though the functional significance or 
necessity to their coexistence remains to be elucidated (Wang et al., 2008). 
All histone modifications discovered to date are reversible.  This flexible control makes them 
ideal for situations where plasticity in gene expression is required, such as development.  
Histone methylation and acetylation are of particular relevance to this study and are 
discussed below in greater detail. 
1.2.1 Histone Methylation 
 
Compared with acetylation, methylations of histone tails have been thought of as rather 
stable marks. Both arginine and lysine residues can be methylated. Lysines can carry mono-
di or tri-methylation, resulting in four different states for each lysine, and the potential for 
different readouts by, for example, binding of different effector molecules.  
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Methylation of histone tail lysines is carried out by SET domain containing Histone Lysine 
Methyltransferases (HKMTs) such as Ezh2, which is found within the PRC2 complex (Cao 
et al., 2002).  Product specificity (i.e. whether the product is mono, di, or trimethylated 
lysine) of SET domain proteins can be defined by variations in the SET domain active site 
(Zhang et al., 2003).  Substrate specificity can vary; in the example of Ezh2, its specificity is 
altered by interaction with a variety of Eed isoforms (Kuzmichev et al., 2004). 
It was only recently that lysine methylation was shown to be reversible, with the discovery 
of the first histone demethylase, LSD1 (Shi et al., 2004).  Another distinguishing feature of 
histone methylations is a variety of features between the different modified residues; for 
example though generally considered stable, lysine methylations have a different turnover 
rate, so some are more stable than others (Zee et al., 2010).   
In contrast to histone acetylation (discussed below) which is generally associated with active 
transcription and open chromatin; methylation of histone tails can correlate with either 
activation or silencing, depending on which residue is modified (Fig 1.3).  For example, 
along the H3 tail the residues are functionally diverse; H3K4me3 is broadly correlated with 
the promoters of active genes(Wang et al., 2008), and H3K36me3 with elongation of 
transcription (Krogan et al., 2003), whilst H3K27me3 is important for gene silencing via the 
polycomb repressive complexes (Cao et al., 2002). H3K9 methylation has been associated 
with formation of heterochromatin (Fischle et al., 2005).  As expected from such a variety of 
different functions, the mechanism of action for histone methylation is not fully understood, 
but the diversity makes them powerful mediators of regulation.   
Unlike lysine acetylation, lysine methylation does not appear to have a direct effect on 
chromatin structure, nor does it affect the charge of the lysine, which remains cationic (Fig 
1.4B).  Instead, the most studied regulatory effects of lysine methylation are mediated 
through proteins which contain a methyl-binding domain such as a chromodomain, PWWP 
domain or WD40 repeats.  Again, although broadly the domains’ binding is affected by 
methylated lysine, there is variety.  Some are prevented from binding lysine by methylation 
of the residue; for example, the PHD domain of TRIM24, (a multifunctional protein, 
overexpression of which correlates with poor prognosis in breast cancer patients) binds to 
only unmethylated H3K4.  This leads to co-activation of the oestrogen receptor alpha (ERα), 
and expression of the target genes which are generally associated with cellular proliferation 
(Tsai et al., 2010).  Other binding proteins lead to effects on transcription by binding to 
methylated lysines.  For example, the PHD domain containing proteins are known to bind to 
H3K4me3.  BPTF contains two PHD domains, and is the biggest subunit of the ATP 
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dependent chromatin remodelling complex NURF.  BPTF binding to chromatin is dependent 
on H3K4me3, and Xenopus mutants which lack H3K4me3 show the same developmental 




Figure 1.3 Different H3 methylation marks can associate with euchromatin or heterochromatin  
Euchromatic and heterochromatin regions of the S. pombe mating locus contain different H3 methylation marks.  Open reading frames 
are shown with arrows indicating direction of transcription.  Region between IR-L and IR-R (inverted repeats) is heterochromeric.  Graph 
represents ChIP experiments for H3K9me (red), and H3K4me (blue).  From (Zhang and Reinberg, 2001).
10 
 
1.2.2 Histone Acetylation 
 
The various histone modifications in this category are frequently counted together under the 
umbrella term of histone acetylation; though not all have the same function, some of the 
lysine acetylations have a coordinated function and an additive effect. 
Gene activity and histone acetylation were first positively correlated in the 1960s when it 
was discovered that nucleosomes with acetylated histones show less inhibition of RNA 
polymerase, and that ‘activated’ lymphocytes incorporated a much larger amount of acetate 
into their histones than did inactivated cells (Allfrey et al., 1964; Pogo et al., 1966).  This 
correlated with a large increase in transcription in the activated cell type.  Subsequent 
investigations showed directly that histone acetylation was present on transcriptionally active 





Figure 1.4 Covalent modification of lysine 
A: ε-amino group of lysine acetylated by Histone Acetyl Transferase (HAT), resulting 
in loss of positive charge.  Reverse reaction is catalysed by Histone DeACetlyases 
(HDAC). 
B: ε-amino group of lysine modified by addition of 1-3 methyl groups, without 




There are 12 potential sites for histone acetylation on the histone tails (five on H3, four on 
H4, two on H2B and just one on H2A – Figure 1.2) All are lysine acetylations, which is 
important given that lysine is a positively charged amino acid, and acetylation neutralises the 
charge.  This means that the net positive charge of the histone tail is reduced, reducing its 
attraction to the DNA (Fig 1.4A).  Since the histone tails lie outside the DNA, their binding 
to the DNA could obscure transcription factor binding sites and thus repress transcription; a 
process which would be reduced by acetylation.  An early report suggested that on 
nucleosomes assembled on 5S rDNA in vitro, acetylation of the histones, or removal of the 
histone tails, allows binding of the transcription factor TFIIIA, where unacetylated histones 
do not (Lee et al., 1993).  Acetylations on H2A and H2B are poorly studied, while those of 
H3 and H4 are widely studied.  There is a striking difference between the phenotypes of 
histone tail deletions of H3 and H4 in yeast; both deletions are viable, whilst the double 
mutant is not.  Deletion of the H3 tail leads to activation of a selection of genes (Mann and 
Grunstein, 1992) where deletion of the H4 tail results in a loss of repression on the silent 
mating loci (Johnson et al., 1990), but also a reduction in transcription of certain genes 
(Durrin et al, 1991).  Deletion of other histone tails has no effect on the transcription of the 
subset of genes affected by H4 or H3 tail deletion. 
Histone acetylation on H4 is also more enriched on euchromatin, whereas heterochromatin is 
generally hypoacetylated  - however, no correlation was found between total H4 acetylation 
and transcription (O’Neill and Turner, 1995).  Subsequently, the four H4 lysine acetylations 
were examined individually.  Interestingly, in spite of the fact that acetylation is generally 
associated with activation and euchromatin, in Drosophila, H4K12Ac is enriched at 
heterochromatin and at telomeric heterochromatin in yeast (Turner et al., 1992; Zhou et al., 
2011), though not in humans.  On newly synthesised histones (in a manner conserved across 
species), H4 is diacetylated, on lysines 5 and 12 (Sobel et al., 1995), but the bulk of nuclear 
histones are instead monoacetylated on lysine 16 (and monoacetylated H4 tails contain only 
H4K16ac).  Histone acetylation proceeds in a preferred order towards the N-terminal through 
H4K12, K8 and K5 (Turner et al., 1989; Thorne et al., 1990; Zhang et al., 2002). 
The acetylation status of histones at particular loci is dictated by a balance between HATs 
and HDACs.  The conservation of these enzymes from yeast to human implies they are 
functionally extremely important.  The importance of HATs in transcription was confirmed 
with the discovery that a number of well-established transcriptional co-activators (such as 
CBP and Gcn5) had HAT activity (Bannister and Kouzarides, 1996; Brownell et al., 1996).  
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By contrast, it was discovered that a transcriptional repressor carried HDAC activity 
(Taunton et al., 1996). 
Based on their sequence and function, HATs fall into one of five families (GNAT, MYST, 
p300/CBP, TAFII250, and nuclear receptor coactivators).  MOF belongs to the MYST family 
of HATs, which frequently contain Zinc finger domains and a PHD or chromodomain (Roth 
et al., 2001). 
Similarly, HDACs fall into one of four classes (I-IV).  Class I, II, and IV HDACs remove the 
acetyl group by hydrolysis (reviewed in (Lombardi et al., 2011)), whilst Class III HDACs 
(also known as the Sirtuins) rely on NAD+ (Fig 1.5), and can be specifically inhibited by 
Sirtinol (reviewed in (Sauve et al., 2006).  Class III HDACs are known to deacetylate 





Figure 1.5 NAD+ dependent histone deacetylation by Class III HDAC 
From (Sauve et al., 2006).  First, the Sir enzyme binds to NAD+, and catabolises this 
into activated ADP-ribose and nicotinimide (released).  Then the Sir enzyme 
transfers the acetyl group from the histone lysine to the ADP-ribose, generating O-
acetyl-ADP ribose as a by-product.
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The association of histone acetylation with active regions of the genome and connection with 
transcribed genes is extremely clear, but what is less clear is whether some, all, or any of the 
histone modifications are necessary for transcriptional activation and chromatin 
decompaction at different gene loci. 
A comprehensive genome wide study in human (CD4+T cells) looked at the profile of 
eighteen histone acetylations (including some histone core modifications, as well as those of 
the N-terminal tails) (Wang et al., 2008).  All the histone acetylations studied showed a 
positive correlation with expression – genes which showed presence of the acetylation had 
higher expression than those which did not.  Although acetylations were increased on active 
genes, the profile of the modification across those active genes was very different.  For 
example, H3K9ac (along with H2AK9ac, H2BK5ac, H3K18ac, H3K27ac, H3K36ac and 
H4K91ac) shows a sharp peak over the TSS region, and is absent from the body of the gene.  
By comparison, H3K23ac (and H2BK12ac, H2BK20ac, H2BK120ac, H3K4ac, H4K5ac, 
H4K8ac and H4K16ac) has a lower peak over the TSS, and tails off gradually through the 
body of the gene.  The profiles of histone acetylations are not identical.  For example 
H4K12ac also has a low peak over the TSS, which reduces slightly at around 10% through 
the gene length, but remains even through the rest of the gene, tailing off to background level 




Figure 1.6 Histone acetylation profiles around the TSS. 
Normalised tag counts at active or silent genes across averaged gene bodies +/- 5kb.  txStart, transcription start, txEnd, transcription end.  




Although histone acetylation has a general association with active genes, the different 
binding profiles suggest that some may have individual effects, though this has not yet been 
widely studied.  Of the H4 lysine residues in yeast, it has been shown that mutation of K5, 
K8 and K12 to Arginine has an additive, negative effect on transcription.  Individually, these 
mutations have a similar effect on the same genes.  Mutation of K16, however has a specific 
effect, separate from the other residues on the histone tail (Dion et al., 2005).  The specific 
effects of H4K16ac will now be discussed in detail. 
 
1.3 H4K16 Acetylation 
1.3.1 Direct Effects of H4K16ac 
 
Acetylation of H4K16 is one of the only histone marks which has a direct, causative 
relationship with chromatin decompaction and upregulation of transcription. Though, as 
mentioned, many histone modifications have a correlation with euchromatin or 
heterochromatin and gene expression or silencing, H4K16ac is one of the few which has 
been shown to have a direct impact on either.   
Acetylation of the H4 tail has an impact on higher order chromatin folding.  Acetylation of 
lysines results in an overall reduction in positive charge of the histones (Fig 1.4A), and it is 
this non-specific electrostatic mechanism which is responsible for chromatin condensation 
between nucleosome arrays (i.e. aggregation of single nucleosomes or self-association of 
nucleosome arrays) (Allahverdi et al., 2010; Liu et al., 2011).  
However, in vitro, acetylated nucleosome arrays are more disordered than unacetylated 
arrays, and it was found that this effect is specific to residues 14-19 of the H4 tail (Tse et al., 
1998; Dorigo et al., 2003).  This specific region of the H4 tail has been shown to make 
contact with the H2A/H2B dimer on the following nucleosome (Fig 1.7), which implicates 
the region in intramolecular nucleosome folding.  This region is functionally important in the 
formation of heterochromatin in yeast, since it binds to the silencing SIR3 protein (Hecht et 




Figure 1.7 H4 tail modifications interact with H2A/H2B of following nucleosome 
A:  Nucleosome Core Particle (NCP) stacking derived from NCP crystals, using the 
frequently reported structure in which H4K16-R23 (magenta – blue sphere 
represents NZ atom of H4K16, red spheres = oxygen atoms of carboxylate groups 
which form the electronegative patch) locates between two NCPs and interacts with 
the acidic patch of NCP2 H2A.  B and C:  As A, for different projections.  From (Liu 
et al., 2011).  D:  H4R23 and H4L22 (and a Mn2+ ion in magenta) interact with the 
acidic region of H2A-H2B dimer of second NCP.  H4 = green, H2A = red.  From 
(Davey et al., 2002).
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H4K16 is found within this specific region, and its acetylation has been shown to specifically 
disrupt intramolecular nucleosome folding to a similar extent to deletion of the entire H4 N-
terminal tail (Shogren-Knaak et al., 2006).  Not only can H4K16ac disrupt the formation of 
higher order structures in vitro but its removal is also necessary for their formation, even on 
extremely long nucleosome arrays.  The longer nucleosome arrays were generated in order to 
more accurately represent the situation in vivo and also contain the chicken erythrocyte 
isoform of linker histone H1, known as H5.  Decompaction of arrays requires removal of the 
linker histone, and the effect of acetylation of H4K16 and removal of the linker histone are 
additive (Robinson et al., 2008), adding further evidence that H4K16ac has a vital role in 
decompaction.  Decoupling the specific effect of H4K16ac on intermolecular nucleosome 
folding from the non-specific electrostatic mechanism; the charge neutralising K16Q 
mutation does not cause decompaction of nucleosome arrays (Robinson et al., 2008).  This 
adds further evidence that the interaction of the H4 tail with H2A/H2B is the important 
mechanism in intra-array folding.  Additionally, the basic region of H2B can also be bound 
by the K+ ion – in this situation, 12-mer nucleosome arrays are unable to compact.  It was 
proposed that binding of the K+ ion prevents binding of the H4 lysine residues, which would 
otherwise be able to bind to the H2B region and allow chromatin compaction (Allahverdi et 
al., 2010). 
Although H4K16ac is associated with decompacted chromatin in vitro, the role of H4K16ac 
in modulating chromatin compaction in vivo is less well-studied. 
H4K16ac has also been shown to have a direct effect on transcription.  In in vitro 
transcription assays (Akhtar and Becker, 2000), targeting MOF to a nucleosome array for the 
Drosophila hsp1 gene lead to H4K16ac and derepression. 
1.4 Roles of H4K16ac in vivo 
 
In vivo, H4K16 is specifically acetylated by MOF (also known as MYST1 or KAT8) 
(Morales et al., 2004), and in mammals, MOF is required for H4K16ac, but not acetylation 
of other H4 lysine residues (Taipale et al., 2005).  In mouse, MOF is expressed uniformly in 
adult tissues, but is overexpressed in testis (Thomas et al., 2007, 2008).  Like most MYST 
family HATs, it contains a chromodomain as well as a histone acetyl transferase domain (Fig 
1.8A).  These domains share homology in mice and flies (Fig 1.8B). 
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There are many cellular processes in which H4K16ac and MOF are integral.  A selection 







Figure 1.8 Conserved domains of mouse and Drosophila MOF (Previous page) 
A:  Locations of conserved domains detected using UniProtKB (The UniProt 
Consortium, 2011) and InterPro (for zinc finger domain) (Hunter et al., 2012).  
Domains are represented in orange (cd = chromodomain), green (zf = zinc finger 
domain) and yellow (HAT = histone acetyl transferase domain).  hMOF adapted 
from (Gupta et al., 2005a), dMOF adapted from (Akhtar, 2001).  
B:  Sequence alignment for conserved domains, generated through ClustalOmega 







Figure 1.9 Functions of H4K16ac. 
Nucleosomes represented by gold cylinder with DNA represented by blue line.  
H4K16 acetylation is depicted in the top half of the figure by a blue circle over K16 
(red line).  Functions discussed below are highlighted in purple.  Modified from 
(Vaquero et al., 2007).
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1.4.1 Dosage Compensation in Flies and Mammals 
 
X chromosome dosage compensation is an example of a situation where histone acetylation 
is important, in both flies and mammals.  In mammalian systems, where females carry two 
copies of the X chromosome, and males only one, the females silence one entire 
chromosome to ensure that the dose of genes on the X-chromosome is equivalent to that in 
males.  This silencing is achieved by formation of facultative heterochromatin, and involves 
multiple layers of regulation.  In flies, the situation is reversed, and males must upregulate 
the genes on the X-chromosome twofold to ensure equal dosage (reviewed in (Baker et al., 
1994)) . 
Modification of chromatin structure and its ability to allow transcription is a hallmark of 
dosage compensation across species.  In Drosophila, the generation of more relaxed 
chromatin on the male X chromosome is seen on the polytene chromosomes after 
knockdown of the ISWI  chromatin remodelling complex– by comparison to the wild type, 
the chromosome is ‘bloated’ and expanded.  Preventing acetylation of H4K16ac rescues this 
phenotype (Straub and Becker, 2007). 
MOF was first discovered as a regulator of X-chromosome dosage compensation in flies, 
which is reflected in its name; MOF, or Males absent on the first.  In the mof mutant male 
flies, the X chromosome loses H4K16ac (Turner et al., 1992; Hilfiker et al., 1997), and the 
male flies die. 
In mammals, the mechanism of dosage compensation is regulated differently, but the 
inactive X is hypoacetylated on K5, 8, 12 and 16 (Jeppesen and Turner, 1993), and 
hypoacetylation has been proposed to be important for maintainance of the inactive state 
(Keohane et al., 1996; O’Neill et al., 1999). 
1.4.2 The role of H4K16ac in genome wide transcription 
 
The role of MOF in Drosophila was initially thought to be limited to dosage compensation, 
due to the mof mutant’s male specific lethality (Hilfiker et al., 1997).  However, it was later 
shown that females homozygous for a different mof mutation (lacking the entire HAT and 
chromodomain) are sterile, and have a significantly shortened lifespan compared with wild 
type flies (Conrad et al., 2012a).  In addition, it was noted that the distribution of MOF 
across the genome is much wider than that of the MSL proteins (Gelbart et al., 2009) and 
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that MOF binds to the majority of active autosomal promoters (Raja et al., 2010).  MOF is 
also necessary for genome wide H4K16ac in both male and female flies (Conrad et al., 
2012a), and H4K16ac correlates with transcriptional activation on female chromosomes and 
male autosomes (Prestel et al., 2010).   
In mammals, genome wide studies of H4K16ac have shown it to be associated with active 
promoters across the genome (Wang et al., 2008; Wong et al., 2011), and it also has a 
functional connection with transcription; in HeLa cells, knockdown of MOF leads to a 
reduction in both H4K16ac at the promoter of HOXA9, and transcription of the gene (Dou et 
al., 2005).   
 
1.4.3 Functional Separation of MOF roles 
 
In flies, MOF and H4K16ac have a role in both dosage compensation and genome wide 
transcription.  Separation of these two roles is achieved through differing interaction partners 
of MOF.  The interaction partners are important for the histone substrate specificity of MOF, 
which is unusually narrow for a HAT; other HATs generally acetylate a broad group of 
histone residues (summarised in (Rea et al., 2007)).    In isolation, MOF is less specific when 
acetylating free histones, and has no HAT activity on nucleosomal histones (Morales et al., 
2004).  By contrast, when partnered with MSL1 and 3, MOF acetylates only H4K16. 
The reliance of MOF on its interaction partners for enzymatic activity is key to organisms’ 
ability to segregate its functional roles. 
For hyperacetylation targeted to the male X chromosome in flies (Bone et al., 1994), the 
MSL complex and a series of non-coding RNAs, expressed only in male flies are vital.  
Together with MOF, these are known as the Dosage Compensation Complex (DCC).  The 
first step is production of the MSL2 protein, which is silenced in females.  MSL2 is also an 
E3 ligase, ubiquitinating H2B (Wu et al., 2011).  The rest of the DCC is assembled using 
MSL2 as a scaffold, and consists of MSL1, MSL3, MOF, and MLE, which are also 
expressed in female flies, and the male specific non coding RNAs (roX), which are not.  The 
DCC specifically binds to the male X chromosome in a manner dependent on the roX non 
coding RNA transcripts.  MOF can bind to the roX2 RNA via its chromodomain (Akhtar et 
al., 2000). Since roX RNAs are very quickly degraded it is thought that the DCC is fully 
assembled at their site of transcription on the X chromosome, and then spreads to the rest of 
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the chromosome, allowing MOF to acetylate H4K16ac.  H4K16ac is required for spreading 
of the complex across the chromosome, indicating that a certain extent of chromatin 
decompaction mediated by acetylation may be required for the DCCs progress along the 
chromosome (reviewed in (Conrad and Akhtar, 2012)). 
Though MOF can bind to one of the roX RNAs, this function can be dispensed with for its 
integration into the DCC (Morales et al., 2004).  Instead, MOF has a direct interaction with 
MSL1 through its zinc finger domain.  A point mutation in the zinc finger can prevent MOF 
association with the male X chromosome entirely (Morales et al., 2004).   
The chromodomain of MOF is dispensable for its integration into the DCC and efficient 
targeting of the DCC to the male X chromosome, but its highly conserved state indicates that 
it still holds some functional importance.  Interestingly, in Drosophila, there is a large region 
between the chromodomain and the N-terminal of the protein.  This region is not conserved 
in species with different dosage compensation systems.  Though point mutations in the 
chromodomain did not affect DCC localisation (Morales et al., 2004), the same point 
mutation led to total male lethality and defective spreading of MSL1 and 3 (Conrad et al., 
2012a).  
H4K16ac is central to the eventual downstream effect of the DCC, though the exact 
mechanism of upregulation of transcription has yet to be elucidated.  A clue comes from 
ChIP-sequencing experiments for MOF, H4K16ac and a subunit of RNApolII performed in 
flies.  These experiments also show how H4K16ac profile changes according to function. 
On the autosomes of male flies (and all chromosomes of female flies), H4K16ac is found 
only around the gene promoters. However, on the male X chromosome it is found through 
the length of the genes (Fig 1.10).  Additionally, on the male X chromosome, MOF is 
enriched towards the 3’ ends of the gene (Kind et al., 2008; Larschan et al., 2011). This 
correlates with increased enrichment of RNApolII on the genes of the male X (Conrad et al., 
2012b).  These genes also have increased transcriptional elongation, which has been posited 
as a potential mechanism for H4K16ac action (i.e. the increased accessibility of the 
chromatin after acetylation allows the transcriptional machinery an easier path through the 
gene) (Larschan et al., 2011).  This is supported by the fact that in isolated nuclei the male X 




Figure 1.10 Differing profiles of H4K16ac on Drosophila male X or autosomes 
From (Larschan et al., 2011).  H4K16ac is localised across the body of the genes on 
the active genes of the male X chromosome (red), but is restricted to the 5’ end of 
active genes on the autosomes. 
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In Drosophila, targeting of MOF and H4K16ac to the promoters of male and female 
autosomal genes relies on interaction with the ‘Non-specific lethal’ (NSL) complex (Feller et 
al., 2011) – so called because its disruption is lethal to both male and female flies.  In flies, 
the NSL complex is capable of transcriptionally activating a promoter if it is artificially 
tethered there; importantly, depletion of MOF seriously reduced the level of reporter gene 
transcribed (Raja et al., 2010).  The biological role of NSL targeting to autosomal genes 
seems to be regulation of the housekeeping genes (Lam et al., 2012), though not all NSL 
bound housekeeping genes are active (Feller et al., 2011).   The activation potential of MOF, 
measured by transcriptional output of its target genes, is much higher when MOF is in the 
context of the NSL complex than the MSL complex. As part of the MSL complex MOF only 
effects a twofold increase of expression, as required for accurate doseage compensation 
(Prestel et al., 2010). 
Both the MSL and NSL complexes are evolutionarily conserved, indicating that there may 
also be a separation of function for MOF in mammals.  In humans, like in flies, the NSL 
proteins do not join the MSL complex, but instead form a distinct complex with a size of 
approximately 300-400kDa, which includes MOF (Mendjan et al., 2006; Cai et al., 2009).  In 
mammals the NSL complex is also known as MSL1v1, and KANSL; for simplicity here it 
will be referred to as the NSL complex in both species.   The human NSL complex is 
enzymatically active in vitro, not only on H4K16, but also on H4K5 and H4K8 (Cai et al., 
2009).  However, in vivo in Drosophila, relaxation of MOF substrate specificity was not 
observed (Lam et al., 2012).  MOF interacts with the NSL complex via an interaction 
between its HAT domain and the C-terminal domain of NSL1 (Raja et al., 2010).  The 
functional purpose behind segregation of MOF into two complexes in mammals is still 
unknown, but it has been suggested that as part of the NSL complex, the principle substrate 
of MOF is the non-histone protein p53 (Li et al., 2009).  Alternatively, MOF has also been 
shown to potentially interact with the H3K4 methyltransferase MLL.  This interaction is 
mediated through WDR5, which is shared between the NSL-MOF complex and the MLL 
complex, but not the MSL-MOF complex (Dou et al., 2005).  The interaction with MLL has 
been disputed, however (Cai et al., 2009). 
It is interesting to note that the 17q21.31 microdeletion syndrome (which causes intellectual 
disability, epilepsy, heart and urogenital defects, along with a facial morphology phenotype) 
was recently shown to be caused by a mutation in the NSL complex protein KANSL1 (or 
NSL1).  Cell lines established from patients showed transcriptional misregulation of a 
number of genes, which are enriched for similar GO terms as NSL1 bound genes in 
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Drosophila.  This implies that the NSL-MOF complex may target MOF binding to a specific 
subset of genes (Koolen et al., 2012; Zollino et al., 2012).  NSL/MSL known functions are 




Figure 1.11 Segregation of MOF function by integration into separate complexes in flies and mammals 
Model of MOF functions in MSL and NSL complexes in flies (top) and mammals (bottom), mammalian data summarised from pull downs 
in HeLa cells (Cai et al., 2009).  Drosophila complexes from (Raja et al., 2010) and (Mendjan and Akhtar, 2007).
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1.4.4 Histone Acetylation and H4K16ac in Mammalian Development 
 
ES cell differentiation is an example of a developmental situation in which histone 
acetylation may be important.  Leukaemia Inhibitory Factor (LIF), is added to the culture 
media of mouse ES cells, in order to maintain them in the pluripotent state.  If the LIF is 
withdrawn, the cells begin to differentiate non-specifically (i.e. down a variety of lineages) 
(Williams et al., 1988).  There is a global increase in bulk acetylation of H3 and H4 upon 
differentiation, and treatment with a HDAC inhibitor can reversibly induce differentiation 
without removal of LIF (McCool et al., 2007).  These experiments did not distinguish 
between the four acetylated lysines on the H4 tail, but H4K16ac has also been shown to be 
specifically involved in development. 
Mice deleted for MOF die prior to the blastocyst stage, with extreme morphological 
abnormalities. At E4.5, wild type cells show distinct development of the Inner Cell Mass 
(ICM), an ordered group of cells distinct from the Blastocoelic Cavity (BC).  However, in 
MOF-/- embryos, the ICM does not develop properly and by E5.5 has degenerated into an 
entirely disordered structure (Fig 1.12A).  In vitro culture of the embryos revealed that the 
cells die by apoptosis, but prior to activation of caspase-3, they show chromosome 
abnormalities characterised by a loss of focused bisbenzimide staining (the staining is 
present throughout the nucleus in strongly affected cells).  MOF-/- cells also show a loss of 
H4K16ac (Thomas et al., 2008).  This data showed that H4K16ac is important for 
development in mammals. 
In addition, MOF was recently shown to be of vital importance in the maintenance of 
pluripotency of ES cells.  Interestingly, prior to this discovery, it was shown that HDAC 
inhibitors were amongst a variety of molecules which enhanced formation of induced 
pluripotent stem cells (iPS cells) in vitro (Feng et al., 2009), in spite of the fact that TSA (a 
HDAC inhibitor) can induce pluripotent cells to differentiate (McCool et al., 2007).  Thomas 
et al (2008) were unable to produce ES cells from MOF-/- mice, and therefore a recent study 
(Li et al., 2012) instead used an inducible Cre-floxing approach, though even this method 
resulted in eventual cell death.  In wild type cells, MOF protein levels are reduced upon 
retinoic acid differentiation, supporting the idea that it has a specific role in ES cells.  
Further, by working with MOFflox/flox cells  (prior to cell death) Li et al showed that 
chromatin structure is greatly perturbed by loss of MOF in ES cells, with a large increase in 
apparently condensed chromatin compared to wild type (Fig 1.12B).  MOFflox/flox  ES cells 
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show a reduction in markers for pluripotency, including reduced Alkaline Phosphatase (AP) 
staining (O’Connor et al., 2008), and reduced expression of key pluripotency associated 
genes, such as Oct4 and Nanog.  The pluripotency associated genes Klf4 and c-Myc showed 
an increase in expression, surprisingly, though MOF binding and H4K16 acetylation were 
reduced in MOFflox/flox cells on these genes. MOF has a broad role in transcriptional 
regulation in ES cells.  Upon removal of MOF from ES cells, approximately 3000 genes 
show a 2-fold change in expression (around half are upregulated and half downregulated). 
These genes fall into many categories, including cell cycle regulation and DNA repair, 
though downregulated targets are enriched for pluripotency maintainance, and upregulated 
targets for differentiation specific genes.  Interestingly, the misregulated genes correlated 
highly with targets of Nanog, and overexpression of Nanog was capable of rescuing the 




Figure 1.12 Effects of Mof knockout on development and ES cell nuclear 
morphology 
A)  Sectioned uteri from timed matings at E4.5. BC, blastocoelic cavity; EC, 
ectoplacental cone; EE, embryonic ectoderm; EEE, extraembryonic ectoderm; ICM, 
inner cell mass; TE, trophectoderm; ZP, zona pellucida.  From (Thomas et al., 
2008).  B)  Electron Microscopy (EM) images of wild type (right) and Mof knockout 
ES cell nuclei.  Dense staining of heterochromatin is highlighted with red arrow.  




1.4.5 Histone Acetylation and DNA Damage Repair 
 
Since histone acetylation, and H4K16ac in particular, are associated with changes in 
chromatin structure, it is to be expected that other processes for which the organisation of the 
DNA would have some impact would also be affected by acetylation. An example of this is 
DNA damage repair.  Exactly how the DNA damage machinery accesses damaged DNA 
when it is located in compacted chromatin in mammals is not yet known, but chromatin 
remodelling complexes and histone modifications are involved (reviewed in (Wong et al., 
2006)).   
In yeast, there is a significant amount of work linking histone acetylation and double strand 
break repair.  Indeed, acetylation of H4 is considered to be essential.  Mutation of lysine 
residues to glutamine results in hypersensitivity to double strand breaks induced by 
camptothecin (CPT).  Replacing only one of the lysines rescues the phenotype (lysines 5-12 
show equal rescue of CPT sensitivity, but lysine 16 is slightly less effective), insertion of an 
extra lysine (which is acetylated) also rescues the phenotype (Bird et al., 2002).  Deletion of 
Esa1 (a MOF homolog in yeast which is responsible for acetylation of all the lysines on the 
H4 tail) also leads to sensitivity to DSBs (Bird et al., 2002). 
Additionally, after a double strand break, the histone acetylation is removed; HDACs are 
recruited approximately three hours after induction of the DSB, and levels of all H4 acetyl-
lysines is reduced (Tamburini and Tyler, 2005).    
The function of histone acetylation in DNA damage repair is linked to the histone H2AX, 
which is phosphorylated on serine 139 upon breakage of the DNA (Rogakou et al., 1998).  
Upon induction of a double stranded break (DSB) in yeast, H2AX phosphorylation may 
recruit the HAT complex NuA4 through an interaction between phosphorylated H2AX, and 
a subunit of NuA4 (Arp4).  The HAT complex is found at the site of double stranded breaks, 
and acetylates the H4 tail.  The mechanism by which H4 acetylation aids in the cells ability 
to cope with DSBs is not known, but replacing the lysines in the H4 tail, or mutating the 
HAT complex responsible leads to hypersensitivity to DNA damage by induction of DSBs 
(Attikum and Gasser, 2005).  This points to a general role of histone acetylation in DNA 
damage repair (suggested to be due to ‘opening’ of the chromatin at the site requiring repair), 
but it has also been shown that H4K16ac and MOF have a more specific role in this process. 
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In humans, MOF has been identified as an interaction partner of the protein ATM (ataxia-
telangiectasia-mutated) which is a critical part of the cellular response to DNA damage.  
Cells with reduced level of MOF activity (either through knockdown or expression of a 
mutant with no HAT activity) show an increase in the number of spontaneous chromosome 
breaks, but also decreased survival after irradiation (Gupta et al., 2005b).  Reduction in 
levels of MOF mediated H4K16ac did not lead to reduction in expression of any proteins 
involved in DDR.  Instead, it has a direct effect on H2AX focus formation, which is delayed 
upon reduction of H4K16ac (Sharma et al., 2010), though, again, the exact mechanism has 
yet to be elucidated. 
1.5 Histone Acetylation, H4K16ac and Disease 
1.5.1 Cancer 
 
Consistent with its role in regulation of transcription and DNA damage repair, histone 
acetylation has also been implicated in situations when regulation of these processes goes 
wrong.  Histone acetylation and cancer is one example of this association.  HDAC inhibitors 
that are FDA approved for use in anti-cancer therapy include Vorinostat and Romidepsin.  
HDAC inhibitors are proposed to act on cancer via their interference with histone 
acetylation, but they could have many off target effects (Mack, 2010).  The DNA binding 
activity of p53, for example, is activated by acetylation; binding of DNA is a feature of p53 
frequently absent in oncogenic mutants (Gu and Roeder, 1997).   
Acetylation of p53 is a process which is affected by inhibition of HDACs, which are known 
to deacetylate p53 in mammals (Brooks and Gu, 2011).  Histones do, however, represent the 
most abundant substrate for HDACs, so at least some of the effect of HDAC inhibitors may 
be due to changes in histone acetylation. 
The p53 protein is widely regarded as one of the most important in the cancer field.  Its 
inactivation leads to tumours due to its ability to trigger either arrest of the cell cycling 
process or apoptosis leading to cell death, by stimulating transcription of the genes involved 
in one pathway or the other (Sykes et al., 2006). 
Interestingly, MOF is amongst the HATs which are known to acetylate p53.  MOF and 
another HAT, Tip60, acetylate p53 on lysine 120.  Deacetylation of p53 K120ac prevents 
p53 from activating transcription of its pro-apoptotic target genes, but does not affect its 
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ability to upregulate the transcription of pro-cell cycle arrest targets, such as p21 (Sykes et 
al., 2006).  
Evidence for a direct involvement in H4K16ac in cancer, aside from its effect on double 
strand break repair, discussed above, is limited, but human MOF has been shown to be 
downregulated in a subset of breast cancer cases (Pfister et al., 2008). 
1.5.2 Ageing 
 
Like organismal development, the process of ageing is linked changes in chromatin, and 
histone acetylation has been implicated particularly in determination of lifespan, through the 
action of the Sir proteins, a group of HDACs.  Ageing and epigenetics is reviewed in (Fraga 
and Esteller, 2007). 
In yeast for example, ‘ageing’ is a function of the number of daughter cells one parent cell 
can produce – the two cells can be distinguished in budding yeast, since the daughter cell is 
smaller.  The mother cell will eventually cease to divide and die, after a number of divisions, 
(between approximately 10 and 40) (Mortimer and Johnston, 1959). 
Screens in yeast for proteins which affected lifespan yielded the SIR proteins (reviewed in 
(Kennedy et al., 1997) – HDACs important for gene silencing in yeast.  Sir mutants can 
increase lifespan as well as reduce it – for example, in the SIR4-42 mutant, two Sir proteins 
relocate from the telomeres to the nucleolus and lifespan is extended (Kennedy et al., 1997).  
Deacetylation of H4K16ac has subsequently been shown to be important for telomeric 
silencing (Kimura et al., 2002), and H4K16ac is also important in regulation of cellular 
lifespan in yeast. 
The profile of histone modification post translational modifications changes upon aging in 
yeast, as it does upon cellular differentiation in mammals.  For example, H3K56ac is 
increased in younger cells which have produced few daughter cells, whereas in older yeast, 
H4K16ac is increased as the level of the HDAC Sir2 is decreased.  In these older cells, as 
would be expected from the role of histone deacetylation on silencing of telomeres, the 
increased H4K16ac is associated with a reduction of silencing on the telomeres.  Lifespan of 
yeast can be extended somewhat by either deletion of the HAT responsible for H4K16ac, or 
overexpression of Sir2 (Dang et al., 2009). 
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In mammals, the effect of H4K16ac on ageing is less well studied, and whilst the life 
elongating effect of Sir2 expression is replicable in both C. elegans and Drosophila, similar 
pathways have not yet been found in humans (reviewed in (Longo and Kennedy, 2006)).  
Telomeres in mammals are, like in flies and yeast, heterochromatic, and are hypoacetylated 
on H4 (Benetti et al., 2007). 
A role for H4K16ac in mammalian ageing has, however, been found, although the 
mechanism is rather different, and is associated with Lamin A and the role of H4K16ac in 
DNA damage.  Lamin A is a nuclear membrane protein associated with premature ageing 
disorders when truncated (Eriksson et al., 2003).  In mice which cannot produce mature 
Lamin A and which show a premature ageing phenotype, there is a reduction in global 
H4K16ac.  There is an interaction between mature Lamin A and MOF, which is not 
replicated with prelamin A (the immature version of the protein).  Lack of this interaction 
leads to a reduction in MOF presence at the nuclear envelope, and a poor response to DNA 
damage which can be rescued by treatment with HDAC inhibitors or MOF overexpression 
(Krishnan et al., 2011). 
1.6 Long Range Control 
1.6.1 Enhancers in development 
 
Although some genes are controlled with only the core promoter, for many genes, regulation 
of expression is achieved through the action of cis-regulatory elements.  The first enhancers 
were discovered in 1981; sequences from the SV40 virus that are capable of upregulating 
expression of a transgene up to 200 fold, even when positioned ~3000bp downstream of the 
transcription start site (Banerji et al., 1981).  Other cis-acting regulatory regions have been 
shown to have a silencing effect, for example sequences 5’ of murine Igβ repress its 
transcription (Malone et al., 1997).  Cis-regulatory regions have been located as much as 1 or 
1.5Mb away from the transcription initiation site (Lettice et al., 2002; Benko et al., 2009). 
Cis-regulatory regions are also potentially interesting since 88% of trait associated SNPs fall 
within non-coding regions (Hindorff et al., 2009), and mutations of cis-regulatory regions 
have been shown to explain disease phenotypes.   
For example, an insufficient doseage of Pax6 has been associated with aniridia (where 
patients lack an iris) for some time(Axton et al., 1997).  However, patient studies revealed 
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that there were some cases of aniridia which showed no mutation in the coding region of 
PAX6, even though the phenotype was the same as those which did (Fantes et al., 1995).  
This implied that another region was exerting control over the eventual dosage of Pax6.   
The functional region of PAX6 includes a regulatory region >150kb downstream of the 
PAX6 promoter, known as the Downstream Regulatory Region (DRR).  Selected conserved 
regions of the DRR are capable of driving tissue specific expression of a reporter gene in 
mice (Kleinjan et al., 2001). 
The DRR is located within the final intron of the ELP4 (a.k.a PAXNEB) gene (Fig 1.13), 
which is a universally expressed HAT which functions to enhance transcriptional elongation 
(Kleinjan et al., 2001).  However, it was subsequently shown that mutations in ELP4 do not 
lead to aniridia, but the phenotypes of chromosome breakages in the DRR are due to 
disruption of PAX6 regulation(Kleinjan et al., 2002).   
Another example is that of the Sonic Hedgehog (Shh) regulatory region.  Sonic hedgehog is 
a morphogen with a vast array of functions in a variety of systems including neuronal 
development (reviewed in (Jessell, 2000)), muscle determination (Borycki et al., 1999), and 
limb development (reviewed in (Anderson et al., 2012)). 
In a healthy mouse limb bud, Shh is expressed in the posterior (the Zone of Polarising 
Activity, or ZPA) limb mesenchyme to form a gradient of Shh to the anterior side.  When 
grafted to the anterior of the limb, the ZPA induces formation of a mirror image digit 
duplication.  This is due to the effect of the Shh gradient.  Ectopic expression of Shh in the 
anterior limb buds also results in mirror image digit duplications (Riddle et al., 1993). 
Mutations in intron 5 of the Lmbr1 gene (which is some 1Mb away from the Shh 
transcription start site) lead to a phenotype of extra digits - preaxial polydactyly (PPD), due 
to the region’s regulatory effect on Shh (Lettice et al., 2002).  Genetic analysis in mice has 
shown that mutations in intron 5 of Lmbr1 lead to ectopic expression of Shh in the anterior of 
the limb bud (Lettice et al., 2003), and deletion of the conserved regulatory sequence 
abrogates expression of Shh (Sagai et al., 2005).  The region was titled the ZRS, or ZPA 
Regulatory Sequence.  
Point mutations in the ZRS can cause PPD and other limb defects in mice (as in the 
Sassquatch mutant and humans (Lettice et al., 2003; Furniss et al., 2008), cats (Lettice et al., 




Figure 1.13 Human and mouse PAX6 locus and regulatory regions 
SGL and SIMO indicate aniridia associated chromosomal breakpoints.  Eye specific regulatory elements (which can drive specific 
expression in reporter assays) are indicated for surface ectoderm (se), neural retina (nr), lens (l), and a retina (r) enhancer which drives 
expression in neural retina and retinal pigment epithelium.  Box123 indicates a regulatory region for neural retina.  DRR denotes the PAX6 







Figure 1.14 ZRS region and functional consequences of mutations 
A:  Schematic representing location of the Lmbr1 locus with 1.7kb limb specific Shh 
regulatory region (red box).  Shh loss of function in mice phenotypically resembles 
human acheiropodia; mutations for this disease map close to the ZRS. 
B:  Phenotypes of ZRS mutations.  Mutations that lead to PPD have their effect 
through ectopic expression of Shh.  Other mutations, such as deletion of an 800bp 
region within the ZRS (known as the Mouse Fish Conserved Sequence 1, or 
MFCS1), and human acheiropodia deletions lead to loss of Shh, resulting in a 




The Hox loci are an interesting example in which long range regulatory regions control 
changes in function by generating a variety of expression profiles in different embryonic 
structures.  During development of vertebrate organisms, the Hox genes are activated 
according to ‘temporal colinarity’, i.e. temporally according to their relative positions along 
the genome.  This pattern of expression leads to different combinations of Hox genes 
instructing different cell fates for groups of cells along the axis (reviewed in (Kmita and 
Duboule, 2003)). 
The core anterior posterior body patterning functions of the Hox loci seem to be regulated 
from within the clusters themselves; expression of the Hoxd cluster from a PAC clone is 
capable of re-capitulating its colinar expression pattern as it is found in wild type embryos 
(Spitz et al., 2001). 
However, in vertebrate evolution, organisms have taken advantage of the duplications of 
Hox genes which have occurred, by putting the genes to use in other contexts at different 
locations and times during development.  For example, expression of the Hoxd genes 
(particularly Hoxd13) is required for correct limb formation in mice (Davis and Capecchi, 
1996). Hoxd expression occurs in two waves, the first for limb growth and patterning, and 
the second at embryonic day 10.5 for formation of the digits (Spitz et al., 2003).  Expression 
of the Hoxd genes in the limbs is not reproduced by its introduction by PAC clone (Spitz et 
al., 2001), implying that they are under control of a regulatory region which is not found 
within the Hox clusters proper. 
An example of such a regulatory region is the GCR, or Global Control Region which was 
discovered to be located upstream of the Hoxd locus.  The GCR can drive expression of a 
transgene in the developing mouse limb in a pattern which recapitulates that of the Hoxd 
genes.  The GCR is the region mutated in the mouse Ulnaless mutant, which has reductions 
in the size of the proximal limb due to deregulation of the posterior Hoxd genes (Peichel et 
al., 1997; Spitz et al., 2003).  
Interestingly, expression of Hoxd13 in cells derived from the posterior of the distal limb is 
accompanied by decompaction of the chromatin, compared to cells derived from the anterior 
of the distal limb, where Hoxd13 is not expressed.  Additionally, there is colocalisation 
between the GCR and the 5’ end of the Hoxd locus which occurs only in the posterior 
derived cells.  This indicates that chromatin organisation may be extremely important for the 
action of this enhancer on transcription of the Hoxd genes (Williamson et al., 2012).  
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There are several enhancer regions which act on the Hoxd genes (Fig 1.15).  For example, 
Hoxd10 and 11, in wild type embryos, are acted on by the same enhancers, and are found in 
the same expression pattern both in the distal and proximal parts of the developing limb.  
Splitting the genes by inverting a section of the loci from between Hoxd10 and Hox11 to 
between Itga6 and Itga6r removes each of the genes from the influence of one of these 
enhancers, and therefore splits their expression pattern so that Hoxd11 is expressed only in 
the distal portion of the limb, whilst Hoxd10 is found in the proximal portion (Spitz et al., 
2005).  The GCR is not the only enhancer region responsible for the effects of Hoxd genes in 
digits as subsequent studies determined that the ‘Prox’ enhancer (located between Lnp and 
Evx2) also has activity in digit formation.  Additionally, a further five regulatory regions 
located in the gene desert upstream of Lnp and the GRC, and were shown to have a positive 
effect on Hox gene transcription.  Deletion of these elements leads to malformation of the 






Figure 1.15 Several enhancers act on the Hoxd genes leading to different 
expression patterns 
β-gal staining for Hoxd10 in mouse embryo.  Cis-acting sequences are represented 
by ovals which control expression of genes highlighted in the same colour.  Domain 
of expression induced by these genes is indicated.  GCR = global control region.  
From (Spitz et al., 2005).
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1.6.2 Chromatin State and Long Range Control 
 
Chromatin state is very important for enhancer action.  Classically, DNaseI Hypersensitive 
Sites (DHSs) have been used to analyse the location of regulatory elements in the genome 
(reviewed in (Gross and Garrard, 1988)).  DHSs are likely to be nucleosome free regions, 
and are sensitive to nuclease cleavage (Elgin, 1981; McGhee et al., 1981) possibly due to 
binding of a transcription factor or factors (Felsenfeld et al., 1996).  DNAse I footprinting 
has shown that 75% of DHSs contain a bound protein (Neph et al., 2012).    
A genome wide study noted that approximately 80% of DHSs fell within a regulatory region 
or regions (Crawford et al., 2006), and 95% of DHSs are located outside coding regions, 
making them important for identification of regulatory elements genome wide (Thurman et 
al., 2012).    
Reflecting the importance of cis-regulatory regions in control of cell fate and development, 
many DHSs are cell type or tissue specific, meaning that the chromatin accessibility of 
enhancers differs depending on whether they are active or not (Thurman et al., 2012). 
Histone modifications are another method of predicting the location of regulatory regions 
which has recently come to the fore. An early genome wide ChIP experiment noted the 
association of H3 acetylation with regulatory regions (Roh et al., 2005), and that this was 
capable of predicting the presence regulatory elements, even those which are not conserved 
by sequence (Roh et al., 2007).  The H3 acetyltransferase p300 is also known to bind at 
enhancers, as well as promoters (Heintzman et al., 2007), and other HATs have been shown 
to mark enhancers which are not p300 bound (Krebs et al., 2011).  Recently H3K9ac and 
H3K14ac were shown to mark regulatory regions in ES cells (Karmodiya et al., 2012).   
ChIP-chip experiments highlighted for the first time the potential for histone methylations as 
a predictor for chromatin function.  Looking at 30Mb of the human genome in HeLa cells, 
H3K4 methylation state can distinguish promoters from enhancers, which are marked by 
H3K4 trimethylation, and H3K4 monomethylation respectively.  The methylation state was 
shown to be capable of predicting the location of novel enhancers (Heintzman et al., 2007).  
This was followed by a genome wide profile of 20 histone methylations (of lysine and 
arginine) in CD4+T cells, which showed that amongst enhancer elements identified by DHSs, 
H3K4me1, me2 and me3 were all elevated, with H3K4me2/3 showing more defined peaks, 
and H3K4me1 marking the regions more broadly (Barski et al., 2007).  Further genome wide 
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studies provided evidence that H3K4me1 is a signature of enhancers (Birney et al., 2007; 
Koch et al., 2007), and reviewed in (Bulger and Groudine, 2011)), whilst H3K4me3 is a 
signature of promoters (Fig 1.16A).  H3K4me1 is now commonly used as a marker of both 
active and inactive enhancers, but since many histone modifications remain to be tested, a 
single histone modification ‘profile’ for enhancers has not yet been defined. 
As noted by Roh and colleagues, H3 acetylation can be useful in predicting enhancer sites.  
A more specific genome wide profile of 18 individual acetylation marks showed that 
H3K18ac was associated with the most enhancers (defined by DNAseI hypersensitivity), 
associating with about 20% of the enhancer set used in the paper.  H3K27ac was the next 
highest of the H3 acetylations, associating with around 15% (Wang et al., 2008). 
The enhancer regions responsible for the expression profile of Hoxd are present in all cell 
types, but are clearly active in very specific locations and times during development to 
restrict ectopic expression which can cause deformities.  How the enhancers are controlled 
so specifically is not fully understood, but it has been established that the histone 
modification profiles of enhancers are very variable, depending on the cell type. Whilst 
H3K4me3, H3K4me1, and H3K27ac remained relatively stable at the promoters of the five 
different cell types, the profiles on the enhancers were significantly different.  For example, a 
HeLa specific enhancer close to a gene generally meant the gene would have higher 
expression in HeLa cells than other cell types (Heintzman et al., 2009). 
A broader study which looked at 19 different cell types in mouse (including both tissue 
sections and cell lines) also showed that these histone modifications on enhancers were very 
cell type specific (Shen et al., 2012).  This difference in enhancer histone modification 
profiles has also been shown in differentiating cell types, implying its importance for in vivo 
developmental control.  Although the H3K4me1 profile does differ between cell types 
(Heintzman et al., 2009), it was shown that some enhancers marked by H3K4me1 were not 
active.  It was therefore proposed that H3K4me1 may mark enhancers which have the 
potential to become activated later, making it of particular interest in developmental systems.  
Notably, H3K4me1 is lost on the enhancers of pluripotency genes upon differentiation.  This 
is dependent on LSD1, without which differentiation does not proceed normally (Whyte et 
al., 2012).  Genes close to distal enhancers which are marked by H3K27ac and H3K4me1 
have higher expression level on average than genes close to enhancers marked only by 
H3K4me1, and GO term annotations showed that cell type specific genes have H3K27ac and 
H3K4me1 marks on the closest enhancer in the correct cell type (i.e. neural specific genes 
have enhancers marked by both histone modifications in neural cells, but not ES cells) 
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(Creyghton et al., 2010).  ‘Poised’ enhancers in human embryonic stem cells were also 
determined to show not only a lack of H3K27ac, but instead, trimethylation of that residue 
(Rada-Iglesias et al., 2011).  Upon differentiation along a neuronal pathway, H3K27me3 was 
lost, and H3K27ac was gained.  Later, three classes of enhancer were defined in mouse ES 
cells; poised enhancers which contained H3K27me3 and H3K4me1, ‘intermediate’ 
enhancers, which contained H3K4me1 but were not covalently modified on H3K27, and 
active enhancers, with both H3K4me1 and H3K27ac (Zentner et al., 2011) (Fig 1.16B).  
Poised enhancers could also be distinguished from the intermediate set by presence of 
H3K9me3.  Though earlier studies showed that H3K4me3 was present on regulatory regions 
(Barski et al., 2007), Zentner and colleagues noted a general depletion of H3K4me3 on 
enhancers. 
Histone modifications are certainly associated with enhancers in a tissue specific manner.  It 
remains to be determined exactly which histone modifications are associated, and potentially 
more ‘classes’ of enhancers will be defined as further ChIP-seq datasets become available. 
Acetylation in particular may be generally associated with enhancers, though H3K27ac has 
been studied in more detail in this context than other acetyl PTMs.  Significantly more work 
is needed to define the function of histone modifications on enhancers, but it has been 
suggested that they may contribute to a receptive chromatin environment.  That is, the 
histone modifications keep enhancers poised to maintain their “activation potential” for 
binding of transcription factors and gene induction upon differentiation/stimulation (Ong and 




Figure 1.16 Histone modifications at enhancers and promoters 
A:  Red circles indicate methyl groups on H3K4.  Monomethylation is found around enhancers, whilst trimethylation is found around the 
TSS. 
B:  An example of the subset of enhancers marked by both H3K4me1 and H3K27me3.  These enhancers are referred to as “poised”.  




1.7 ChIP and ChIP-sequencing technology 
1.7.1 Chromatin Immunoprepitation  
 
Proteins and DNA interact in ways which have functional consequences for processes like 
transcription, DNA repair and replication and so on.  Studying these interactions has been 
significantly helped by development of the Chromatin Immunoprecipitation (ChIP) 
technique.  ChIP can be used to analyse the localities of transcription factors and other 
proteins that interact with DNA, but also to isolate the DNA which is wound around 
nucleosomes with particular PTMs.  The principle of ChIP is to use antibodies against the 
protein or histone modification of interest to isolate both the protein and its bound DNA 
sequences.  The DNA can then be purified and analysed for enrichment of sequences of 
interest, using conventional or quantitative PCR, microarrays, or most recently, deep 
sequencing.  There are two methods for ChIP, both of which have their advantages and 
disadvantages (Turner, 2001).  More commonly, proteins are bound to the DNA by UV or 
formaldehyde cross linking prior to shearing of the chromatin by sonication (X-ChIP) 
(Gilmour and Lis, 1985; Solomon et al., 1988).  The protein-DNA complexes are then 
isolated using antibodies bound to protein beads.  This technique works well and is necessary 
for analysis of transcription factors and other DNA binding proteins which often have 
transient interactions with their target sequences.  However, X-ChIP can be inefficient, 
especially when working with histone modifications, as formaldehyde cross linking 
frequently involves lysine groups, which can cause problems with antibody specificity to 
lysine containing epitopes.  This is of particular relevance to this study, concerned with 
lysine acetylation, but also many other histone modifications of interest.  In the second 
method of ChIP, native chromatin is used (N-ChIP), omitting the cross linking step (Hebbes 
et al., 1988).  For transcription factors this is impractical, as their transient interactions would 
not survive for the length of the protocol, but for histone modifications, which by their nature 
are more stably associated with DNA, it is a more useable method (O’Neill and Turner, 
2003).   
Another advantage of using native chromatin is the fact that there is no epitope loss due to 
formaldehyde cross linking, which may be the reason that N-ChIP is more efficient in 
pulling down DNA than X-ChIP.  Downstream, this means that analysis can take place on 
unamplified DNA.  Amplification is often a necessary process for X-ChIP, but can introduce 
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biases, or an increase in background from amplification of non-specific DNA.  N-ChIP has 
some disadvantages, for example nuclease digestion is not without bias, but these can be 
overcome by using input digested chromatin as a control; this DNA is not enriched for any 
modification, but is subject to the same digestion bias. 
After isolation by ChIP, the DNA is analysed, typically an initial test would involve qPCR 
on control regions to ensure specificity.  This would then be followed by analysis of a 
broader region of interest using mircoarrays, or an unbiased genome wide analysis using 
deep sequencing. 
1.7.2 Analysing DNA isolated by ChIP 
 
Analysing ChIP DNA using microarrays (ChIP on chip) has advantages over simple qPCR 
analysis, principally the fact that a much broader region of interest (even up the entire 
genome) can be analysed (reviewed in (Buck and Lieb, 2004)).  By hybridizing the DNA to 
input, positive biases from nuclease digestion are minimised, and the assay is swift and 
relatively inexpensive over loci that can be covered on one array, allowing multiple 
experiments and biological replicates, which may be impossible presently using genome 
wide sequencing. 
Although ChIP on chip can be useful for studying particular loci of interest, the requirement 
for large amounts of DNA (≥ 100ng per hybridization), and the expense and impracticality of 
using arrays for genome wide analysis means that in recent years, deep sequencing has come 
to the fore as a method to map the genome wide location of DNA binding proteins and 
histone modifications (Park, 2009).  A variety of technologies for deep sequencing have 
become available, including 454 sequencing (Roche) and sequencing by synthesis 
(Illumina), which is used in this study.  
After DNA isolation by ChIP, there are three major steps involved in Illumina’s sequencing 
by synthesis technology 
(http://www.illumina.com/technology/sequencing_technology.ilmn).  The first step in the 
analysis is the preparation of the libraries.  The sheared DNA is size selected, repaired, and 
adenylated.  Adapter sequences are then attached to both ends of the fragment.  These 
adapter sequences match those which are covalently bonded to the flow cell used for 
sequencing.  The second step is cluster generation, which means generating many copies of 
each piece of DNA to be sequenced.  The adaptor sequence bound DNA hybridises to the 
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‘lawn’ of matching oligos on the flow cell and is copied.  The copy is therefore covalently 
bonded to the flow cell.  Each of the potentially hundreds of millions of sequences is copied 
by extension and bridge amplification.  The reverse strands are then cleaved and washed 
away, and end blockers and sequencing primers are added, resulting in a large number of 
clusters, ready to be sequenced.  
All the clusters are sequenced simultaneously, base by base.  Fluorescent (one colour for 
each base), reversibly terminated nucleotides are added, and are free to compete for binding 
to the DNA templates during the synthesis reaction.  After each round of synthesis, a laser 
excites the clusters, and an image is taken of the colour pattern on the flow cell, which 
corresponds to the nucleotide which successfully bonded to the template DNA.  Then the 
blocking group is removed, and the next round of synthesis takes place so that the next base 
in the template sequences can be detected. 
After synthesis is complete, the images are analysed and converted into sequences, which 
can then be mapped to the genome assembly of the organism from which they came.  The 
data are then used in downstream analyses, such as peak calling, or visualisation of the 
modification/DNA binding protein enrichment over a particular locus of interest. 
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1.8 PhD Aims 
 
Research on H4K16ac has largely focused on the association of the mark with transcriptional 
activation and euchromatin in vivo, whilst studies into its effect on chromatin compaction 
have been restricted to in vitro work.  As H4K16ac clearly has an important role in 
mammalian development, it is possible that it may be linked to changes in chromatin 
compaction associated with differentiation. 
Additionally, studies of the interaction partners of MOF have revealed that in mammals, as 
well as flies, it is part of two complexes which are functionally different.  However, these 
studies have all taken place using overexpression of tagged proteins in human cancer cell 
lines, rather than endogenous protein. 
The aim of this thesis is to: 
• Use differentiation of ES cells along the neuronal pathway as a model, and to 
determine how global H4K16ac profile changes upon differentiation in conjunction 
with expression.   
• To look for large scale changes in H4K16ac upon differentiation and determine 
whether these can be used to predict changes in chromatin compaction state. 
• To use antibodies against endogenous MOF in ES and somatic cells to determine 





Chapter 2:  Materials and Methods  
2.1 Stock solutions, reagents, and buffers 
Water used in solutions is deionised, and solutions were stored at room temperature unless 
otherwise stated. 
Acetate Buffer:  3M Potassium Acetate, 11.5% glacial acetic acid (v/v). 
Antibiotic Stock Solutions:   
Chloramphenicol, 25µg/µl (w/v in ethanol), stored at -20ºC.   
Ampicillin, 100mg/mL (w/v in water), aliquoted and stored at -20ºC. 
Kanomycin  35 mg/mL (w/v in water), aliquoted and stored at -20ºC 
Puromycin 10mg/mL (w/v in 20mM HEPES buffer), stored at -20ºC (purchased prepared 
and sterile filtered from Invitrogen, cat#A11138) 
Zeocin/G418 50mg/mL (w/v in water), stored at 4ºC (purchased prepared and sterile filtered 
from Sigma, cat# G8168) 
 
ChIP Blocking Solution: 1 x PBS, 0.5% BSA (w/v), premade and stored at -20ºC. 
ChIP Elution Solution:  0.1M NaHCO3, 1% SDS, made fresh before each use.  For X-
ChIP, elution solution was passed through a 0.2 micron filter prior to use. 
N-ChIP Wash Buffers:  Wash 1, 150mM NaCl, 10mM TrisHCl pH8, 2mM EDTA, 0.05% 
Triton X-100 (v/v); Wash 2,  10mM TrisHCl pH 8, 1mM EDTA, 150mM LiCl, 0.1% sodium 
deoxycholate (w/v).  Washes were made in the absence of detergents at 10 x concentration 
and stored at room temperature.  Protease Inhibitor Cocktail (Calbiochem, cat #539131), 
5mM sodium butyrate, 0.2mM PMSF, 1mM DTT, and 5µM Sirtinol were added to both 1 x 
washes immediately prior to use. 
Colloidal Coomassie Stain:  Colloidal Blue Staining Kit was purchased from Life 
Technologies (cat #LC6025) and used as specified by manufacturer instructions.  Destain 
was performed with water. 
Coomassie Destain:  30% methanol (v/v), 10% glacial acetic acid (v/v). 
Coomassie Stain:  0.25% Coomassie brilliant blue R-250 (w/v) dissolved in 45% methanol 
(v/v), with the addition of 10% glacial acetic acid. 
DNA Loading Buffer:  50% glycerol, 5mM EDTA pH8, 0.3% Orange G (v/v).   
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Farnham Lysis Buffer:  5mM PIPES pH8, 85mM KCl, 0.5% NP-40 (v/v), Protease 
Inhibitor Cocktail was added immediately prior to use.  Buffer was made fresh each use, and 
passed through a 0.2 micron filter. 
FISH Hybridisation Mix:  50% deionised formamide (v/v), 10% dextran sulphate (v/v), 1% 
Tween 20 (v/v), prepared in 2x SSC. 
Fixation Solution (2D FISH):  75% methanol (v/v), 25% glacial acetic acid (v/v), prepared 
fresh before each use. 
Glutathione Elution Buffer:  50mM Tris-HCl pH8, 10mM reduced glutathione. 
GTE Buffer:  50mM glucose, 25mM Tris-HCl pH8, 10mM EDTA, stored at 4ºC.   
Approximately 10mg lysozyme/mL was added prior to use.  
Hypotonic Buffer (2D FISH):  33mM KCl, 17mM tri-sodium citrate. 
Luria agar*:  Per litre: 10g tryptone, 5g yeast extract, 10g NaCl, 15g agar. 
Luria-Bertani (LB) Broth*:  Per litre: 10g tryptone, 5g yeast extract, 10g NaCl, 1g glucose.   
Lysis Buffer (alkaline lysis mini-prep):  0.2M NaOH, 1% SDS (v/v), made fresh prior to 
each use. 
Micrococcal Nuclease (MNase):  Definition of one unit of MNase differs between 
suppliers.  Boehringer Mannheim (Roche) Units are used throughout this work.  MNase was 
purchased from Sigma (500 Sigma Units/vial, cat #N3755-500UN), and resuspended in 
MNase Nuclease Buffer to 50 Roche units/µl. 
MNase Buffer:  50% glycerol, 10mM Tris pH7.6, 50mM NaCl. 
MNase Stop Buffer:  215mM NaCl, 10mM TrisHCl pH8, 20mM EDTA, 5.5% sucrose (v/v) 
0.2mM PMSF, 0.2% Triton X-100. 
Nick Translation Salts:  Made as a 10x solution, which was aliquoted and stored at -20ºC.  
0.5M Tris pH7.5, 0.1M MgSO4, 1mM DTT, 0.5mg/mL BSA fraction V (Sigma). 
NP-40 Lysis Buffer:  50mM TrisHCl pH8, 150mM KCl, 1.5mM MgCl2 0.1M DTT, 0.2mM 
EDTA.  Aliquoted at stored at -20ºC.  Protease inhibitor cocktail (Calbiochem) was added 
immediately prior to use. 
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Nuclear Buffer A (NBA):  85mM NaCl, 5.5% sucrose, 10mM TrisHCl pH7.5, 0.2mM 
EDTA. 0.2mM PMSF, 5mM sodium butyrate, 5µM Sirtinol and 1mM DTT added fresh 
prior to use. 
Nuclear Buffer B (NBB):  85mM NaCl, 5.5% sucrose, 10mM TrisHCl pH7.5, 0.2mM 
EDTA, 0.2mM PMSF, 5mM sodium butyrate, 5µM Sirtinol, 1mM DTT and 0.1% NP-40 
added fresh prior to use. 
Nuclear Buffer R (NBR):  85mM NaCl, 5.5% sucrose, 10mM TrisHCl pH7.5, 3mM 
MgCl2, 1.5mM CaCl2, 0.2mM PMSF, 5mM sodium butyrate, 5µM Sirtinol and 1mM DTT 
added fresh prior to use. 
Phosphate Buffered Saline (PBS)*:  160mM NaCl,3mM KCl, 8mM Na2HPO4, 1mM 
KH2PO4 from tablets (Oxoid, ThermoScientific, cat# BR0014).  PBS was made by technical 
services at MRC HGU, except for PBS used in embryonic stem cell culture. 
Proteinase K:  20mg/mL (w/v) in 50mM Tris (pH8), 1.5mM calcium acetate, 50% glycerol 
(v/v).  After preparation, proteinase K was aliquoted and stored at -20ºC. 
RIPA Buffer:  1% NP-40 (v/v), 0.5% sodium deoxycholate (v/v), 0.1% SDS in 1x PBS.  
Protease Inhibitor Cocktail added immediately prior to use.  Buffer made fresh each use, and 
passed through a 0.2 micron filter.  For use in SILAC IP Benzonase (20U/mL, Novagen) and 
DNAseI (200U/mL, Invitrogen) were added prior to use. 
Saline Sodium Citrate Buffer (SSC)*:  Per litre for 20x solution: NaCl 175.3g, 
Na3C6H5O7 88.2g. 
SDS Loading Buffer:  50mM TrisHCl pH 6.8, 2% SDS (w/v), 10% glycerol (v/v), 1% β-
mercaptoethanol, 12.5mM EDTA, 0.02% bromophenol blue (w/v).  Made as 5x stock, 
aliquoted and stored long term at -20ºC, and short term at 4ºC. 
Sodium Dodecyl Sulphate*:  Prepared as 20% stock (w/v). 
Sonication Buffer (SB):  2mM NaCl, 5M Urea. 
Swelling Buffer (SILAC IP):  10mM Hepes pH9.0, 1.5mM MgCl2, 0.5mM DTT.  Buffer 
prepared fresh for each experiment, with addition of protease inhibitor cocktail immediately 
prior to use. 
                                                     
* Prepared by Technical Services at MRC HGU 
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Tris-Acetate EDTA (TAE) Buffer*:  40mM Tris base, 20mM acetic acid, 1mM EDTA.  
Prepared as 50x stock. 
TE Buffer*:  10mM Tris-HCl pH 7.6, 1mM EDTA. 
Tris Buffered Saline (TBS):  50mM Tris-HCl pH 7.4, 150mM NaCl.  Made as 10x stock. 
Tris-Glycine SDS-Page Running Buffer: 25mM Tris base, 250mM glycine pH 8.3, 0.1% 
SDS (w/v).  Prepared as 10x stock.   
Trypsin:  Trypsin-EDTA solution at 10x concentration (0.5% Trypsin, 0.2% EDTA) was 
purchased from Sigma (cat #59418C), aliquoted and stored long term at -20ºC, and short 
term at 1x concentration at 4ºC. 
Western Transfer Buffer:  25mM Tris base, 200mM glycine, 20% methanol (v/v), 0.02% 
SDS (v/v).  Made fresh prior to use. 
X-ChIP Lithium Chloride Wash Buffer:  100mM Tris pH 7.5, 250mM LiCl, 1% NP-40 
(v/v), 1% sodium deoxycholate (v/v).  Made fresh each use, and passed through a 0.2 micron 
filter.  
X-ChIP PBS/BSA:  5mg/mL BSA (fraction V), prepared in 1x PBS fresh for each use, and 
passed through a 0.2 micron filter. 
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Table 2.1  Primers used. 
 
 Primer Set Name Forward Sequence Reverse Sequence 
ChIP qPCR ActinPromoter CCTCGATGCTGACCCTCATCC GACACTGCCCCATTCAATGTCTC 
 Olig2Promoter GCCTGACGCTACAGTGACAA GGCTAATTCCGCTCAATGAA 
 Hoxb1Promoter TTAGCCCATTGGCCTGGGAGAGAT TGAAGCTTGAGCTTGAGCCCATGGCCCG 
 Hoxb13Promoter ATGAGCCTCTCTCCCCCAGG AATCGCTCCCAGCTCGAACGG 
 Hoxd1Promoter GAGTAACTTGACCTTCTCAGAG ATTGCGGGAGAAAGGCAGGGAAG 
 Pou5f1Promoter GCTGGCGGAAAGACACTAAG CAGAGCATGGTGTAGGAGCA 
    
Reverse Transcription 
PCR MofExpression ACAACTTCAGGAACTGTAGG TCGCCTGTTAAAGCCC 
 Hoxb2Expression AGGGAGCCAAAAGCAAGCC CGCCGATTCTGGCAATCC 
 Olig2Expression AGAGCCAGGTTCTCCTCCGC ACTAGACACCAGGCTGGCGTC 
 Spry4Expression GCAGCTCCTCAAAGACC TGGAGCCGGCTGTGGG 
 Lrrc2Expression AGCGCCCTGGAGAAGATA AGGCAGCTCCTTCCAC 
 Cyp26b ATTGGCGACATCCACCG GCACGGCCATTCGGAAGGT 
 Hoxd1 CCACAGCACTTTCGAGTGGA ACTCTTTCTCTAGCTCTGTCAG 
 Pou5f1 CGAGAACAATGAGAACCTTC CCTTCTCTAGCCCAAGCTGAT 
 GAPDH TGGTGAAGGTCGGTGTGAACG TGAGTGGAGTCATACTGG 
 Hoxb1Expression ACCTCCTCTCTGAGGACAAGG AGTCCCAGCTCGGACACCTTC 
 Hoxb13Expression CATTCTGGAAAGCAGCGTTTGCAG GATAACTTGTTGGCTGCATACTCC 
    
Cloning MOFFlag AGTTAATTAATGGACTACAAGGACGACGATGACAAGGCGGCACAGGGAGCTACAGC AAGCTAGCTCACTTCTTGGAAAGCTTGACTTG 
 MOFChromo CACCGGATCCTGGCATTCAGCAG GTTGCGGCCGCTCACTTCTGCAC 
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 MOFBam1Not1Sites GTAGCGGCCGCTCACTTCTTGGAAAGCTT ACGCGGATCCATGGACTACAAGGACGACGATG  
    
Sequencing MofM AGAACCTGTGTCTACTGGC AGTAGACACAGGTTCTGAC 
 SP6 ATTTAGGTGACACTATAG n/a 
 T7 TAATACGACTCACTATAGGG n/a 
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Table 2.2:  Fosmid Probes 
 
Region name Ensembl name start  end 
Alpha globin I19r WI1-2837A17 G135P60495H4 32056569 32100774 
 Hbq1 WI1-2903N21 G135P603718B2 32196269 32241313 
Sox2 Sox2Up WI1-1766B8 G135P601568H9 34503694 34543065 
 Sox2Down WI1-1185J11 G135P603742D7 34686049 34722693 
Nanog NanogUp WI1-2049I9  G135P604583D8 122574082 122610708 
 NanogDown WI1-196C18  G135P62993G4 122916571 122959014  
Names are ensembl (r45) (http://jun2007.archive.ensembl.org/Mus_musculus/index.html).  Alpha globin fosmids were previously used in (Eskeland et al. 
2010). 
 
Table 2.3:  Plasmids used 
Plasmid Source Antibiotic Resistance Use Reference 
pTLC gift from Josh Brickman lab Ampicillin FLAG-MOF overexpression Eskeland et al, 2010 
pGAGASIZXN (pCAGxn) pCAGASIZ plasmid with deletion of Alkaline Phosphotase (N.  Gilbert) Ampicillin FLAG-MOF overexpression 
pGEX6P1 GE Healthcare, cat#28-9546-48 Ampicillin MOF Chromodomain bacterial expression 
pEGFP-N1 Clontech, cat#6085-1, gift from Ian Adams lab Kanomycin Positive control for GFP in FACS sorts 





Centrifugation steps were performed at room temperature unless otherwise stated. 
2.2.1 Cell Culture 
All mammalian cells were cultured in 5% CO2 at 37ºC unless otherwise stated. 
ES cells: 
Low passage cells (<40) were used throughout.    
Embryonic Stem cell (ES cell) strains used were OS25 (Billon et al. 2002) and E14 (Hooper 
et al. 1987).  OS25 ES cells are derived from E14 cells and contain the hygromycin 
thymidine kinase gene targeted to the Pou5f1 locus.  Undifferentiated cells were selected for 
by inclusion of Hygromycin in media.  
OS25s were cultured in Glasgow Minimal Essential Medium (GMEM) (Gibco) 
supplemented with 10% (v/v) foetal calf serum (FCS), 0.1mM β-mercaptoethanol, penicillin 
(10,000 units/mL) and streptomycin (650µg/mL), 0.3mg/mL L-Glutamine, 1mM sodium 
pyruvate, and non-essential amino acids (Sigma).  For undifferentiated cells, 1000 units/mL 
human recombinant LIF and 0.1mg/mL hygromycin (Roche) was added to the media. 
E14s were cultured in GMEM as above, but supplemented with 15% (v/v) FCS, and grown 
without hygromycin. 
ES cells were cultured on either 0.1% gelatin coated tissue culture flasks (Corning) or 
without gelatin on hydrophilic culture flasks (Cell+ culture flask, Sarstedt).  Media was 
replaced every 24 hours, and cells were passaged every 72 hours and seeded at a density of 
0.1x106 cells/mL.   
For differentiation using retinoic acid (RA), undifferentiated ES cells were passaged and 
seeded at a density of 0.2x106 cells/mL into GMEM supplemented with 10% (v/v) FCS, 
0.1mM β-mercaptoethanol, penicillin (10,000 units/mL) and streptomycin (650µg/mL), 
0.3mg/mL L-Glutamine, 1mM sodium pyruvate, and non-essential amino acids (Sigma).  
After 24 hours, RA was added to a concentration of 5x10-6M. 48 hours after seeding, cells 
were checked for morphological changes (an elongated shape, and a lack of rounded 
colonies), and fresh media containing RA was added.  Cells were used in experiments 72 




Human HEK 293T (293T) cells were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM), supplemented with 10% FCS, penicillin (10,000 units/mL) and streptomycin 
(650µg/mL).  Media was replaced every 2-3 days, and cells were passaged shortly prior to 
100% confluence. 
Mouse limb mesenchymal 14fp cells were kindly supplied by Iain Williamson and Bob Hill 
(Williamson et al., 2012). 14fp cells were cultured at 33ºC (permissive temperature for 
temperature sensitive T-antigen) in DMEM supplemented with 10% FCS, 
penicillin/streptomycin, and 20ng/mL γ-Interferon (Peprotech). Media was changed every 3 
days and cells were passaged prior to 100% confluence. 
Transfection: 
For transient transfection, ES cells and 293T cells were transfected using Lipofectamine 
LTX plus reagent (Invitrogen, cat#15338) according to manufacturer instructions. 
For stable transfection of pTLC-MOF plasmid into E14 ES cells, approximately 15µg 
linearized plasmid was cleaned by double phenol:chloroform extraction, and resuspended in 
tissue culture quality PBS (Sigma).  Approximately 0.8x107 cells were used per 
electroporation, at a concentration of 1x107 cells/mL in a 0.4cm electroporation cuvette 
(BioRad) on a Gene Pulser II (BioRad).  Electroporation conditions are as follows; High 
Capacitance (>50µF), infinite resistance, 250V, 500uF, time constant between 5-8 ms. 
Cells were seeded into two gelatinised 10cm tissue culture dishes (Nunc, ThermoScientific), 
puromycin selection (1.2µg/mL) began after 24 hours and continued with daily media 
replacement until colonies had formed in positive samples and all cells in non-transfected 
controls were dead (approximately 9 days).  Colonies were picked and grown under selective 
conditions, then analysed for RFP fluorescence by Fluorescence Activated Cell Sorting 
(FACS). 
pTLC-MOF plasmid was floxed by introduction of pCAG-Cre to cells by transfection using 
Lipofectamine LTX plus reagent (Invitrogen).  After 5 hours incubation with lipofectamine 
and plasmid, the cells were split harshly to encourage colony growth.  After 5 days, the plate 




2.2.2 Bacterial Culture 
 
Genomic clones were supplied by BacPac Resources Centre at the Children’s Hospital 
Oakland Research Institute (http://bacpac.chori.org/).  For FISH experiments, fosmid clones 
were used from the WIBR2 library derived from a human female (Broad Institute) in a 
pEpiFOS-5 vector in DH10B T1 resistant competent cells, and supplied as stab cultures in 
agar.  Clones used are listed in Table 2.1. 
Bacteria (from stab cultures or frozen glycerol stocks) were streaked out onto LB agar 
(section 2.1) to form single colonies and grown overnight at 37ºC; antibiotics were added to 
cool, melted agar prior to plates being poured.  Fosmids were grown on agar supplemented 
with 25µg/mL chloramphenicol.  Plasmids containing ampicillin resistance were selected for 
with ampicillin at 100µg/mL.  Plasmids containing kanamycin resistance were selected for 
with kanamycin at 50µg/mL. 
To prepare DNA, a single colony was picked from an LB agar plate and used to inoculate 3-
5mL LB broth (antibiotics used as required; for fosmids, 12.5µg/mL chloramphenicol was 
used in LB broth, for plasmids, concentrations are as above).  Cultures were then incubated 
with shaking at approximately 300rpm (InnOva 4230 incubator, New Brunswick Scientific) 
at 37ºC overnight with a 5:1 air to liquid ratio. 
To prepare larger amounts of DNA, 1mL of inoculated LB broth (cultured overnight as 
above) was used to inoculate 200mL LB broth supplemented with appropriate antibiotics, 
and incubated for not more than 16 hours at 300rpm at 37ºC with 5:1 air to liquid ratio. 
2.2.3 Glycerol Stocks 
Glycerol stocks of bacteria were prepared by adding glycerol to a concentration of 40% v/v 
to 1mL of an overnight culture, and stored frozen at -70ºC. 
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2.2.4 Protein overexpression in bacteria 
 
The chromodomain of mouse MOF (as defined by NCBI protein) was amplified by PCR 
with inclusion of BamHI and NotI restriction sites, and cloned into a pGEX6P1 plasmid for 
expression with glutathione-S-transferase (GST) in E. coli.  Insertion was confirmed by size 
separation of digested DNA on an agarose gel, and the insert was sequenced on a 3130/3170 
genetic analyser (Applied Biosystems) by technical services at MRC HGU.  Plasmid was 
transformed into bL21-RIPA competent bacteria (transfection proceeded as below, with the 
exception that SOC media was heated to 42ºC before addition to heat shocked bacteria).  A 
colony of transformed bacteria was grown in 10mL LB broth containing 100µg/mL 
ampicillin and 50µg/mL chloramphenicol for 3 hours at 37ºC until an Optical Density 
(OD600) of 0.6, as measured on an Ultraspec 3000pro spectrophotometer.  Protein production 
was induced with 0.5mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) for 3 hours at 37ºC 
and cells were lysed with NP-40 lysis buffer, proteins separated on an SDS-PAGE gel, and 
analysed by Colloidal Coomassie and western blot with α-GST primary antibody (Abcam, 
cat#ab6613, used at a dilution of 1:5000) to confirm expression of specific protein.  1mL of 
uninduced culture was then used to inoculate 500mL LB broth containing ampicillin and 




2.2.5 Preparation and handling of DNA 
Extraction of DNA from overnight bacterial culture: 
Fosmid DNA was extracted using alkaline-lysis miniprep.  Approximately 3mL of cultures 
were pelleted at 16,000g for 30s, then resuspended in 200µl GTE buffer for 5 minutes before 
addition of 400µl ice cold lysis buffer and incubation on ice for 5 minutes.  300µl of acetate 
buffer was added, and the preparation was incubated on ice for a further 5 minutes.  The 
flocculent precipitate was centrifuged at 16,000g for 5 minutes at 4ºC, and the clear 
supernatant was removed to a fresh eppendorf.  Phenol:chloroform extraction was then 
performed by adding an equal volume phenol-chloroform to the sample, centrifuging (at 
16,000g for 2 minutes at 4ºC), and removing the top layer.  The DNA was precipitated with 
an equal volume of isopropanol, and incubated for >1 hour at -20ºC, then pelleted by 
centrifugation at 16,000g for 15 minutes at 4ºC.  The DNA was then washed in 70% ethanol, 
re-pelleted as previously for 5 minutes, and finally resuspended in approximately 30µl of 
TE, and stored at -20ºC. 
Plasmid DNA was extracted using a Qiagen mini- or maxiprep kit, according to 
manufacturer instructions. 
Restriction Digestion and ligation of DNA: 
Plasmid DNA was digested using appropriate restriction enzymes (all purchased from New 
England Biolabs and used according to manufacturer instructions).  Typically 1-2 units of 
enzyme were used to digest ≤ 1ug DNA which was diluted in the required buffer.  Digestion 
was carried out for 1 hour at 37ºC.  
Ligation of insert DNA into vector DNA was performed using T4 ligase (NEB) as 
manufacturer instructions.  A 3:1 molar ratio of insert to vector was used, and the reaction 
was incubated overnight at 4ºC. 
Transformation of competent bacteria: 
Approximately 10ng plasmid DNA was added to 50µl Library Efficiency DH5α Competent 
Cells (Invitrogen, cat#18262-012) and incubated on ice for 45 minutes to 1 hour.  The cells 
were then subjected to heat shock at 42ºC for 45 seconds, and incubated on ice for 2 minutes.  
900µl SOC medium (Invitrogen) was added and the cells were incubated for 1 hour at 37ºC 




Quantification of DNA using spectrophotometry: 
Throughout experiments, DNA concentration was measured using spectrophotometry with a 
Nanodrop ND-1000 (Nanodrop Technologies) or a Nanodrop 8000 (Thermoscientific) 
according to manufacturer instructions.  Absorbance of sample at a wavelength of 260nm 
(A260) was measured.  An A260 measurement of 1 equals a double stranded DNA 
concentration of 50µg/mL. 
Resolution of DNA on agarose gels: 
Routinely, DNA was resolved on gels made to appropriate agarose percentage (“Hi-Pure” 
Low Eeo agarose, Biogene UK, w/v) in TAE with 0.5µg/mL ethidium bromide.  5x DNA 
loading buffer was added to the sample to result in a final 1x concentration.  Commercial 
DNA size marker ladders (NEB, Invitrogen) were used for reference, and gels were 
visualised under UV light. 
For analysis of MNase digest ladder for ChIP sequencing, input chromatin was resolved on a 
1.3% agarose gel with no ethidium bromide, stained with SYBR Gold (Invitrogen) according 
to manufacturer instructions, and scanned using a 532nm laser with a 575nm Long Pass filter 
(LPG filter on Fuji FLA-5100 phosphoimager). 
Extraction of DNA bands from agarose gels: 
Gel slices containing correct size DNA fragment were cut out of the agarose gel using a 
clean razor blade, and DNA was extracted using a QIAquick Gel Extraction kit (Qiagen, cat# 




2.2.6 Preparation of RNA and cDNA for Expression Analysis: 
RNA Extraction: 
Total RNA was isolated from cells using Trizol reagent (Invitrogen) according to 
manufacturer instructions.  Briefly, 1mL of Trizol per 5-10x106 cells was added directly to 
the culture flask, and incubated for 5 minutes at room temperature.  Per 1mL Trizon, 200µL 
chloroform was added, the tubes mixed vigorously, incubated at room temperature for 2 
minutes and centrifuged at 12,000g for 15 minutes at 4ºC.  The aqueous phase was removed 
and precipitated with isopropanol at room temperature for 10 minutes, then centrifuged at 
12,000g for 10 minutes at 4ºC.  The pellet was washed in 75% ethanol, centrifuged as 
previously for 5 minutes, and dissolved in 25-50µl H2O.  Concentration was estimated using 
Nanodrop (A260 of 1 equals 40µg/mL concentration of RNA). 
RNA was then DNAse treated with 2 units of DNAseI (Ambion), for 30 minutes at 37ºC, 
and analysed for quality on an Agilent 2100 Bioanalyser with an RNA 6000 Nano chip 
according to manufacturer instructions (analysis was performed by technical services at 
MRC HGU).  Only RNA with a RIN number of >8 was used in subsequent experiments. 
cDNA Preparation:   
cDNA was prepared using a First Strand cDNA Synthesis kit (AMV) (Roche, 
cat#11483188001) according to manufacturer instructions, and including a negative control 
reaction without reverse transcriptase.  Samples which failed the negative control were 




2.2.7 Expression Analysis: 
RT-PCR: 
cDNA generated using First Strand kit (above) was amplified by PCR using primers for gene 
of interest (Table 2.1) with Reddymix PCR Mastermix (Thermoscientific, cat# AB0575) 
according to manufacturer instruction.  Reddymix contains Thermoprime Plus DNA 
Polymerase, buffering salts, and dNTPs, in addition to a precipitant and dye for subsequent 
electrophoresis. 
PCR reaction was incubated at 95ºC for 15 minutes, followed by 30 cycles of amplification 
(95ºC for 20 seconds, 56ºC for 30 seconds, 72ºC for 30 seconds), and products were checked 
by electrophoresis (see section 2.2.4). 
Gene Expression Microarrays: 
Illumina: 
For Illumina expression arrays, RNA was extracted from 3 biological replicates of 
undifferentiated ES cells, and 400ng of RNA were amplified using the Illumina TotalPrep 
RNA Amplification Kit according to manufacturer instructions (Ambion, cat#AMIL1791), 
and checked for quality using Agilent 2100 Bioanalyser as described above.  Amplified, 
biotinylated cRNA was labelled and hybridized to Illumina MouseRef6 Gene Expression 
beadchip arrays and run on an Illumina Beadstation by the Wellcome Trust Clinical 
Research Facility. 
Probe level expression data was analysed by Graeme Grimes (MRC HGU) using R 
Bioconductor packages Limma and beadarray.  Genes were sorted according to probe 
detection level, and the top 500 were designated as highly active genes, whilst the lowest 500 
were designated as genes with little expression, and used in downstream analysis. 
Agilent: 
1ug of total RNA from 3 biological replicates of undifferentiated and differentiated (3 days 
in Retinoic Acid) was amplified using one round of amplification with an Amino Allyl 
MessageAmp II aRNA Amplification kit (Ambion, cat#AM1753) according to manufacturer 
instructions, and checked for quality on the Agilent 2100 Bioanalyser.  The RNA was dye 
coupled to Cy3 using the same kit, and for 3 technical replicates per biological replicate, 
1.34µg cRNA was hybridized to Agilent whole mouse genome 4x44k oligomicroarrays 
(Agilent cat# G4122F) according to manufacturer instructions (hybridisation proceeded for 
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17 hours).  Arrays were scanned on a Nimblegen MS200 scanner at 5µm resolution and spot 
intensities were extracted using Array-Pro Analyser (by Jurriaan Hölzenspies, University of 
Copenhagen).  Quantile normalisation and calculation of log2 fold change and adjusted p 
values were performed in Limma by Graeme Grimes (MRC HGU).  Genes differentially 
expressed with adjusted p value of <0.005 were used for H4K16ac tag density analysis.  
A selection of genes highly upregulated in UD or D3 samples was checked by RT PCR (see 
above) using primers detailed in Table 2.1.  To ensure global gene expression changes were 
consistent with expected results from a retinoic acid differentiation, the 7758 differentially 
expressed genes (5190 upregulated in undifferentiated cells and 2568 upregulated in D3 
cells) with an adjusted p-value of <0.005 were searched for enriched gene ontology (GO) 
terms against a background of total probes on array, using Gene Onotology enrichment 
analysis and visualisation tool GOrilla (Eden et al. 2009).  To avoid false positives, a P value 






2.2.8 Chromatin Immunoprecipitation (ChIP) 
Native ChIP: 
 Approximately 2x108 ES cells were treated for 2 minutes prior to trypsinisation with 5µM 
sirtinol and 5mM sodium butyrate.  After trypsinisation, the cells were washed twice in ice 
cold PBS containing 5µM sirtinol and 5mM sodium butyrate, and pelleted at 200g for 4 
minutes at 4ºC. The cell pellet was resuspended in 5mL NBA buffer, and 5mL NBB buffer 
were added.  The cells were incubated on ice for 3 minutes, then centrifuged for at 400g for 
4 minutes at 4ºC to pellet nuclei.  Nuclei were resuspended in 10mL NBR buffer and 
centrifuged again at 400g for 4 minutes at 4ºC.   
Chromatin concentration was measured by taking an aliquot of chromatin diluted 1:20 in 
NBR buffer and treating with DNAseI for 5 minutes.  400µl of Sonication Buffer were 
added, and absorption at 260nm was measured on an Ultraspec 3000pro spectrophotometer.  
500µg of chromatin were used in each IP, and digested with 40-50 Boehringer units of 
MNase (Sigma) to generate a chromatin ladder enriched in tri-, tetra-, and pentanucleosomes 
for qPCR analysis, or 70-100 units to generate a chromatin ladder enriched in mono-, di-, 
and trinucleosomes for deep sequencing (which requires smaller fragments of DNA).  
MNase digestion proceeded at room temperature for exactly 10 minutes, and was stopped by 
addition of an equal volume of stop buffer, and incubated on ice at 4ºC overnight. 
Between 50-150µg of released chromatin were incubated with 10ug anti-H4K16ac 
(Millipore, cat#07-329) or Rabbit IgG (Santa Cruz, cat#sc-2027)  prebound to Protein A 
Sepharose beads (Amersham cat#17-5280-01) with 100µg BSA for 3 hours at 4ºC.  Beads 
were washed twice with wash buffer 1, once with wash buffer 2 for 10 minutes at 4ºC, and 
once in TE.  Bound complexes were eluted from beads using elution solution.  10% input 
and immunoprecipitated chromatin were adjusted to pH8 using 2M TrisHCl pH6.8, and 
treated with 40µg Proteinase K (Genaxxon) at 55ºC for 1 hour.  DNA was purified using a 







Cross Linked ChIP 
In order to compare H4K16ac profile in 14fp limb cells with existing data for H3K27ac and 
H3K4me1, it was necessary to generate a cross linked ChIP dataset for H4K16ac in this cell 
line. 
Approximately 1.5x108 cells were cross-linked with 1% formaldehyde (v/v) (Sigma, 
cat#F87750) for 10 minutes at room temperature. Cross-linking was halted by addition of 
0.125M glycine for 5 minutes.  Cells were then washed with ice cold PBS, and removed 
from the tissue culture flask with a cell scraper, then pelleted at 400g for 5 minutes at 4ºC.  
Samples were subsequently kept on ice.  Cells were resuspended in 5mL Farnham Lysis 
Buffer, incubated for 5 minutes on ice, then pelleted at 420g for 5 minutes at 4ºC and 
resuspended in 5mL ice cold RIPA buffer for sonication.  Sonication was carried out with 
the resuspended nuclei in 1mL aliquots, using a Bioruptor Next Gen (Diagenode) for 60 
minutes with 30 second on off cycle at 4ºC.  Samples were spun down at 20,000g for 15 
minutes at 4ºC and supernatant collected.  Sonication efficiency was checked with a 20µl 
sample of chromatin treated with 10µg RNAse A at 37ºC for 15 minutes, followed by 
treatment with 10µg Proteinase K at 65ºC for one hour, and visualisation on an agarose gel.  
Samples which were over-sheared (significant portion of chromatin <100bp) or under-
sheared (>1000bp) were discarded.  Chromatin concentration was checked on a 
spectrophotometer.    
For IP, magnetic Protein A Dynabeads (Invitrogen, cat#100-02D) were briefly pre-blocked 
using 5mg/mL BSA in PBS, then coupled to 5µg H4K16ac or Rabbit IgG antibodies  (as 
above) for 1 hour at 4ºC, then washed in BSA/PBS as above, and resuspended in BSA/PBS.  
200µg of chromatin were incubated with antibody-coupled beads overnight at 4ºC.  Beads 
were collected using a magnet and washed five times with 3 minute incubations at 4ºC using 
LiCl wash buffer, and once in TE.  Bound material was eluted from beads using 200µl 
elution solution at 65ºC for 1 hour, with intermittent vortexing.  Supernatent was then 
collected and treated with RNAse A for 30 minutes at 37ºC before addition of 40µg 
Proteinase K and incubation at 65ºC for 5 hours for reversal of formaldehyde cross-links. 
The DNA was then purified using a Qiagen PCR purification kit, according to manufacturer 
instructions, and quantified on Nanodrop. 




For relative quantification of ChIP DNA by real-time qPCR, DNA isolated from 10% of 
total MNase digested native chromatin input was used to generate a standard curve for 
immunoprecipitated H4K16ac and IgG samples.  For each of the three biological replicates, 
PCR was performed in triplicate using Quantitect SYBR Green detection kit on a Biorad 
CFX96 Real Time System C1000 Thermal Cycler using primers described in Table 2.1.  
Thermal cycler programme:  15 minutes hotstart at 95°C, and 45 times 95°C for 20s, 56°C 
for 30s, 72°C for 30s and plate read.  Analysis was performed in Biorad CFX Manager 
version 2.0. 
ChIP on chip 
For H4K16ac, in UD and D3 ES cells, array analysis was previously performed for 3 
biological replicates with dye swaps (Gillian Taylor, MSc thesis, 2009) on custom arrays 
printed at Liverpool Microarray Facility (Eskeland et al. 2010), and so only one biological 
replicate was performed on the custom Nimblegen arrays used in this work.  For 14fp cells, 
two biological replicates with dye swap were performed. 
400ng (for OS25s) or 500ng (for 14fp) ChIP/Input DNA were labelled with Cy3/Cy5 by 
random priming according to NimbleGen ChIP-chip protocol (Roche).  Briefly, the DNA 
was denatured with the Cy3/Cy5 random nonamers at 98ºC for 10 minutes, then incubated 
on ice for 2 minutes.  The sample was then incubated with dNTPs and Klenow fragment at 
37ºC for 4.5 hours (for OS25s) or 3 hours (for 14fp).  An equal amount (15µg) of ChIP/Input 
DNA was combined for each experiment, and hybridized to custom 3x720K NimbleGen 
mouse tiling arrays (Roche) (genomic regions covered by arrays based on the mm9 
(NCBI37) mouse genome build are listed in Appendix 1).  Hybridisation proceeded for 20 
hours at 42ºC, and arrays were scanned on a NimbleGen MS200 Microarray Scanner 
(Roche) using 100% laser power at 2µm resolution.  Signal intensities were quantified from 
raw TIFF images with MS200 Data Collection software. 
Data processing was performed by Graeme Grimes (MRC HGU) in R.  Mean signal was 
taken for duplicate probes on the array, and scale normalisation was applied between 
biological replicates, with loess normalisation to correct for dye bias.   
Log2 ChIP/input was calculated by Log2 of the product of division of ChIP signal by input 
signal. Analysis was performed in Bioconductor in R using Epigenome (PROT43 protocol).  
The R Ringo sliding quantile function was used to generate the mean Log2 ChIP/input score 




Library preparation and Next Generation Sequencing of ChIP and Input DNA were 
performed by GenePool (University of Edinburgh) on an Ilumina Genome Analyser IIx.  
Library preparation and sequencing proceeded according to the standard Illumina protocol, 
with paired end sequencing of 50bp read length from either end of the fragment.  Input DNA 
was sequenced as a control for nucleosome occupancy, MNase digestion bias, and 
sequencing bias.  Briefly, DNA was end repaired, and polyadenylated.  Illumina paired end 
adapters were ligated to the ChIP DNA, and the ligated DNA was purified and amplified, 
and library fragments of >200bp were gel purified, then captured on the Illumina flow cell 
for cluster generation and sequencing. 
Processed image data was converted to FASTQ format (Solexa v1.3) by GenePool, and then 
used for further processing in-house. 
ChIP sequencing analysis 
I thank James Prendergast, Rob Illingworth, John Thomson and Duncan Sproul for their 
generous assistance with analysing ChIP-seq datasets.  
In addition to the dataset generated in this study, the following publicly available datasets 
were downloaded in SRA lite format from the Gene Expression Omnibus 
(www.ncbi.nlm.nih.gov/geo/):  H3K4me1, H3K27ac , H3K4me3, p300 
(GSE24165)(Creyghton et al. 2010), MOF (GSE37268)(Li et al. 2012) and RNApolII 
8WG16 (GSE34520)(Brookes et al. 2012).  All datasets were aligned to the mm9 genome 
assembly (July 2007, NCBI37) in Bowtie (Langmead et al., 2009), allowing a maximum of 
two mismatches per read.  Only sequences which mapped to one location were kept, and 
output was in SAM format. 
Format Conversion: 
SRA-lite formal files were converted into FASTQ format using the SRA-toolkit fastq-dump 
tool.  FASTQ files were used as input for Bowtie alignment for which the output was a SAM 
file.  SAM files were conversed to BAM files using Samtools view function (Li et al., 2009), 
and BAM files were converted to BED files (tag location in “chromosome, start, stop” 
format) using BEDtools (Quinlan and Hall, 2010). 
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Wiggle files for visualisation of tag density across the genome were generated in WCB 
Edinburgh Galaxy server in 200bp windows with 20bp step, and were normalised to reads 
per million using a custom Perl script. 
Quality Control: 
 Solexa quality scores were visualised (along with other quality control information such as 
overrepresented reads and base composition of reads) using FASTQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). 
Transcription Start Site/End Site Tag Density Graphs: 
TSS/TES tag density graphs were generated using custom perl scripts written by Duncan 
Sproul.  Briefly, TSS/TES locations were downloaded from Ensembl61 Biomart (NCBI 
37, http://feb2011.archive.ensembl.org/index.html), and processed to generate a list of 
unique, autosomal TSS/TESs.  For each ChIP-seq tag the distance from this midpoint to its 
nearest TSS/TES was calculated.  Tags equidistant from two TSS/TESs were discarded.  A 
histogram was then generated using a list of genes of interest, and a region of interest around 
the TSS/TES.  Each tag was analysed to determine whether it mapped to a TSS of interest, 
and whether it fell within an interval of interest.  Tag density was then normalised to number 
of reads per million aligned reads (RPM) in the ChIP-seq dataset used. 
Average Gene Profile Graphs: 
Profile of histone modifications over an ‘average’ transcript were generated using custom 
perl scripts and the coverageBED function of BEDtools.  Transcript locations were 
downloaded from Ensembl61 Biomart (NCBI37), and the location (chromosome, start, and 
stop) of a division of each transcript in 10% intervals was determined, along with the region 
2kb upstream and 2kb downstream in 200bp intervals.  The tag density of each interval was 
determined using coverageBED, and plotted. 
Promoter Window Correlations: 
Promoter windows were defined as 2kb upstream of the TSS, and the normalised (RPM) 
number of tags for each ChIP-seq dataset within each TSS promoter window was calculated 
using custom perl scripts and the coverageBED function of BEDtools.  Spearman correlation 




Visualisation of Tag Density: 
Wiggle tracks were uploaded to the Integrated Genome Browser (IGB) version 6.7.1 (Nicol 
et al., 2009), found at http://bioviz.org/igb/releases.html, along with RefSeq gene set for 
mm9 (July 2007) genome assembly.  Higher peaks indicate an increased depth of 
sequencing. 
Normalisation: 
For the bulk of analysis, ChIP-seq datasets were normalised according to total tag number by 
division by number of million aligned reads in the total dataset. 
For exploratory quantile normalisation, which was not selected as the most appropriate 
method of normalisation, custom R scripts written by Rob Illingworth, and the Limma 
package in Bioconductor were used.  Minimum read depth for ChIP and Input wiggle tracks 
were set to 0.1, and quantile normalisation (using Limma NormaliseBetweenArrays function 
with method=Quantile argument) was performed on the two datasets.  Wiggle tracks were 
then generated for the normalised ChIP and input samples, or for Log2 ChIP/Input and 
visualised in the Integrated Genome Browser. 
Peak Calling: 
Three methods were tested for peak calling; Nucleosome Positioning from Sequencing 
(NPS), Model-based Analysis for ChIP-seq (MACS), and Spatial clustering approach for the 
Identification of ChIP-Enriched Regions (SICER). 
NPS version 1.3.2 (Zhang et al., 2008b) identifies positioned nucleosomes from histone 
modification ChIP-seq data.  Both undifferentiated and differentiated datasets were used as 
input for one run then tag density was calculated within each positioned nucleosome for each 
dataset separately using custom perl scripts.  Nucleosomes which had a significantly 
different tag number from either UD or D3 datasets (Fisher’s Test) were taken for further 
examination. 
MACS version 1.3.7.1 (Zhang et al., 2008a) uses the fact that ChIP-ed fragments are 
sequenced from one end or the other (or in the case of paired end sequencing, both ends) of a 
larger fragment, and that therefore tags form a bimodal distribution around the  “binding 
site” (or enriched region, for histone modifications).  To pinpoint the exact peak location, the 
algorithm takes the distance between the two bimodal peaks (d), and shifts tags a distance of 
d/2, to centre them onto the actual peak location.  It then slides a window of d2 distance 
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across the genome to locations of potential peaks, and overlapping enriched regions are 
merged.  The local background around these peaks is calculated from sequencing input 
chromain, and false positives are removed.  
SICER version 1.1 (Zang et al., 2009) was developed in response to a lack of algorithms 
designed to cope with the frequently diffuse profile of histone modifications as compared to 
transcription factor binding sites for which most peak calling algorithms had been developed.  
The algorithm partitions the genome into non-overlapping windows (200bp), and the number 
of reads in each window is calculated, and each window is given a score based on the 
probability of finding x number of reads in that window, given the input background.  
Eligible windows are then clustered according to their local environment (i.e. windows 
located close to other eligible windows are clustered together to form ‘islands’), depending 
on a ‘gap size’ (600bp for H4K16ac, but user-variable depending on the observed profile of 
the modification; for example, H3K4me3 forms sharp peaks rather than domains, so a 
smaller gap size would result in more relevant data for this modification).  Eligible windows 
which are located at a distance less than the gap size from another eligible window are 
clustered together.  
Saturation Curves: 
A random selection of a proportion of reads (from 10% to 100% in 10% intervals) was 
selected from aligned sequencing data in Unix, then used as input for SICER peak calling.  
The number of peaks for each fraction of data was then plotted. 
CpG Promoter Definition: 
A list of CpG promoters was determined by using a defined list of CpG islands (Illingworth 
et al., 2010).  CpG promoter windows were defined over a 2kb region of TSSes which 
overlapped a known CpG island.  Non-CpG promoters were defined from TSSes which did 
not overlap one of the known CpG islands.  Tag density within the promoter regions was 
determined using the coverageBED function of BEDtools and plotted as a boxplot in R. 
Genomic Distribution of Histone Modification/HAT peaks: 
The genomic distribution of H4K16ac, H3K27ac, H3K4me3, MOF and p300 were 
calculated using Cis-Regulatory Element Annotation System (CEAS) 
(http://liulab.dfci.harvard.edu/CEAS/), using default parameters, with the exception that the 




For enhancer heatmaps, candidate active enhancers were defined as regions with overlapping 
peaks (at least 50bp) of H3K4me1 and H3K27ac (Creyghton et al. 2010), and inactive 
candidate enhancers were defined as H3K4me1 peaks which did not overlap any peak of 
H3K27ac.  The number of reads in twenty 500bp windows +/-5kb around the enhancer 
midpoint was determined using coverageBED, normalized to reads per million, and clustered 
based on sum of windows for H4K16ac using CreateTreeView Files in WCB Edinburgh 
Galaxy server, then visualised using Java TreeView (http://jtreeview.sourceforge.net/).  
Pluripotency transcription factor bound candidate enhancers were taken from a publicly 
available dataset (Whyte et al. 2012), and overlapped with H3K4me1 peaks defined in that 
study.  Unbound candidate enhancers were defined as H3K4me1 peaks which did not 
overlap with TF bound enhancers.   The number of reads in twenty 500bp windows +/-5kb 
around the enhancer midpoint was determined using coverageBED, and normalized to 
average RPM per enhancer. 
Subtraction and overlap of peaks was performed in WCB Edinburgh Galaxy server with 
custom tools. 
Bioconductor Tools: 
Bioconductor version 2.9 was used in R version 2.14.1 for several applications.  
ChIPpeakAnno (Zhu et al., 2010) was used to generate the Venn diagram of overlapping 
histone modification peaks.  The closest TSS to H4K16ac/H3K27ac+/- candidate enhancers 
was defined using the AnnotatePeakInBatch function of ChIPpeakAnno to annotate peak 
locations with their nearest TSS, and selecting those less than 5000bp from the enhancer 
using custom R commands.  
75 
 
2.2.10 Fluorescence In-Situ Hybridization (2D FISH) 
Fosmid Labelling 
Fosmids were labelled with biotinylated dTTP or digoxygenin dUTP by nick translation.  
500ng to 1µg of fosmid DNA prepared as described in section 2.2.4 was incubated with 2µl 
Nick Translation Salts, 0.5U DNAseI (Invitrogen, cat#18047), 5U DNA polymerase I 
(Invitrogen, cat#18010), 2.5µ each of dATP, dCTP, dGTP (0.5mM), and either 2.5µl bio-16-
dUTP (Roche) or 1.5µl digoxigenin-11-dUTP and 1µl dTTP for biotin or dig labelling 
respectively.  The incubation took place for 90 minutes at 16°C, and the reaction was 
stopped by addition of 2µl 20% SDS and 3µl 0.5M EDTA.  Reaction was made to 90µl 
volume by addition of TE, then processed through QuickSpin sephadex columns (Roche, 
cat#11273965001) according to manufacturer instructions. 
Labelling was detected using Streptavidin alkaline phosphatase or anti-DIG alkaline 
phosphatase on nitrocellulose filters which were prepared by soaking in 20x SSC and dried.  
A standard curve of biotin and DIG labelled λ DNA was spotted onto the filtres, along with 4 
dilutions of fosmid DNA from 1/500 to 1/10,000.  DNA was crosslinked to the filter by UV 
irradiation (1500mJ) in a UVC500 Crosslinker (Hoefer), then the filter was washed for 5 
minutes in 0.1M Tris pH7.5 and 0.15M NaCl, followed by addition of 3% BSA (w/v) and 
incubation at 60°C for 30 minutes.  The filter was then transferred to 0.1M Tris pH7.5 and 
0.15M NaCl and 1% streptavidin alkaline phosphatase and 1% anti-DIG alkaline 
phosphatase for 15 minutes at room temperature, then washed in 0.1M Tris pH7.5 and 
0.15M NaCl twice for 15 minutes, and once in 0.1M Tris pH 9.5.  The biotin/DIG were 
detected using a Vector BCIP/NBT kit according to manufacturer instructions, and fosmid 
probe concentrations were calculated by comparison to known standards. 
2D FISH 
Approximately 1x107 cells were washed with PBS and trypsinized, then swollen in 
hypotonic buffer for 15 minutes, and centrifuged at 1200g for 4 minutes, after which the 
hypotonic buffer was removed, and the cells resuspended in fixation solution (3:1 
Methanol:Acetic Acid).  Cells were then centrifuged at 1200g for 4 minutes, and fresh 
fixation solution was added.  The cells were then stored at -20°C. 
Glass slides were stored in dilute HCl in ethanol, and were dried prior to use.  Cells were 
resuspended in 1-3mL fresh fixation solution and dropped from a height of approximately 
20cm and dispersed by blowing on the slide.  Quality of slides was monitored by phase 
76 
 
contrast microscophy, and slides were aged by incubation at room temperature for 48 hours, 
or baking at 60°C for 1 hour. 
Slides were then treated with RNAseA at 100mg/mL for 1 hour at 37°C then washed in 
2xSSC and dehydrated through 70, 90 and 100% ethanol for 2 minutes each, and air dried.  
Slides were then incubated at 70°C for 5 minutes, and denatured in 70% formamide (in 
2xSSC, pH7.5) at 70°C for 1 minute exactly.  Slides were then quickly transferred to ice cold 
70% ethanol and dehydrated through ethanol series as previously, then air dried. 
200ng of labelled probe was used per slide, with 8ug CotI DNA (Invitrogen, cat#18440-016) 
and 10ug sonicated salmon sperm DNA (Sigma, cat#31149) and denatured in hybridization 
mix at 70°C for 5 minutes, the preannealed at 37°C for 15 minutes.  The probe was then 
hybridized to the denatured slides in a humid chamber at 37°C overnight. 
The slides were washed for 4x3 minutes in 2xSSC at 45°C, then 0.1xSSC at 60°C, and were 
transferred to 4xSSC.  Slides were incubated for 5 minutes in 4xSSC, 1% Marvel (w/v).  
Digoxigenin labelled probes were detected using Fluorescin anti-DIG FAB fragments 
(Roche, cat#11207741910) followed by FITC-conjugated anti-sheep (Vector, cat#FI-6000).  
Biotin labelled probes were detected in a double reaction, first using Texas Red conjugated 
avidin (Vector, cat#A-2016) then by biotinylated antiavidin (Vector cat#BA-0300), and then 
again by Texas Red conjugated avidin.  Slides were washed between each antibody 
incubation for 3 x 2 minutes in 4xSSC containing 0.1% Tween20 (v/v) at 37°C.  After final 
wash, slides were counterstained in 0.5 µg/mL DAPI and mounted. 
Image Analysis 
Scripts for 2D Image analysis were written by Paul Perry (MRC HGU), who also provided 
assistance for all microscopy work.  
Slides were imaged on a Hamamatsu Orca AC CCD camera (Hamamatsu Photonics (UK) 
Ltd) and a Zeiss Axioplan II fluorescence microscope with Plan-neofluar objectives, a 100W 
Hg source (Carl Zeiss), and Chroma #83000 triple band pass filter set (Chroma Technology 
Corp) with excitation filters installed in a motorised filter wheel (Prior Scientific 
Instruments).  Image capture and image analysis were performed with in-house scripts 
written by Paul Perry for IPLab Spectrum (Scanalytics Corp). 
Only nuclei which were evenly shaped and not in contact with another nucleus were selected 
for analysis.  Probe spots which were bright and easily distinguished from background were 
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used, and only nuclei with two pairs of probe spots were used (selecting for diploid cells).  
Nuclei were imaged using a 100x objective in bin2.  The squared interprobe distances (d2) 
were measured and normalised to nuclear radius squared (r2) or left unnormalised.  Statistical 
significance of mean interprobe distance were examined with non-parametric Mann-Whitney 
U test in R version 2.14.0 with the null hypothesis that the two datasets contain the same 
distribution.  Each dataset consisted of at least 50 nuclei (100 loci) for each cell type and 
probe combination.  Control probe sets and experimental probe sets were hybridised to cells 
in parallel, within the same experiment. 
2.2.11 Protein handling and preparation 
Preparation of Whole Cell Extract 
Cells were trypsinised and washed in ice cold PBS and pelleted at 400g.  Cell pellet volume 
(in µl) was estimated by eye.  The cell pellet was resuspended in 5x its volume of NP-40 
lysis buffer and incubated on ice for 30 minutes with intermittent vortexing.  Lysed cells 
were centrifuged at 15,000g for 10 minutes at 4°C, and supernatant collected and stored in 
the short term at -20°C. 
SDS PAGE Resolution of Proteins 
Cell extracts were resolved by sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE).  Denaturing polyacrylamide gels were made with 10% (v/v) Acrylamide/Bis 
(29:1, Biorad cat#161-0156), 0.33M Tris-HCl pH8.8, 0.1% SDS (v/v), 0.1% APS 
(ammonium persulphate, v/v), and 0.05% Tetramethylethylenediamine (TEMED, v/v) in 
water.  The gel was set with a cover of isopropanol, which was removed when the gel was 
set, and stacking gel made with 5% Acrylamide/Bis, 0.125M Tris pH6.8, 0.1% APS and 
0.1% TEMED. 
Gels were run in a Novex minicell X-Cell Sure Lock (Invitrogen) electrophoresis tank in 
SDS-PAGE running buffer at 130V for approximately 90 minutes.  A prestained protein size 
ladder of standard molecular weights was loaded alongside all gels (PageRuler Plus, 10-
250kDa, Thermoscientific, cat#26619). 
Coomassie Staining for loading control and visualisation 
The stacking gel was removed from SDS-PAGE gel, and the SDS-PAGE gel was washed in 
water, then fixed in Coomassie destain solution for 10 minutes at room temperature.   The 
gel was then transferred to 30mL 10% acetic acid, and 10% coomassie stain was added (v/v).  
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Gel was incubated for 1 hour at room temperature, then transferred to destain solution for >2 
hours. 
Colloidal coomassie staining was carried out with a Colloidal Blue Staining Kit purchased 
from Life Technologies (cat #LC6025) and used as specified by manufacturer instructions.   
Western Blotting 
Stacking gel was removed from SDS-PAGE gel, and samples were transferred to 
polyvinylidene difluoride (PVDF) membrane.  PVDF membrane was soaked in methanol 
and then transferred to western transfer buffer for 2 minutes before being used in transfer on 
a Genie Blotter (Idea Scientific).  Gel and membrane were sandwiched between two sheets 
of 3mm filter paper soaked in western transfer buffer, and transfer proceeded for 90 minutes. 
After transfer, the membrane was blocked in 3% BSA (v/v) in TBS with 0.2% Tween 20 for 
1 hour at room temperature or overnight at 4°C.  α-FLAG primary antibody (Sigma 
cat#F7425) was diluted to 1:10,000 in 3% BSA in TBS-Tween, and membrane was 
incubated in primary antibody overnight at 4°C with agitation.  Membrane was washed three 
times for ten minutes in TBS-tween at room temperature.  Secondary antibody (α-Rabbit IgG 
conjugated to HRP, Sigma) was diluted to 1:10,000 in 3% BSA/TBS-Tween, and membrane 
was incubated with antibody with agitation for 1 hour at room temperature and washed as 
previously.  Signals were detected with ChemiGlow West Chemiluminescence Substrate Kit 
(Protein Simple) according to manufacturer instructions, using Amersham Hyperfilm (GE 
Healthcare).  
GST-tagged protein isolation 
GST-tagged chromodomain of MOF was was amplified from MOF cDNA 
(clone MGC:30369 (IMAGE:5136304), clone sequence BC036284.1, in pCMV-SPORT6) 
by PCR with inclusion of BamHI and NotI restriction sites, and cloned into a overexpressed 
in bL21-RIPA competent bacteria in a pGEX6P1 plasmid as described in section 2.2.4.  The 
bacteria were pelleted, and resuspended in 20mL 1x ice cold PBS with 1mg/mL lysozyme, 
0.2mM PMSF, and Protease Inhibitor cocktail.  The resuspended bacteria were sonicated on 
a Soniprep 150 sonicator for 20 minutes on ice with 30 second on off cycles.  1% Triton X-
100 (v/v) was added, and the solution was mixed gently for 30 minutes at room temperature, 
then centrifuged at 12,000g for 10 minutes at 4ºC.  200µl of Glutathione Sepharose 4B beads 
(GE Healthcare, cat#17-0756-01) were washed in 1mL PBS, then the supernatant was 
incubated with the beads for 30 minutes at room temperature.  Protein was eluted from beads 
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using four incubations with 200µl Glutathione Elution Buffer for 10 minutes at room 
temperature.  A sample of elutions was checked by coomassie stain and western blot for 
specific expression of GST-tagged protein, and positive elutions were dialysed with 
membrane with a molecular weight cut off of 6-8000 (Spectrum Labs), against PBS and 20% 
glycerol (v/v) overnight at 4ºC.  Protein concentration was checked using Bradford reagent 
(BioRad) according to manufacturers’ directions on a spectrophotometer using a standard 
curve of BSA (New England Biolabs) to determine the correct concentration. 
 
 
MODified Histone Peptide Array 
 MOFified Histone Peptide Array was purchased from Activ Motif (cat#13005) and used 
according to manufacturer instructions.  Briefly, the slide was blocked in 5% MARVEL 
powdered milk at 4ºC overnight, then washed in TBS-Tween (10mM Tris-HCl pH8.3, 
150mM NaCl, and 0.05% Tween-20 v/v) for 5 minutes.  The slide was then incubated with 
10nM GST-tagged MOF chromodomain protein, or GST tag alone at room temperature for 1 
hour, then washed 3x5 minutes in TBS-Tween.  Bound proteins were detected with α-GST 
primary antibody (Abcam, cat#ab6613, used at a dilution of 1:5000 for 1 hour at room 
temperature), washed as previously, then α-goat HRP (Sigma, used at a dilution of 1:12,000 
for 1 hour at room temperature), washed again as previously, and signal was detected with 
ChemiGlow West Chemiluminescence Substrate Kit (Protein Simple) on an ImageQuant 
LAS4000 (GE Healthcare).  Signal intensities and further analysis was performed with Array 
Analyser software (Activ Motif) as directed. 
H4K16ac antibody specificity was calculated using MOFified Histone Peptide Array as 
above, with the exception that no protein was incubated with the array, and H4K16ac was 
used as primary antibody and α-Rabbit IgG HRP was used as secondary antibody. 
SILAC IP 
SILAC IP experiments were carried out in collaboration with Pradeepa Madapura 
Marulasiddappa (MRC HGU).  
10 x 14cm dishes of OS25 or MEF cells were grown to approximately 80% confluence in 
SILAC DMEM (R0K0, R6K4, and R10K8, Dundee Cell Products) media supplemented with 
10% FCS and penicillin (10,000 units/mL) and streptomycin (650µg/mL) for MEFs, or 10% 
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FCS, 0.1mM β-mercaptoethanol, penicillin (10,000 units/mL) and streptomycin (650µg/mL), 
0.3mg/mL L-Glutamine, 1mM sodium pyruvate, non-essential amino acids (Sigma), 1000 
units/mL human recombinant LIF and 0.1mg/mL hygromycin (Roche) for OS25s.  Cells 
were trypsinised and pelleted, then resuspended in 5mL ice cold swelling buffer for 5 
minutes, then dounced with a pre-chilled Dounce homogeniser (for 20 strokes with a tight 
pestle).  The homogenised cells were centrifuged at 228g for 5 minutes at 4ºC, and the 
supernatant discarded.  The nuclear pellet was resuspended in 5mL ice cold RIPA buffer and 
incubated for 30 minutes on ice, then sonicated in a Bioruptor Next Gen (Diagenode) for 10 
minutes at full power with 30s on/off cycle at 4ºC.  Extracts were then centrifuged at 
16,000g for 10 minutes at 4ºC.  Protein concentrations between the heavy, medium and light 
cell samples were tested using the Bradford assay. 
Protein A dynabeads were prebound to 5µg of antibody (Rabbit IgG, αMOF – Bethyl labs 
cat#A300-99219, α-p75) for 1 hour at 4ºC, then equivalent amounts of nuclear extract from 
light, medium and heavy media was incubated with one of the antibodies for 1 hour at 4ºC.  
The beads were washed once separately in RIPA buffer, then combined and washed four 
more times (5 minutes at 4ºC).  Bound proteins were eluted with 4x Invitrogen Loading 
Buffer with freshly added DTT. 
SILAC mass spectrometry was carried out from this point by Dundee Proteomics.   Briefly, 
the boiled proteins were separated by SDS-PAGE.  The entire protein gel lane was cut into 
ten gel slices per fraction, and trypsin-digested peptides were separated on an Ultimate 
U3000 trap-enriched nanoflow LC-system (Dionex).  An LTQ Orbitrap XL Mass 
Spectrometer with a nano-ES ion source (Proxeon Biosystems) was used for identification, 
and data acquired using Xcalibur software.  Quantification was carried out using MaxQuant 




2.2.12 Fluorescence Activated Cell Sorting (FACS) 
Flow cytometric analysis of fluorescent cells was performed on a BD FACSAriaII SORP 
(Becton Dickinson) by Elisabeth Freyer (FACS Technician, MRC HGU).  The instrument 
was controlled, and data was analysed in BD FACSDiva (Becton Dickson, Version 6.1.2).  
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2.2.13 Websites used for Computational Biology 
 
www.ncbi.nlm.nih.gov/geo/:  Gene Expression Omnibus 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/:  FASTQC 
http://www.perl.org/:  Perl programming language for multiple custom scripts. 
http://feb2011.archive.ensembl.org/index.html:  Ensembl archive version used. 
http://bioviz.org/igb/releases.html:  Integrated Genome Browser (version 6.7.1 used)  
http://liulab.dfci.harvard.edu/CEAS/:  CEAS (version 1.0.2 used) 
http://jtreeview.sourceforge.net/:  Visualisation of enhancer heatmaps. 
http://bifx-core.bio.ed.ac.uk:8080/:  Edinburgh University Wellcome Trust Centre for Cell 
Biology Galaxy Server. 
http://www.r-project.org/:  R software (Version 2.14.0 used) 
http://www.ebi.ac.uk/Tools/msa/clustalo/:  ClustalOmega, for sequence alignment of cross-
species MOF-chromodomains.  




Chapter 3: H4K16 Acetylation is found on active promoters 
and enhancers in Embryonic Stem Cells 
3.1 Introduction 
 
Acetylation of H4K16 (H4K16ac) has been noted in vitro, for its role in upregulating 
transcription (Akhtar and Becker, 2000), for its ability to decompact nucleosome arrays, and 
to prevent their compaction (Shogren-Knaak et al., 2006; Robinson et al., 2008).  In vivo 
H4K16ac has rarely been studied in mammalian cells, but has been examined in more detail 
in D. melanogaster where it forms an essential part of the X chromosome dosage 
compensation system, and in S. cerevisae, where targeting H4K16ac to a responsive 
promoter can trigger transcription(Akhtar and Becker, 2000). 
Because of its direct role in chromatin structure and nucleosome-nucleosome interaction, I 
wanted to examine the role of H4K16ac in vivo in mammalian cells.  Given that H4K16 has 
a potentially important role in murine development (Thomas et al., 2008), I made the 
decision to use embryonic stem cells (ES cells) to study the pattern of H4K16ac genome 
wide. 
3.2 H4K16ac antibody verification, ChIP and ChIP-Seq QC 
 
Antibody verification is an important step in any ChIP-sequencing experiment, as non-
specific binding can give a false picture of the target profile.  I therefore used the MODified 
Histone Peptide array (Activ Motif) which contains 59 modifications on N-terminal tails in 
combinations to form 384 targets for antibody testing.  The H4K16ac antibody (Millipore) 
has previously been shown to be suitable for ChIP  (Egelhofer et al., 2011), but batches of 
antibody can vary in efficiency.  The results of the histone peptide array show that the 
antibody used is extremely specific to H4K16ac (Fig 3.1).  The antibody binding to non-
specific modifications gives very low signal (Fig 3.1A), and only histone tails which contain 
H4K16ac show visible signal (Fig 3.1B).   H4K16ac is calculated to have a specificity factor 
approximately twenty times that of the highest background modification (Fig 3.1C). 




Figure 3.1 H4K16ac antibody is specific 
A: Signal intensities for all spots on MODified Histone Peptide array.  Orange line 
represents threshold for signal intensity designated as background.  B:  Example of 
H4K16ac antibody signal on MOFified Histone Peptide array.  Spots containing 
H4K16ac modification are circled in blue.  C:  Specificity factors calculated by Array 
Analyse software (activ motif) given background designated in (A) for top 10 hits.  
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Native ChIP for H4K16 acetylation was carried out as shown in Figure 3.2A.  Briefly, 
isolated chromatin from OS25 ES cells was digested with MNase to mono di and 
trinucleosomes (Fig 3.2B) that were then incubated with antibody-coupled beads.  This was 






Figure 3.2 ChIP-Seq workflow 
A: Schematic detailing Native ChIP workflow.  Cells are lysed, chromatin extracted 
and digested with MNase to mono di and tri nucleosomes (which fall within the 
correct DNA length suitable for ChIP-seq library preparation).  Buffers contain HDAC 
inhibitors throughout.  The digested chromatin is then incubated with antibody 
coupled sepharose A beads, washed, and the bound DNA is eluted, purified, then 
used in downstream applications.  First, qRT-PCR and microarrays for ChIP quality 
control, and then Solexa sequencing.  B:  MNase digested input and H4K16ac ChIP 
chromatin, digested with proteinase K, size separated on a 1.3% agarose gel, and 
stained with SYBR Gold.  Size marker indicated on left (bp). 
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The initial step was to verify the ChIP specificity and efficiency by qRT-PCR.  H4K16ac is 
known to be enriched on the promoters of active genes (Wang et al., 2008) and is not found 
on inactive genes.  I therefore opted to look at the promoters of housekeeping and 
pluripotency genes (β-actin and Oct4/Pou5f1) as positive controls.  Two lineage specific 
genes not expressed in ES cells (Olig2 and Hoxb1) were used as negative controls. 
As expected for a specific ChIP, H4K16ac is found on the promoters of the positive controls, 
but not those of the negative controls (Fig 3.3A).  To further verify the ChIP across whole 
genes rather than just promoters, and to provide controls and verification for the subsequent 
ChIP-sequencing data, I hybridized the ChIP DNA to custom NimbleGen microarrays.  
These in house designs (Pradeepa et al., 2012) contain various pluripotency and control 
genes (array designs are detailed in Appendix 1), in addition to the four mouse Hox loci.  
The results show that, as expected, H4K16ac is found most densely on the promoters of the 
positive control genes, and not at all on the negative control gene (Fig 3.3B).  Though 
H4K16ac is slightly more highly enriched on the promoter of Pou5f1, it is also found 
through the body of this gene.  This is in contrast to the profile over β-actin and Nanog, 
where it is more obviously restricted to the promoter region.  The profile of H4K16ac on 
these genes is inversely correlated with the silent-gene associated histone mark H3K27me3 
(data used from (Illingworth et al., 2012)). 
Across the Hox loci (Hoxb and Hoxc are shown as examples - Fig 3.4), H4K16ac is largely 
excluded from the Hox genes (again, in a roughly inverse relationship with H3K27me3), 
though interestingly Gm53 (upstream of Hoxb9, Fig 3.4, top) is acetylated at H4K16, and 
trimethylated at H3K27.  The overlap is unlikely to be due to poor resolution of the 






Figure 3.3 H4K16ac ChIP quality control 
A: ChIP for H4K16ac at active or inactive promoters in undifferentiated (UD) ES 
cells assayed by qRT-PCR.  Enrichment is shown as mean % input bound +/- SEM 
over three biological and three technical replicates.  B: RT-PCR for expression of 
active/inactive genes in OS25 ES cells.  C: Log2H4K16ac/Input (top, blue) or 
Log2H3K27me3/Input (bottom, black) in UD ES cells over housekeeping (β-actin), 
pluripotency (Nanog, Pou5f1), lineage specific (Olig2) genes on custom Nimblegen 
arrays.  RefSeq gene annotations are from the July 2007 (mm9) Build 37 assembly 





Figure 3.4:  H4K16ac ChIP quality control over Hox loci (previous page) 
Log2H4K16ac/Input (top, blue) or Log2H3K27me3/Input (bottom, black) in UD ES 
cells over Hoxb (top) and Hoxc (bottom) loci on custom Nimblegen arrays.  RefSeq 




The H4K16ac ChIP was deemed to be specific and efficient, and therefore I proceeded with 
deep sequencing of H4K16ac bound DNA, and MNase digested input to be used as a control.  
Generating a sequenced profile of input DNA is important, firstly to account for biases in the 
chromatin digestion - not all chromatin is released after MNase digest, which could lead to 
designating false negative regions.  Conversely, there may be some sequence bias in the 
MNase digestion (Dingwall et al., 1981).  In addition, biases exist in the library preparation, 
the sequencing process itself, and the mapping process (reviewed in (Liu et al., 2010) and 
references therein).  For example, whole cell extract DNA input has been shown to peak 
around transcription start sites (Vega et al., 2009). 
The sequenced DNA was then subjected to quality control checks, before being mapped to 
the mouse genome, and used in downstream bioinformatics analysis. 
I used FASTQC, a program designed to analyse the quality of deep sequencing data 
(http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc) to determine whether the data would 
be useable.  The results indicated that some adapter sequences had been amplified and were 
overrepresented in the data (data not shown) but given that these do not map to the mouse 
genome, would not be present in the data after mapping, and represented a very small 
proportion of the reads, this was not a large concern.  All other control checks were passed, 
and the Solexa Quality Scores (Fig 3.5) were acceptable.  The Solexa 1.3 pipeline used in 
this experiment attaches a Phred score to each read to designate read quality.  Phred scores 
range in value from 10 to 50; a Phred score of 10 means that the probability of an incorrect 
base call is 1 in 10, whilst a score of 50 means the probability of an incorrect base call in the 
read is 1 in 100,000.  Scores in my ChIP-seq experiment are generally above 35, with some 





Figure 3.5 Phred scores for deep sequencing quality control 
Quality scores generated in FASTQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) for all reads in H4K16ac 
ChIP (left) and MNase digested input (right).  Quality scores from Solexa 1.3 
pipeline, maximum = 50 
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Having determined that the sequencing data was of sufficient quality, I mapped the 
sequences to the mm9 assembly of the mouse genome using Bowtie (Langmead et al., 2009).  
Table 3.1 shows the alignment statistics; the H4K16ac ChIP sample has nearly 75% of reads 
aligned, and the Input sample has close to 80%.  Given that the sequencing quality of my 
reads declines after approximately 40bp, it is possible that trimming the reads before 
alignment could result in a slightly higher percentage of read alignment.  However, the 
aligned read depth of my experiment was already considerably higher than most published 
datasets (with input and H4K16ac ChIP samples having 105 and 79.5 million reads aligned 
respectively), and I therefore decided that the read depth was likely sufficient. 
To further investigate whether I had generated a sufficient depth of sequencing I decided to 
generate saturation curves by randomly sampling proportions of my data, and calling peaks 
using SICER (Zang et al., 2009)(peak calling will be discussed in more detail in Chapter 4).  
To compare my dataset saturation with that of published datasets, I used two published 
ChIP-seq profiles to perform the same analysis; H3K4me1, and H3K4me3 (Creyghton et al., 
2010).  H3K4me3 is known to form discreet peaks on active and bivalent promoters (Barski 
et al., 2007), whilst H3K4me1 forms broader, less defined peaks, which provides more of a 
challenge to peak calling algorithms (Zang et al., 2009).  As expected, the H3K4me3 dataset 
saturates with a low proportion of reads – with only 30% of the reads, the majority of the 
total peaks detected with 100% of the reads have been detected.  For H3K4me1 and 
H4K16ac the picture is more complicated, it seems likely that saturation has not been 
achieved, and that further sequencing would reveal further peaks, though in the case of 
H4K16ac the rate of peak discovery slows dramatically when approximately 50% of the data 
is used.  At this same proportion of reads used from the H3K4me1 dataset, the number of 
peaks discovered is half that found with 100% of the data (Fig 3.5).  Determining the 
appropriate depth necessary in ChIP-seq experiments is a matter of balancing the need to 
generate useful data against the cost of sequencing.  Some datasets will never achieve 
saturation within a reasonable amount of sequencing, and it must be accepted that peaks 
determined are a proportion of what exists in the genome. 
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Table 3.1:  Read alignment statistics. 
 
Total Reads 




UDH4K16ac 107027050 79531348 74.30957688 
UDInput 134829138 105346646 78.13344175 
    
Total number of H4K16ac and input and number of reads aligned to mm9 genome 
assembly using Bowtie 
 
 
Figure 3.6 Saturation curves 
Saturation curves for H4K16ac (this study) and H3K4me1 and H3K4me3 (Creyghton 
et al., 2010).  Plotted as number of peaks found using SICER (Zang et al., 2009) 
with increasing percentage of reads randomly sampled from dataset. 
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3.3 Correlating gene expression and H4K16ac in 
undifferentiated ES cells 
 
In order to examine the correlation between H4K16ac distribution and gene expression, I 
generated a profile of expressed and silent genes in undifferentiated OS25 ES cells.  The 
expression profile was generated on the Illumina MouseWG-6 v2.0 Expression Bead Chip 
platform.  I used this expression data to generate a sample of highly expressed or silent genes 
which could be examined for H4K16ac level, by taking the 500 genes with the highest 
average probe signal with a detection p value <0.005, and conversely, the 500 genes with the 
lowest signal, and a detection p value of >0.9.  The highest and lowest genes in the sample 
are detailed in Tables 3.2 and 3.3, and the GO terms (Fig 3.7) most enriched in the active 
sample indicate that these genes are largely housekeeping genes and are not specific to ES 
cells, with the highest p-values belonging to such general GO terms as translation, and 
metabolic processes (H4K16ac profile for genes specific to undifferentiated and 




Figure 3.7 Enriched GO terms in most active ES cell genes 
GO terms with pvalue <10-8 for sample of active genes used in downstream 
analysis.  Generated in GOrilla (Eden et al., 2009).  Top 500 genes with detection 
pvalue <0.005 against array total probe background.
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Table 3.2 Most active expressed genes in UD ES cells by Illumina bead array. 






UD 1 UD 2 UD 3 Mean 
  EG667728 22847.61 19572.47 20257.38 20892.48667 575.8236481 0 
Rplp1 22718.56 23245.13 22428.11 22797.26667 138.052516 0 
LOC100047759 22159.66 21203.19 22394.61 21919.15333 210.3576311 0 
Hist1h2ao 22134.52 20104.8 20739.11 20992.81 346.1235468 0 
LOC623466 22031.25 21084.53 21128.81 21414.86333 178.0884835 0 
LOC100043209 21801.67 19051.38 17977.16 19610.07 657.5053926 0 
Tuba1b 21696.84 20637.79 21421.38 21252.00333 183.1553885 0 
LOC677215 21661.02 20116.19 19070.31 20282.50667 434.4460715 0 
Rps2 21429.98 22152.6 21830.65 21804.41 120.6746403 0 
mtDNA_ND1 21367.66 21540.04 22622.7 21843.46667 226.7725627 0 
Zyx 21284.27 21815.24 22736.39 21945.3 244.9149118 0 
Atp5b 21272.15 18556.81 19419.05 19749.33667 462.4914162 0 
Rps12 20598.31 20835.68 18849.96 20094.65 361.4824456 0 
LOC381799 20425.81 20474.13 18314.4 19738.11333 411.0695328 0 
Ubb 20337.17 18879.33 18330.82 19182.44 345.6502463 0 
Rps29 20311.56 18975.64 19120.49 19469.23 244.3552178 0 
Rpl10a 20155 16450.4 17210.41 17938.60333 652.2367019 0 
mtDNA_COXIII 20136.06 19959.76 20189.67 20095.16333 40.09579506 0 




Table 3.3 Least expressed genes in UD ES cells by Illumina bead array. 






UD 1 UD 2 UD 3 Mean 
  scl00093.1_86 48.53136 56.75934 52.78808 52.69292667 1.371605075 0.993233633 
4930563O14Rik 48.76828 49.25138 49.29222 49.10396 0.097141233 0.999643867 
LOC380676 48.95963 62.04847 48.37948 53.12919333 2.576588306 0.9761396 
Prelid2 49.54593 60.67086 61.97208 57.39629 2.276557037 0.9280627 
Sidt1 50.32195 63.25974 52.74836 55.44335 2.292350343 0.9643875 
Olfr1419 50.46786 53.65835 55.67262 53.26627667 0.874812538 0.9910969 
LOC100048814 50.71157 56.66877 49.91697 52.43243667 1.230073953 0.994302 
LOC240131 50.7684 56.5957 56.61086 54.65832 1.122926022 0.985398867 
4930430J02Rik 50.79748 49.36172 46.34458 48.83459333 0.757589488 0.9985755 
LOC385462 50.90368 51.127 52.78337 51.60468333 0.342287184 0.996082633 
Rdh13 50.91822 57.7257 57.4385 55.36080667 1.28335728 0.9804131 
LOC329967 51.46046 57.56039 50.58362 53.20149 1.266763988 0.9928775 
scl000460.1_17 51.47501 56.40339 54.72086 54.19975333 0.83505798 0.988247867 
LOC384552 51.55732 60.30865 55.15291 55.67296 1.466260671 0.9786325 
Shbg 51.58677 54.09728 52.05822 52.58075667 0.444778165 0.996082633 
LOC674094 51.9087 50.46377 48.76921 50.38056 0.523799399 0.9985755 
4930579F01Rik 51.97919 56.60028 56.05273 54.8774 0.841603539 0.9861111 
LOC381427 52.00977 53.73677 56.69771 54.14808333 0.790293852 0.988247867 
B930041G04 52.02512 58.13614 58.74847 56.30324333 1.239197386 0.97151 
EG546894 52.0894 53.79928 57.41793 54.43553667 0.906882627 0.985042733 
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To examine the profile of H4K16ac over active and inactive genes, I used custom perl scripts 
(modified from scripts written by Duncan Sproul) to determine the tag density across the 
Transcription Start Sites (TSS), and Transcription End Site (TES) of the 500 active and 500 
inactive genes (Fig 3.8A). The H4K16ac profile is considerably higher on the active genes 
than on the silent genes across the TSS (Wilcox test p-value for a 500bp window over the 
TSS, <2.2x10-16), but the profile on the TES is unaffected by the gene expression level (p-
value = 0.01927). 
This result is expected, as it follows the previous H4K16ac ChIP-seq dataset conducted in 
CD4+T cells (Wang et al., 2008), where H4K16ac was determined to be increased on the 
promoters and the transcribed regions of active genes. 
I also examined the promoters of several examples of active genes individually (a sample is 
shown in Figure 3.8B).  The profile of H4K16ac over these genes shows a broad peak, 
beginning in the promoter, and at its highest approximately over the transcription start site 
(with a visible dip representing the +1 nucleosome - (Shivaswamy et al., 2008)) then 
reducing a short way into the gene body. 
On the inactive genes, there is generally little H4K16ac beyond background, and no visible 
peak over the promoter in most genes (Fig 3.8C), however, some inactive genes do carry a 












Figure 3.8 H4K16ac has higher peaks on the promoters of active genes than 
inactive genes, and is less prevalent on TES of active and inactive genes. (Previous 
page) 
A: Normalised (RPM) tag counts of H4K16ac surrounding the TSS (left) and TES 
(right) for active and inactive genes.  Each group represents the 500 genes with the 
highest or lowest expression measured by Illumina bead chip expression array. 
B: Wiggle tracks plotted against the mm9 mouse genome build using IGB 
programme for a selection of active genes determined by expression array.  
Direction of transcription is indicated by arrow.  Wiggle files show raw aligned 
sequencing data; height of signal represents the sequencing depth of ChIP’d 
fragments in reads per million per base pair.  Data displayed over 200bp sliding 




Given that H4K16ac is generally higher on transcriptionally active promoters (although there 
are small peaks on found on some inactive promoters), I decided to examine whether there is 
a difference in H4K16 acetylation levels on CpG promoters compared to non-CpG 
promoters.  Approximately 70% of promoters in the mammalian genome are classified as 
CpG (reviewed in (Illingworth and Bird, 2009)), and CpG islands generally fall within 
transcriptionally permissive chromatin.  Additionally, CpG rich chromatin is enriched for H4 
and H3 acetylation in HeLa cells (Tazi and Bird, 1990).  It would therefore be expected that 
CpG promoters would contain a higher level of H4K16ac, and this is the case for total 
promoters (Fig 3.9A) (p-value by wilcox test <2.2x10-16).  Interestingly the higher level of 
H4K16ac on CpG promoters is maintained, even when only the 1000 most active promoters 




Figure 3.9 H4K16ac is higher on CpG promoters than non-CpG promoters 
A: Boxplot representing H4K16ac depth over 500bp windows across TSSs which 
overlap mouse CpG islands (Illingworth et al., 2010) or non-overlapping TSSs.  
Sequencing depth normalised to reads per million reads.  B:  As A, for 1000 highest 
expressed genes in UD ES cells, according to mean probe intensity from Illumina 




3.4 H4K16ac profile across promoters and distribution across 
the genome 
To generate a picture of how H4K16ac is distributed across the gene, I produced tag density 
graphs across an average gene, by dividing each gene into percentage intervals and 
calculating the tag density within these intervals, and within 200bp windows to 2kb upstream 
of the TSS and downstream of the TES (Fig 3.10).  I also performed this analysis for 
H3K27ac, H3K4me3, H3K36me3, H3K4me3 and H3K27me3 both as control for my 
analysis (H3K36me3 is known to accumulate at the 3’ end of active genes in mammals 
(Bannister et al., 2005)) and to compare the H4K16ac profile to other “active” or “inactive” 
associated histone marks. 
As in CD4+T cells (Wang et al., 2008), H4K16ac has a much broader profile than H3K4me3, 
or H3K27ac, both of which were shown to mark the area surrounding the TSS of active 
genes (Barski et al., 2007; Wang et al., 2008).  Both of these histone marks show a distinct 
peak directly over the transcription start site, with tag density beginning to increase less than 
1kb from the TSS, and sharply decreasing again after it.  H4K16ac, by contrast, shows a 
much broader peak, with tag density beginning to increase at least 2kb from the TSS, and 
only reaching background level again by approximately 40-50% of the way through the 
gene.  In this way, H4K16 acetylation over active promoters seems to have a more similar 
profile to H3K27me3, which also shows a broad peak over the TSS – albeit for inactive 
genes.  All histone marks found on active promoters show a dip at the TSS, representing the 
nucleosome free region found at these promoters (but not at inactive promoters) (Schones et 
al., 2008). 
This profile presents a challenge for peak calling algorithms (to be discussed in Chapter 4), 
since most were developed with transcription factors in mind, and so expect a much 




Figure 3.10 Average profiles of histone marks across active/inactive genes 
Normalised (RPM/bp) tag counts of histone modifications in UD ES cells across 
gene bodies of 500 active or inactive genes, extending 2kb up and downstream of 
the TSS/TES.  Data sources; H4K16ac (this study), H3K27ac, H3K4me3, H3K4me1 
(Creyghton et al., 2010), H3K36me3 and H3K27me3 (Mikkelsen et al., 2007).
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Having shown that in ES cells, H4K16ac falls on the promoters, I wanted to determine how 
it correlates with other histone marks which associate with promoters.  I determined tag 
density within 2kb windows across TSSs (ensembl61, February 2011, mouse NCBI37 
genome build) for seven ES cell ChIP-seq datasets, and MNase digested input DNA, then 
calculated the Spearman correlation of the distributions using R.  I plotted the correlations as 
a heatmap (Fig 3.11A) clustering modifications which had a similar distribution. H4K16ac 
and RNApolymerase II (hypophosphorylated isoform) had the most similar distributions, 
followed by H3K27ac and surprisingly H3K4me1, which does not mark the region over the 
TSS but shows peaks either side of the H3K4me3 TSS peak (Fig 3.10).  H3K4me3 showed a 
low correlation with H4K16ac distribution, potentially due to the fact that in ES cells, a 
proportion of the genes marked by H3K4me3 are in fact inactive, and bivalently marked with 
H3K27me3 (Bernstein et al., 2006).  These genes are unlikely to be marked with H4K16ac, 
and this would therefore reduce the correlation between these two generally active chromatin 
associated histone marks in ES cells.  Unsurprisingly, H4K16ac shows the lowest correlation 
with H3K27me3, a marker of polycomb repressed genes (Cao et al., 2002).   I then wanted to 
determine how the peaks overlap genome wide, as opposed to only on promoters, between 
the four histone modifications, and used the bioconductor program ChIPpeakAnno (Zhu et 
al., 2010) to generate Venn diagrams of the peak overlap (Fig 3.11B).  Of the ~60,000 
H4K16ac peaks around a third did not overlap with any of the other marks analysed, whilst 
~15,000 overlap with both H3K27ac and H3K4me1.  A further ~11,000 peaks overlap with 
only H3K4me1, and another 10,000 overlap with H3K4me3, H3K4me1 and H3K27ac.  This 
final group likely represents active promoters, but regions with a combination of H3K27ac 
and H3K4me1 without H3K4me3 have been shown to represent active enhancers (Creyghton 





Figure 3.11 Correlation of H4K16ac with other histone marks 
A: Clustered heatmap displaying Spearman correlation of distribution of tag 
densities over 2kb windows across all mouse TSSs (NCBI37) between histone 
modifications (and hypophosphorylated RNApolII).  Correlations and heatmaps 
generated in R.  B:  Venn diagram for overlap of peaks between H416ac, H3K27ac, 
H3K4me1, and H3K4me3 calculated in ChIPpeakAnno (bioconductor).
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Next, I wanted to determine where on the genome the majority of H4K16ac peaks fall.  
Previous analyses have focused around the TSS of known genes, but I wanted to use a less 
biased approach in order to determine whether H4K16ac has influence on other elements of 
the genome.  I used a program called CEAS (Cis-Regulatory Element Annotation System) 
(http://liulab.dfci.harvard.edu/CEAS/index.html) which determines the percentage of ChIP-
seq enriched regions which fall into various categories of the genome. 
The bulk of H4K16 acetylation peaks (by comparison to the genome) fall within the 
promoters and the coding exons, though a significant percentage of peaks fall downstream of 
the genes, in the introns, and in the 3’UTR (Fig3.12A-C).   
By comparison to H3K27ac, and H3K4me3, H4K16ac has a greater percentage of peaks in 
the region between 1kb and 10,000kb upstream of the TSS (Fig3.12D), though it has more 
similarity with H3K27ac than H3K4me3, which has a considerably greater percentage of 
enriched regions which fall within the area immediately surrounding the TSS – 8.3% fall 
within the 5’UTR and 1kb promoter region, compared with 2.2 % in the H3K27ac dataset 
and just 0.8% for H4K16ac. 
This large percentage of H4K16ac peaks which fell without the promoter/coding 
region/downstream area offered the interesting prospect that there was a sub population of 
H4K16ac which marked something other than the promoters of active genes.  Given that 
these were unlikely to overlap with H3K4me3, they potentially represented the population of 
H4K16ac peaks which showed overlap with H3K4me1 but not H3K4me3 (Fig 3.11B). 
Over promoters, H4K16ac showed the greatest correlation with H3K4me1 and H3K27ac.  
Both these marks are well known for marking enhancers and active cell type specific 
enhancers respectively (Heintzman et al., 2007, 2009; Creyghton et al., 2010), and it 
therefore seemed logical that if H4K16ac shows a correlation with these marks around 




Figure 3.12 Distribution of H4K16ac peaks 
A:  Percentage of H4K16ac peaks which fall on promoters compared to expected 
background (mm9 genome assembly), generated in CEAS 
(http://liulab.dfci.harvard.edu/CEAS/index.html).  Purple bars represent the 
percentage of mappable regions located in the specified regions.  Green bars 
represent the percentage of ChIP peaks in located in such regions.   B/C: As A, for 
downstream regions and coding regions.  D: Percentage distribution of 
H4K16ac/H3K27ac/H3K4me3 peaks relative to mm9 genes (left), schematic for the 
categories into which peaks are placed (right). 
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3.5 H4K16ac on active Enhancers 
 
The presence of H4K16ac over enhancers has been investigated before (Wang et al., 2008), 
but it was shown to be present on only a very small fraction (approximately 0.04) of 
enhancers, compared with H3K4me1, present on a fraction of 0.3 of the enhancers.  The 
depth of H4K16ac sequencing in that early ChIP-seq experiment was very low however (a 
total of 7.02 million reads obtained). 
In addition, there was the possibility that H4K16ac in ES cells may have a different profile to 
H4K16ac in CD4+T cells from adults, marking enhancers associated with pluripotency, but 
not in terminally differentiated cell types. 
As an initial exploration, I looked to the literature to find genetically defined enhancers 
known to be active in ES cells (Fig 3.13A) or enhancers that are known to be cell type 
specific, and looked at the profile of H4K16ac across these known enhancers. 
I found that H4K16ac has a similar profile to H3K4me1 over an upstream Nanog enhancer 
(Jiang et al., 2008), which is also heavily marked by H3K27ac.  Similarly, the enhancer 
located downstream of the Vpreb1 locus is known to be marked by acetyl-H3 and 
methylated-H4 (Szutorisz et al., 2005), and primed for subsequent activation by Sox2 in 
undifferentiated ES cells (Liber et al., 2010).  This region is marked by a domain of 
H4K16ac, as well as the known enhancer marks H3K27ac and H3K4me1. 
I also looked at cell-type specific enhancers for differentiated cells (Fig 3.13B) and found 
that an enhancer which can drive Satb2 expression specifically in callosal projection neurons 
(Tashiro et al., 2011) is marked, as expected, by H3K4me1, but is marked by neither 
H4K16ac nor H3K27ac.  A neuronal specific enhancer which drives transcription of Mnx1 
(also known as Hb9) (Nakano et al., 2005) shows the same pattern. 
These analyses indicated that H4K16ac was potentially a novel mark for (at least) ES cell 
specific enhancers.  The next step was to determine whether H4K16ac was present on active 




Figure 3.13 H4K16ac profile over defined ES cell active enhancers  
Wiggle files show raw aligned sequencing data; height of signal represents the 
sequencing depth of ChIP’d fragments in reads per million per base pair.  Data 
displayed over 200bp sliding windows with 20bp step, generated in WCB Edinburgh 
Galaxy server, for A: active ES cell enhancers and B: Lineage specific enhancers.
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To test this, I generated a list of putative enhancers using publicly available ES cell histone 
modification data.  I first used SICER to call peaks for H3K4me1 and H3K27ac, and also 
generated a window 2kb around the TSSs.  I excluded these TSS windows, from the 
H3K4me1 peaks, in order to restrict my analysis to distal regions, and to exclude core 
promoters.  Including core would confuse the analysis since H4K16ac is expected to 
correlate with H3K27ac in these locations. 
Of these H3K4me1 peaks, I then selected those which had at least 50bp overlap with a peak 
of H3K27ac, or those which showed no overlap, in order to distinguish between active 
enhancers and inactive enhancers.    I took the midpoint and generated 500bp windows 
extending +/- 5kb then calculated the tag numbers normalised to reads per million within 
them.     
I then generated heatmaps clustered according to H4K16ac level over active or inactive 
enhancers for H4K16ac, H3K27ac, H3K4me1, H3K4me3 and Input (Fig 3.14A).  The 
pattern of H4K16ac on enhancers follows the pattern of H3K27ac; enhancers with more 
H4K16ac at the top of the heatmap show an increased amount of H3K27ac, whilst those at 
the bottom of the heatmap, with the lowest overall amount of H4K16ac show the lowest 
amount of H3K27ac.  Some enhancers with lower levels of H3K27ac lack H4K16ac 
showing that there is not complete overlap between the two marks.  The profile of H3K4me1 
remains relatively constant (though the broadest peaks of H4K16ac also correlate to the 
broadest peaks of H3K4me1) throughout the enhancers, whilst H3K4me3 and Input samples, 
as expected, do not show any coverage. 
On the inactive enhancers (Fig 3.14A, lower) there is a lack of H3K27ac (by necessity, since 
that is how they are defined).  The majority of these enhancers show a lack of H4K16ac too, 
though some few enhancers (at the top of the inactive heatmap) show H4K16ac and 
H3K4me1, but not H3K27ac, presenting the possibility that some enhancers are marked as 
active with H4K16ac instead of H3K27ac.  Again, H3K4me3 and Input as negative controls 
show very low coverage over all enhancers. 
H3K27ac marked enhancers are generally located near genes with higher expression than 
those which are marked only by H3K4me1 in that specific cell type  (Zentner et al., 2011).  I 
replicated this result with my enhancer set in UD ES cells, and also wanted to see whether 
classifying active enhancers using H4K16ac instead of H3K27ac would show this same 
result.  There is no significant difference between the expression level of 
H4K16ac+/H3K4me1+ enhancers and H3K27ac+/H3K4me1+ enhancers, but there is a 
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significant difference between the expression level of both these sets of active enhancers and 




Figure 3.14 H4K16ac profile over total ES cell enhancers  
A: Heatmap showing levels of H4K16ac, H3K27ac, H3K4me1 and H3K4me3 over 
active (H3K4me1+/H3K27ac+/distal from TSS) or inactive (H3K4me1+/H3K27ac-
/distal from TSS).  Intensities are determined by RPM tag density in 500bp windows 
+/- 5kb from enhancer midpoint.  B: Boxplot of expression levels of closet gene with 




To further investigate the presence of H4K16ac on enhancers, I defined active and inactive 
ES cell enhancers in a different way, without relying on the presence or absence of 
H3K27ac.  Active enhancers are not only marked by histone modifications, but are also 
bound by transcription factors.  For example in ES cells, combinatorial binding of Pou5f1, 
Sox2 and Nanog can predict enhancers which are associated with actively transcribed genes 
(Göke et al., 2011).  I therefore took a group of ES cell transcription factor/transcription 
mediator (Pou5f1/Med1/Sox2/Nanog) binding sites (Whyte et al., 2012) and overlapped them 
with H3K4me1 peaks from the same study to generate a set of ES cell transcription factor 
bound enhancers.  For comparison, I also generated a list of unbound enhancers, and plotted 
the average tag density around the enhancer midpoint (Fig 3.15).  For TF bound enhancers, 
as expected there is a peak of H3K4me1 and H3K27ac, but no H3K4me3, and there is a clear 
peak of H4K16ac over these enhancers also.  For the non-TF bound set, there is still a clear 




Figure 3.15 H4K16ac profile over TF bound or unbound enhancers 
Tag density for H4K16ac, H3K4me1, H3K27ac, and H3K4me3, across 10kb region around enhancer midpoint for distal peaks of 
H3K4me1 (Whyte et al., 2012) which overlap peaks of Pou5f1, Sox2, Nanog and Med1 from the same study (left) or distal H3K4me1 
peaks which do not overlap any TF (right). 
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I had noticed that on some genes, the enhancer peak of H4K16ac was much higher than the 
promoter peak of the nearest active gene.  I therefore wanted to investigate whether this was 
a global pattern.  To do this, I took the list of defined H4K16ac peaks in UD ES cells, and 
defined those which overlapped a peak of H3K4me3 as promoter, and those which 
overlapped peaks of H3K4me1 and H3K27ac as enhancer peaks.  I then plotted the tag 
density of the peak in reads per base pair (Fig 3.16A).  Tag density is generally higher for 
promoter peaks, and overall, promoter peaks are wider than enhancer peaks, meaning that 
peaks of H4K16ac which overlap a promoter are generally higher than those which mark an 
enhancer. This is illustrated in Figure 3.16B, the enhancer found towards the 3’ end of Mgst3 
has a much lower peak of H4K16ac than the two flanking promoters of Aldh9a1 and Mgst3. 
Similarly, there is a small peak of H4K16ac over an enhancer between Lyve1 and Mrvi1, 
which is considerably smaller than the peak over the nearby gene Rnf141.   
Though this is overall the case, it is not the case for every enhancer/promoter pairing.  For 
example, the enhancer region downstream of Klf4 (Shen et al., 2012),  shows a broad region 
of H4K16ac/H3K27ac/H3K4me1 approximately 20kb wide, and which peaks much higher 
than the H4K16ac peak over the gene itself.  As can be seen by the broad pattern in Figure 
3.14A, this type of profile is the exception, rather than the rule, and it remains to be seen 




Figure 3.16 Tag density of promoter and enhancer peaks 
A: Boxplot representing tag density (RPM/bp) of H4K16ac peaks which overlap 
promoter or enhancer (left).  Boxplot representing peak width (bp) of H4K16ac 
peaks which overlap promoter or enhancer (right).  B, C:  Wiggle files show raw 
aligned sequencing data; height of signal represents the sequencing depth of ChIP’d 
fragments in reads per million per base pair.  Data displayed over 200bp sliding 
windows with 20bp step, generated in WCB Edinburgh Galaxy server, for B: 
Promoter/Enhancer pairs which show the same pattern as genome wide average 
(lower peak on enhancer than promoter for H4K16ac) and C: Inverse 
promoter/enhancer pair with higher H4K16ac peak on enhancer.
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3.6 MOF/Myst1 is also found at active promoters and 
enhancers 
MOF is the specific histone acetyl transferase (HAT) responsible for H4K16ac (Thomas et 
al., 2008), so it made sense to compare its profile across TSS and enhancer regions with 
p300, which is one of the major HATs which catalyse acetylation of H3K27 in ES cells (Fig 
3.17) (Pasini et al., 2010) .  I downloaded  publicly available ES cell ChIP datasets for MOF 
(Li et al., 2012) and p300 (Creyghton et al., 2010), and generated tag density graphs around 
the TSS of active and inactive genes (as in Figure 3.8A).  As expected from the profiles of 
their respective histone marks, binding of both HATs is increased around the TSS of active 
genes compared with inactive genes (Fig 3.17A) (p-value by Wilcox test for a 500bp region 
around the TSS <2.2x10-16), though p300 peaks are higher than those of MOF.  This is 
expected, since the profile of H3K27ac shows higher, narrower peaks around the TSS of 
active genes than H4K16ac, which has broader, lower peaks over promoters (see section 
3.5).  I then went on to perform the same analysis over active and inactive enhancers.  The 
results mirror those of H4K16ac and H3K27ac; both HATs show a distinct peak over active 
but not inactive enhancers (p-value by Wilcox test for a 600bp region around the TSS 
<2.2x10-16).  The enhancer upstream of Nanog is shown as an example in Figure 3.17C. A 
broad domain of H3K4me1, approximately 10kb wide, overlaps with peaks of H3K27ac and 
H4K16ac.  The profile of MOF over this region matches the profile of H4K16ac very well. 
H3K27ac distribution is similar to that of p300 though there is a peak of H3K27ac 
approximately 12.5kb upstream of the Nanog TSS, which is not accompanied by a peak of 
p300.  This suggests that a different H3K27ac HAT may be acting there.  Whilst a small 
peak of MOF overlaps with this H3K27ac peak, there is no evidence that MOF can acetylate 
any residues on the tail of H3.   
The presence of MOF over active enhancers from an independent dataset adds further 





Figure 3.17 MOF/Myst1 marks active promoters and enhancers in ES cells 
A:  Percentage distribution of MOF peaks relative to p300 peaks across genome 
divided into 9 categories.  B:  Normalised (RPM) tag counts of MOF (left) and p300 
(right) surrounding the TSS for active and inactive genes.  Each group represents 
500 genes with high or low expression.  C:  Normalised (RPM) tag counts of MOF 
(left) and p300 (right) with input (grey) +/- 5kb over active/inactive enhancer 
midpoints.  D: Wiggle files at Nanog locus, for H4K16ac and MOF, H3K27ac and 





3.7 Summary of H4K16ac profile in UD ES cells 
From these results I conclude that in ES cells, H4K16ac marks the promoters of highly 
expressed genes, and not those of silenced genes, as was previously determined in human 
CD4+T cells.  In addition, I have found that H4K16ac marks the active enhancers of ES cells. 
It would be interesting to investigate whether H4 tail acetylation on enhancers is specific to 
H4K16ac, or whether the other H4 acetylations are present there as well.  Unfortunately, this 
cannot be investigated until ChIP-seq profiles are available for these marks in ES cells. 
Next, to look at how changes in expression were associated with changes in H4K16ac 




Chapter 4: Profile of H4K16ac changes upon ES cell 
differentiation 
4.1 Introduction 
Having found that H4K16ac is found on the promoters of active genes and on active 
enhancers in undifferentiated embryonic stem cells (UD ES cells), I decided to investigate 
how the profile of H4K16ac changes genome-wide upon ES cell differentiation. 
Retinoic acid (RA) treatment induces differentiation along the neuronal pathway (Bain et al., 
1995), and causes expression of the Hox genes in temporal colinearity in mouse ES cells 
(Chambeyron and Bickmore, 2004).  I used three days of RA differentiation, by which stage 
there is polarised activation of the 3’ Hox genes  (Morey et al., 2009), loss of H3K27me3 
over the early Hoxb and Hoxd genes, along with chromatin decompation in the region 
(Eskeland et al., 2010). 
At later stages of RA induced differentiation, Mof expression is lowered and subsequently 
eliminated, but by day 3, expression is still at levels approximately equivalent to UD ES cells 
(Li et al., 2012) (and this study) and could therefore still be important for the changes in 
expression which characterise the shift into the neuronal lineage. 
In addition to determining whether H4K16ac presence on promoters correlates with gene 
activation in differentiated ES cells, I also wanted to observe the behaviour of the active 
enhancers upon differentiation.  This was in order to determine whether H4K16ac, like 
H3K27ac shows cell type dependent presence on active enhancers.  H3K27ac is lost from the 
enhancers of genes which are silenced upon differentiation, and placed onto enhancers close 
to genes which gain expression (Zentner et al., 2011).  H4K16ac has not been shown to mark 
enhancers in another differentiated cell type (Wang et al., 2008) and MOF is particularly 
important for gene expression in UD ES cells, and H4K16ac levels gradually diminish 
during retinoic acid (Li et al., 2012).  It was therefore a possibility that H4K16ac may be 
important only for active enhancers in UD ES cells.
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4.2 RA induced differentiation of ES cells 
 
I induced differentiation with RA for 3 days (Fig 4.1A), which causes a change in 
morphology of ES cells from rounded colonies into more flattened and elongated cells.  The 
changes occur across the majority of the cell population and it can be easily verified under 
light microscope, indicating a successful differentiation prior to usage of the cells in further 




Figure 4.1:  ES cell differentiation using retinoic acid (RA) 
A: Schematic representing differentiation protocol.  B: Morphological changes 
associated with RA differentiation in mouse OS25 cells at 4x magnification by phase 
contrast microscopy  C: Morphological changes associated with RA differentiation in 
mouse OS25 cells at 10x magnification. (scale bar 100µm)
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To determine whether the H4K16ac profile changes in line with differentiation induced 
changes in gene expression, I extracted RNAs from undifferentiated ES cells and from cells 
after 3 days of RA differentiation (D3).  I then labelled them with Cy3 before hybridizing 
them to Agilent whole mouse genome (4x44k) oligo microarrays. 
After data extraction and quantile normalisation, I validated genes upregulated in UD or D3 
by RT-PCR (Fig. 4.2A), then took genes which were significantly increased in expression in 
either UD or D3 samples (adjusted p-value of <0.005).  I then used GOrilla (Eden et al., 
2009) to determine enriched GO terms compared with total probes on the array.  As expected 
from previous studies of RA differentiation, the enriched GO terms in genes comparatively 
upregulated in UD ES cells included stem cell maintenance and negative regulation of cell 
differentiation.  Conversely, in the D3 sample, GO terms derived from the expression of Hox 
genes such as skeletal system morphogenesis and anatomical structure morphogenesis were 




Figure 4.2:  Expression changes upon RA differentiation 
A:  RT-PCR for expression of genes with highest p-value upregulated in UD/D3 
cells.  B: Functional annotation of genes upregulated in UD (top) or D3 (bottom) 
using GOrilla for biological process GO terms.  Genes upregulated with adjusted p-
value of <0.005, analysed against total array probes.  Log10 of enrichment p-value is 
displayed.  C: RT-PCR for expression of Mof in OS25 UD and D3 ES cells.
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4.3 H4K16ac profile changes upon ES cell differentiation 
 
I performed ChIP for H4K16ac as previously, in UD and D3 ES cell populations.  I then 
looked for its presence or absence by qRT-PCR, at the promoters of genes which were either 
newly expressed (Hoxb1, Hoxb13, Hoxd1), or reduced in expression (Pou5f1) in D3 cells.  I 
also examined β-actin (positive control) and Olig2 (negative control).  Testing of these genes 
by RT-PCR verified their expected expression status (Fig 4.3A).  Upon differentiation, 
H4K16ac remains largely unchanged on the promoters of β-actin, Olig2, and, surprisingly, 
Pou5f1.  Given the reduction in expression of Pou5f1, I expected that it would lose 
acetylation on the promoter, but this is not the case (Fig 4.3B). 
These results were verified across larger areas using custom Nimblegen arrays.  β-actin is 
acetylated in both cell types, whilst Olig2 is acetylated in neither (Fig 4.3C).  Other 
pluripotency genes (Nanog and Sox2) show the expected pattern of loss of H4K16ac upon 




Figure 4.3:  H4K16ac follows changes in expression of cell-type specific genes upon 
differentiation 
A: RT-PCR for expression of β-actin, Olig2, Hoxb1, Hoxb13, Hoxd1, Pou5f1 in UD 
and D3 OS25 cells.  B: ChIP for H4K16ac at active or inactive promoters in UD 
(blue) and D3 (black) OS25s assayed by qRT-PCR.  Enrichment is shown as mean 
% input bound +/- SEM over three biological and three technical replicates.  C: 
Log2H4K16ac/Input in UD/D3 ES cells over β-actin and Olig2 on custom Nimblegen 
arrays.  RefSeq gene annotations are from the July 2007 (mm9) Build 37 assembly 
of the mouse genome (http://genome.ucsc.edu).  D: As C, for pluripotency factors 
Sox2 (top) and Nanog (bottom).
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The patterns seen over the four Hox loci (Fig 4.4) are broadly similar.  H4K16ac is absent 
from Hox loci in undifferentiated ES cells, but upon differentiation, the early Hox genes 
become acetylated.  By contrast, the later Hox genes remain unacetylated.  For example, in 
the Hox a locus, the novel acetylation in the D3 sample reaches to Hoxa7.  There is a peak of 
H4K16ac in both samples in the centre of the locus, the function of which is unclear, and 
after which, H4K16ac is excluded in both samples. 
In the Hoxb locus, novel acetylation covers the region from Hoxb1 to Hoxb6.  Interestingly, 
this is the same region which loses H3K27me3 in D3 samples also (Eskeland et al., 2010). 
The Hoxc locus shows a clear region of H4K16ac in the D3 sample, which stops abruptly 
upstream of Hoxc6.  
The Hoxd locus shows the smallest change in H4K16ac, with a low amount of acetylation 
over the early Hoxd genes.  
Broadly speaking, I found that H4K16ac follows changes in expression. I then wanted to 
look at the association with expression on a genome wide level.  I therefore generated a 




Figure 4.4: H4K16ac is gained over early Hox loci upon differentiation 
Log2H4K16ac/Input in UD/D3 ES cells over the four mouse Hox loci on custom 
Nimblegen arrays.  Direction of temporal colinearity is indicated with red arrow.  




4.4 Quality Control for H4K16ac ChIP-seq in D3 cells 
 
As with the UD sample (Fig 3.4) I used FASTQC to determine sequence quality of my ChIP-
seq data.  I found that in the initial sample the sequencing was of poor quality, with many of 
the reads falling below a Phred score of 30, indicating base call accuracy of ≤99.9% in these 
reads (Fig 4.5A).  This is not unuseable, previously published ChIP-seq datasets have scores 
of this level and lower (data not shown), but I made the decision to repeat the sequencing for 
the ChIP sample, and the second lane of sequencing yielded better results (Fig 4.5C).  I 
combined the two samples for alignment.  Those which were aligned, and therefore included 
in downstream analysis were of high quality (Fig 4.5D), showing that poor quality sequences 
had been discarded. 
The number of aligned reads for the D3 sample was considerably lower than the UD samples 
(36 million for the ChIP sample and 57 million for input, compared with 79 million and 105 
million respectively for the UD sample).  Therefore normalisation would be challenging, and 
some results must be interpreted with caution before conclusions can be drawn. 
The D3 sample requires a higher percentage of its reads for the peak calling algorithm to find 
the majority of the peaks it finds with 100% of the reads (approximately 60-70%) than the 




Figure 4.5: D3 H4K16ac Sequencing Quality Control 
A:  MNase digested input and H4K16ac ChIP digested with proteinase K and 
separated on a 1.3% Agarose gel, stained with SYBR Gold.  B: Quality scores 
generated in FASTQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) 
for all reads in first lane of D3 H4K16ac ChIP.  C: As B, for D3 input DNA. D: As B, 
for second lane of D3 H4K16ac ChIP. E:  Sanger quality scores for FASTQ output of 
bowtie alignment for all D3 ChIP reads.   F:  Saturation curves for D3 H4K16ac and 
UD H4K16ac (this study) .  Plotted as number of peaks found using SICER (Zang et 
al., 2009) with increasing percentage of reads randomly sampled from dataset.
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Table 4.1:  Read alignment statistics.   
 
Total Reads 
Reads Aligned to 
mm9 % reads aligned 
D3H4K16ac 70012050 36032370 51.46595479 
D3Input 70295210 57283750 81.49026086 
 




4.5 Normalisation of ChIP-seq datasets 
 
Normalisation of ChIP-seq datasets remains an open challenge.  In most publications, ChIP-
seq data is normalised either to input or, more commonly, by scaling tag density to account 
for the differences in sequencing depth.  This is the simplest way to normalise across 
multiple datasets from different experiments which may or may not carry appropriate 
controls.  I used a variety of normalisation strategies and visualised the effect on the 
appearance of H4K16ac around the positive control β-actin promoter, and Hoxb1, which by 
ChIP on chip shows an increase of H4K16ac upon differentiation. 
In all cases, the gain of H4K16ac at Hoxb1 in the differentiated sample (even when 
visualising raw data) is clear.  On the β-actin promoter however, normalisation affects 
whether a difference is detected in the level of H4K16ac between UD and D3 samples. In the 
raw sample, the level of UD H4K16ac is over 3x that of the D3 sample (reflecting the 
difference in sequencing depth).  After normalising to sequencing depth (Fig 4.6B), the 
difference is reduced to approximately 2 fold, and is eliminated entirely by quantile 
normalisation (Fig 4.6C). After the quantile normalised sample is normalised to input (Log2 
ChIP/Input), the difference remains at approximately 2 fold.   
It was unclear, however, whether the broad reduction of H4K16ac over the β-actin promoter 
might represent a biological global reduction in H4K16ac upon differentiation (excluding 
those positions which gain it), given the reduction in MOF and H4K16ac seen by Li and 
colleagues (2012).  Therefore I chose to use simple normalisation to sequencing depth for all 
visualisations.  Recent work has shown a novel way to normalise ChIP-sequencing data 
which takes into account the expectations of peaks in ChIP samples, versus the lack in input 





Figure 4.6: Three types of normalisation for ChIP-seq data (previous page) 
Wiggle tracks plotted against the mm9 mouse genome build using IGB programme 
in 200bp windows with 200bp step over β-actin (left) and Hoxb1 (right) for A: Un-
normalised data, B: Data normalised by division by #million tags in dataset, C: 
Quantile normalisation between UD and D3 datasets, and D: Log ratios of quantile 
normalised ChIP data to respective input samples (and see materials and methods 
for further details of normalisation).  
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4.6 Peak calling using NPS, MACS and SICER 
 
Peak calling can be a difficult problem for certain histone modifications which do not form 
discreet peaks in the way that transcription factors generally do.  I therefore tried three 
different methods of peak calling on my data to determine which was most suited to the 
broad peaks formed by H4K16ac. 
Firstly, I used NPS (Nuclear Positioning from Sequencing) (Zhang et al., 2008b) to position 
nucleosomes from both datasets, then calculated tag numbers from each dataset within those 
nucleosomes.  I took those which were significantly different between UD and D3 datasets, 
taking into account differences in sequencing depth. 
Secondly, I used two published algorithms, MACS (Zhang et al., 2008a) and SICER (Zang 
et al., 2009).  MACS is very widely used (cited by over one hundred articles), whilst SICER 
was designed with the variable peak width of histone modifications in mind.  Both utilise 
input DNA to select peaks significantly above background and account for differences in 




Table 4.2: Total numbers of peaks generated from NPS, MACS or SICER and number which are specific to UD or D3 dataset. 
 
Program Name Total Peaks Cell Type Specific 
 
UD D3 Merged # UD Specific # D3 Specific 
NPS N/A N/A 200000 2372 7915 
MACS 95528 44817 110000 77555 21598 





Figure 4.7: Average width of peaks called with SICER or MACS algorithms 




After calling peaks, to try to determine whether the peaks called were relevant I took the 
closest TSS within 2kb for each peak, and ran GO term analysis.  Knowing that H4K16ac 
marks the promoters of active genes, it would be expected that the closest TSS to UD 
H4K16ac peaks would be genes active in UD ES cells (and the same for the differentiated 
sample).  None of the algorithms were especially skilled at picking up peaks from the D3 
sample.  The NPS method found only one GO term enriched for each dataset, which did not 
seem relevant to UD or D3 cell types.  MACS and SICER performed better, both found UD 
specific GO terms enriched (highlighted in red – Table 4.3), but neither found any GO terms 
associated with RA induced differentiation in the D3 sample. 
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Table4.3:  Functional annotation of closest TSS to UD dataset peaks or D3 dataset peaks (<2kb) using GOrilla for biological process GO 
terms.   
Program GO term (Biological Process) P-value GO term (Biological Process) P-value 
 
UD D3 
NPS negative regulation of protein metabolic process 9.59E-04 regulation of Notch signaling pathway 2.28E-04 
     
     MACS metabolic process 2.32E-07 aromatic compound catabolic process 4.01E-04 
 
primary metabolic process 1.59E-06 glutamine family amino acid metabolic process 8.20E-04 
 
macromolecule metabolic process 7.56E-06 regulation of T-helper 1 type immune response 8.91E-04 
 
cellular macromolecule metabolic process 1.18E-05 
  
 
cellular metabolic process 1.55E-05 
  
 
regulation of primary metabolic process 1.68E-05 
  
 
developmental process 2.73E-05 
  
 
negative regulation of cellular process 3.03E-05 
  
 
reproductive process 3.70E-05 
  
 
regulation of cellular metabolic process 3.73E-05 
  
 
negative regulation of biological process 4.84E-05 
  
 
regulation of nitrogen compound metabolic process 1.18E-04 
  
 
regulation of nucleobase-containing compound metabolic process 1.23E-04 
  
 
regulation of metabolic process 1.27E-04 
  
 
negative regulation of cellular component organization 1.44E-04 
  
 
gamete generation 1.68E-04 
  
 
regulation of cellular component organization 1.70E-04 
  
 
positive regulation of cellular component organization 1.85E-04 
  
 





Program GO term (Biological Process) P-value GO term (Biological Process) P-value 
 
UD D3 
SICER regulation of cellular metabolic process 1.86E-08 
  
 
regulation of primary metabolic process 9.73E-08 
  
 
regulation of macromolecule metabolic process 1.59E-07 
  
 
regulation of metabolic process 1.79E-07 
  
 
negative regulation of biological process 3.73E-06 
  
 
regulation of response to stimulus 4.33E-06 
  
 
regulation of gene expression 4.73E-06 
  
 
regulation of nucleobase-containing compound metabolic process 4.77E-06 
  
 
regulation of nitrogen compound metabolic process 6.22E-06 
  
 
regulation of cellular biosynthetic process 6.33E-06 
  
 
developmental process 7.18E-06 
  
 
positive regulation of cellular process 7.27E-06 
  
 
regulation of signal transduction 8.19E-06 
  
 
regulation of biosynthetic process 8.97E-06 
  
 
negative regulation of cellular process 9.49E-06 
  
 
positive regulation of biological process 1.04E-05 
  
 
negative regulation of signaling 1.27E-05 
  
 
negative regulation of developmental process 1.50E-05 
  
 
regulation of cellular macromolecule biosynthetic process 1.57E-05 
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Knowing that H4K16ac peaks are generally wider than most other active histone 
modifications (Fig 3.10) - promoter peaks are frequently around 2kb wide - I analysed the 
width of peaks picked up by SICER and MACS.  MACS peaks had an average width of 
around 1kb in UD, and around 500bp in the D3 sample.  I was not expecting any difference 
between peaks in the two samples, and indeed, the peaks found in SICER do not differ in 
size profile.  In addition, SICER peaks are generally wider than peaks found by MACS. 
Finally, I visualised a selection of UD or D3 only peaks determined by the three methods 
(Fig 4.8A).  NPS called fewer peaks than the other two methods, and peaks detected were the 
width of a single nucleosome.  The method did not take into account the surrounding peaks.  
This was not useful for my analysis, and so I decided not to use this data in further work.  
MACS peaks were generally good for UD only H4K16ac peaks, but the very large number 
found indicated that regions of H4K16ac may have been split into separate peaks, or 
potentially that the peaks generated contain false positives.  The peaks called by SICER fell 






Figure 4.8: Visualisation of peak calling results over two regions of the genome. 
Wiggle tracks plotted against the mm9 mouse genome build using IGB programme in 200bp windows with 20bp step for UD specific (A) 




4.7 H4K16ac changes with gene expression upon 
differentiation 
 
To test whether genes upregulated in the different samples also saw an increase in H4K16ac 
around the TSS, I took genes which were determined as upregulated in UD and D3 samples 
(with an adjusted p value of <0.005) and mapped the UD and D3 H4K16ac tag density 
around both these sets of genes.  There is an increase of UD H4K16ac around the TSS of 
genes upregulated in UD cells (Fig 4.9A) (p-value by Wilcox test <2.2x10-16).  Conversely, 
there is an increase of D3 H4K16ac around the TSS of genes upregulated in D3 cells (Fig. 
4.9B) (p-value by Wilcox test <2.2x10-16).  The difference remains significant if ChIP tag 
values are normalised to input (Log2ChIP/input, p-value by Wilcox test <0.0002 for both 
gene sets).  Interestingly, the increase over upregulated UD genes is approximately two fold 
higher on average than the increase over upregulated D3 genes, which may reflect the 
declining global levels of H4K16ac during differentiation.  I also wanted to look at the genes 
which go from silent or very lowly expressed in UD ES cells to highly active in D3 cells.  I 
divided the gene expression profile into quartiles, and took genes which fell into the lowest 
quartile in UD expression, and the highest quartile in D3 expression (n=34).  I then mapped 
the tag density of UD H4K16ac and D3 H4K16ac around these genes.  Although the 
H4K16ac peak on these genes is much higher in the D3 sample (Fig.4.9C), this difference is 
not significant (Wilcox test, p=0.4).  Therefore the difference is likely due to a subset of 
genes within the set, and on other genes H4K16ac state does not correlate with expression 
level. 
From this data I conclude that H4K16ac follows changes in expression during 
differentiation, and is found on active cell-type specific genes.  These peaks of H4K16ac are 
then generally lost upon gene silencing.  I did however note the retention of H4K16ac at 
Pou5f1 during differentiation, which requires further study (Fig 4.3B).  Retention of 
H4K16ac on the promoter of Pou5f1 is noted in both the qRT-PCR and ChIP-chip datasets, 
but is not seen in the ChIP-seq dataset (for other pluripotency genes, loss of H4K16ac upon 
differentiation is consistent between ChIP-chip and ChIP-seq).  This discrepancy could 
reflect the lower sequencing depth of the D3 ChIP-seq sample, which may result in some 






Figure 4.9: H4K16ac increases around TSS with increase in gene expression in UD 
and D3 cells (Previous page) 
A: Normalised (average RPM) tag counts of UD H4K16ac surrounding the TSS of 
genes significantly upregulated in UD ES cells (blue) or D3 cells (black).  B: 
Normalised (average RPM) tag counts of D3 H4K16ac surrounding the TSS of 
genes significantly upregulated in UD ES cells (blue) or D3 cells (black).  C: 
Normalised (RPM) tag counts of D3 H4K16ac (black) and UD H4K16ac (blue) 






Fig 4.10:  H4K16ac is retained on Pou5f1 promoter upon differentiation, but this is 
not detected in ChIP-seq dataset. 
Log2H4K16ac/Input in UD/D3 ES cells over Pou5f1 (A) and Nanog (B) on custom 
Nimblegen arrays RefSeq gene annotations are from the July 2007 (mm9) Build 37 
assembly of the mouse genome (http://genome.ucsc.edu) (top), and wiggle tracks of 
H4K16ac ChIP-seq plotted against the mm9 mouse genome build using IGB 
programme in 200bp windows with 20bp step.
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However, having noticed that the increase of H4K16ac was lower on the D3 upregulated 
genes, I wanted to look at how numbers of H4K16ac peaks differed between the samples 
genome wide without restriction to transcription sites. 
I therefore called peaks using SICER, which takes into account input background, and 
determined the number of UD specific, D3 specific, and overlapping peaks (Fig 4.11).  There 
are almost four times as many UD specific peaks as there are D3 specific ones, and around 
20,000 that are shared between UD and D3, and so may not be cell type specific.  Some of 
the UD specific peaks may be due to false positive peak calls from the UD sample, or false 
negative peak calls from the D3 sample; always a potential difficulty in ChIP-seq analysis.  
UD ES cells have more specific H4K16ac, however, which would be consistent with the 





Figure 4.11:  Number of H4K16ac peaks which overlap between UD and D3. 
Venn diagram of peaks unique to UD, or to D3 ES cells.  Within overlapping circle, 
number of UD peaks which overlap D3 peaks (blue) and number of D3 peaks which 




Having shown that an increase in expression generally leads to an increase in H4K16ac, I 
wanted to find out whether gain or loss of an H4K16ac peak over the promoter during 
differentiation would predict a change in expression. 
Overall, there is a large increase in expression level between genes with no H4K16ac, and 
genes which have an H4K16ac peak (Fig 4.12A), so presence or absence of a H4K16ac peak 
is a general predictor of gene expression, but I also wanted to look at how this pattern holds 
over differentiation induced changes in H4K16ac peaks and gene expression. 
I therefore generated a list of putative promoters around mouse TSSs (2kb upstream, and 
0.1kb downstream of the TSS), and determined a list of those overlapped (≥ 150bp) by a 
peak unique to UD, or unique to D3, then determined the log fold UD:D3 change in 
expression of those genes.  Surprisingly, there was only a very small (though statistically 
significant, p <0.001 by Mann-Whitney test) shift towards UD expression in the genes 
overlapped by a UD peak, and towards D3 expression in genes overlapped by a D3 peak.  
Genes overlapped by a peak in neither sample, or by a peak in both, have a log fold change 
value close to 0, indicating generally there is no change in expression in that set of genes 
(Fig 4.12B). The result was interesting, as if H4K16ac presence is determined simply by 
changes in chromatin environment induced by transcription, I would expect that there would 
be a large change shown by this experiment, since presence of an H4K16ac peak followed 
by loss upon differentiation would place the gene in the category shown in Figure 4.9C.  
This is not the case however; some genes with a peak in UD H4K16ac are lowly expressed 
in that cell type. 
To investigate this further, I visualised the peaks over some genes which fell into the lower 
quartile of expression in undifferentiated cells (Fig 4.11C), to see whether the peaks were 
false positives (their presence is not due to sequencing bias, as that is accounted for in 
SICER peak calling against MNase digested input DNA).  As shown in the representative 
examples, the peaks found fall broadly over the promoters, as on active genes, and are lost 
upon differentiation, though some, as in the example Shfm1, show a very small peak, which 
could be a false positive background peak.  This indicates that there at least some situations 
where H4K16ac presence can be decoupled from activity of genes.  This situation is 
reminiscent of that seen at polycomb regulated developmental genes where the active histone 
mark H3K4me3 falls in combination with H3K27me3 over the promoters of silent genes 
poised for expression (Bernstein et al., 2006; Zhao et al., 2007).  H4K16ac is not marking 
this particular set of genes, however, since the Hox genes are polycomb regulated, and 




Figure 4.12: H4K16ac does not always correlate with expression. 
A:  Boxplot for distribution of expression level (mean probe signal intensity) in UD 
and D3 cells, for genes with a TSS overlapped by a peak of H4K16ac in both UD 
and D3 samples, or in neither.  Outliers were excluded.  B:  Boxplot for distribution 
of log fold change UD/D3 (i.e. –ve numbers = more expression in D3 cells) for 
genes with H4K16ac on the promoter only in UD or D3 cells, in both, or in neither.  
C:  Four examples of genes with H4K16ac peak defined by SICER in UD cells, 
which have expression in lowest quartile for UD cells.  Normalised (RPM) wiggle 
tracks plotted against the mm9 mouse genome build using IGB programme in 200bp 
windows with 20bp step.
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I looked at GO term enrichment of genes which have a peak of H4K16ac in UD cells only, 
and those which have a peak in D3 cells only (Table 4.2).  In the D3 gene set, the enriched 
GO terms are as expected for genes which are expressed only in D3 cells.  Whilst the UD set 
does show pluripotency associated GO terms (eg negative regulation of cell differentiation), 
there are also significant GO terms associated with development (which is not present when 
GO terms are analysed for UD expression data (Fig. 4.2).  Therefore, whilst, broadly 
speaking, H4K16ac is associated with expression, and increases around the TSS of genes 
which have differentiation induced increases in expression, there are some cases where 
H4K16ac is present on promoters of silent (or very lowly expressed) genes.  This is similar 
to H3K14ac, which marks a subset of inactive promoters in mouse ES cells (Karmodiya et 
al., 2012), and it was also noticed that MOF marks a subset of development associated 




Table 4.4:  Functional annotation of promoters with H4K16ac peak in UD sample only (top) or in D3 sample only (bottom), using GOrilla 
for biological process GO terms.  
GO Term Description P-value FDR q-value 
GO:0032502 developmental process 7.09E-28 7.57E-24 
GO:0048869 cellular developmental process 4.41E-23 2.36E-19 
GO:0048856 anatomical structure development 1.40E-22 4.99E-19 
GO:0051239 regulation of multicellular organismal process 1.78E-21 4.76E-18 
GO:0030154 cell differentiation 3.07E-18 6.55E-15 
GO:0023051 regulation of signaling 3.44E-18 6.12E-15 
GO:0007610 behavior 4.29E-17 6.54E-14 
GO:0048731 system development 7.19E-17 9.6E-14 
GO:0048518 positive regulation of biological process 1.41E-16 1.68E-13 
GO:2000026 
regulation of multicellular organismal 
development 4.25E-16 4.54E-13 
GO:0007275 multicellular organismal development 6.60E-16 6.40E-13 
GO:0048522 positive regulation of cellular process 1.3E-14 1.16E-11 
GO:0050793 regulation of developmental process 2.70E-14 2.22E-11 
GO:0032879 regulation of localization 1.06E-13 8.1E-11 
GO:0010646 regulation of cell communication 1.25E-13 8.89E-11 
GO:0009966 regulation of signal transduction 1.66E-13 1.11E-10 
GO:0048583 regulation of response to stimulus 2.87E-13 1.80E-10 
GO:0051094 positive regulation of developmental process 4.06E-13 2.41E-10 
GO:0044057 regulation of system process 6.42E-13 3.61E-10 
GO:0045595 regulation of cell differentiation 8.97E-13 4.79E-10 
GO:0007399 nervous system development 3.47E-12 1.76E-09 
GO:0051093 negative regulation of developmental process 1.42E-08 0.00000271 
GO:0045596 negative regulation of cell differentiation 1.76E-07 2.21E-05 
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GO Term Description P-value FDR q-value 
GO:0003002 regionalization 2.7E-10 0.00000288 
GO:0007389 pattern specification process 2.8E-10 0.0000015 
GO:0009952 anterior/posterior pattern specification 4.94E-10 0.00000176 
GO:0048704 embryonic skeletal system morphogenesis 0.000000357 0.000952 
GO:0032502 developmental process 0.000000378 0.000808 
GO:0048705 skeletal system morphogenesis 0.000000776 0.00138 
GO:0030154 cell differentiation 0.00000383 0.00584 




4.8 H4K16ac on enhancers is cell-type specific 
In the previous chapter, I showed that H4K16ac marks the active enhancers of pluripotent ES 
cells.  Here, I wanted to determine whether these active enhancers are still marked after 3 
days of differentiation or whether they are specific only to pluripotent ES cells.  Also, I 
wanted to determine whether there are any putative enhancers which become H4K16ac in 
the differentiated samples.   
Given that there is no data for H3K4me1 or H3K27ac in D3 ES cells publicly available, I 
used the universal enhancer marking property of H3K4me1 to identify a set of candidate 
enhancers.  H3K4me1 is found on both active and inactive/poised enhancers; therefore, 
H3K4me1 marked enhancers in ES cells may be inactive in ES cells, but activate upon 
differentiation along a specific lineage (Creyghton et al., 2010).  Therefore, the locations of 
these candidate enhancers (defined using an ES cell H3K4me1 ChIP-seq dataset) may be 
used to determine putative enhancers (which may be active or inactive) in differentiated 
cells.  I then used H4K16ac ChIP-seq datasets to separate this list of enhancers to those 
which are active (defined by presence of H4K16ac) in UD ES cells or D3 cells (Fig 4.13A).  
The bulk of enhancers were either only marked by H3K4me1 (and therefore active in neither 
cell type) or marked by H4K16ac in both cell types (totalling ~18,000 enhancers).  However, 
a large number were specific to UD H4K16ac, whilst a much smaller proportion (only 
around 1000 regions) were putatively active only in D3 cells (an example is shown in Fig 
4.13B).  There were no significantly enriched GO terms (p-value ≤ 10-5) found from a list of 
the closest TSSs (< 10kb distance from enhancer midpoint) to these enhancers. 
Therefore, it seems that H4K16ac on enhancers is more important for UD specific enhancers 
than across different cell types, although without functional data this cannot be proven.  This 
agrees with data from previous studies which have not shown H4K16ac to be associated with 
enhancers in CD4+T cells. 
Secondly, I looked at the enhancer marks surrounding the core pluripotency genes, Nanog, 
Klf4, and Sox2.  All these pluripotency genes have a broad region of 
H3K4me1+/H3K27ac+/H4K16ac+ in their vicinity, indicating the presence of one or more 
enhancers active in ES cells.  Upon differentiation, the H4K16ac on all these regions is 




Figure 4.13: Most H4K16ac enhancers are unique to UD ES cells 
A:  Venn diagram showing enhancers (H3K4me1+/H3K4me3-) that are overlapped 
by UD H4K16ac compared to D3 H4K16ac.  B: Normalised (RPM) wiggle tracks 
plotted against the mm9 mouse genome build using IGB programme in 200bp 
windows with 20bp step for UDH4K16ac/D3H3K16ac/UDH3K4me1/UDH3K4me3 at 
a putative D3 specific enhancer (location highlighted in purple). 
C: As B, at regions surrounding core pluripotency genes Nanog, Klf4 and Sox2. 
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To investigate whether other known enhancers of other cell types might carry H4K16ac, I 
used immortalised mesenchymal cells.  These are derived from the posterior distal limb of 
E11.5 embryos, and which show expression of genes which correlate with their 
developmental origin (Williamson et al., 2012). 
 A “regulatory archipelago” was identified in a 600kb gene desert upstream of Hoxd, 
between Lnp and Atp5g3 (Montavon et al., 2011) (Fig 4.14A), which acts on the Hoxd genes 
in limb cells.  The term “regulatory archipelago” in this instance refers to a group of 
regulatory elements which are distributed throughout the gene desert upstream of the Hoxd 
locus, and which have an effect on the transcription of the Hox genes in the developing limb.   
I therefore used custom limb arrays (Lettice et al., 2012) and existing datasets for H3K27ac 
and H3K4me1 (Silvia Peluso, unpublished) to determine the epigenetic landscape on this 
archipelago in posterior derived limb cells. 
There is a low level of H3K27ac and H3K4me1 throughout this region, indicating the five 
regions known to be enhancer elements in the developing limb (Montavon et al., 2011) are 
also candidate enhancers in the limb cells used.  However H4K16ac is excluded from the 
region entirely.  By contrast, H4K16ac is present over the ubiquitously expressed Mtx2 and 




Figure 4.14: H4K16 is not acetylated in 14fp limb cells on a regulatory region active 
in limb cells 
A:  Interactions between DNA fragments in gene desert and Hoxd13 (black), 
H3K4me1 (purple), H3K27ac (blue), and RNApolII (orange) in developing digits.  
Regulatory regions are highlighted in purple.  Adapted from (Montavon et al., 
2011).B:  H4K16ac (green), H3K27ac (teal) and H3K4me1 (orange) in 14fp limb 
cells over Hoxd region and distal gene desert.  Regulatory regions defined in A are 
highlighted in purple.  H3K27ac and H3K4me1 data provided by Silvia Peluso.  
Log2ChIP/Input on custom Nimblegen arrays.  RefSeq gene annotations are from 
the July 2007 (mm9) Build 37 assembly of the mouse genome 




4.9 Summary of H4K16ac profile upon differentiation 
 
I conclude that H4K16ac is found on transcribed genes upon differentiation, but presence of 
H4K16ac on the promoter of a gene is not necessarily predictive of its expression level, as 
some lowly expressed/silent genes show a distinct peak of H4K16ac.  Acetylation of inactive 
genes has also been found specifically for H3K14ac (Karmodiya et al., 2012), though unlike 
H3K14ac (and H3K9ac from the same study), H4K16ac is not found over bivalent promoters 
such as the Hox genes in pluripotent ES cells. 
Upon differentiation, the H4K16ac which is found on many enhancers is lost; by contrast 
very few enhancers gain H4K16ac in D3 cells.  All enhancers located close to pluripotency 
genes lose their H4K16ac, indicating that their acetylation is cell type specific.  I failed to 
detect any H4K16ac on a known enhancer region in immortalised limb cells.  H3K4me1 and 
H3K27ac can be detected here, indicating that H4K16 acetylation of enhancers may be 
largely specific to UD ES cells. 
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Histone lysine hyperacetylation neutralises the positive charge carried by an unmodified 
lysine, and generally correlates with euchromatin rather than compact heterochromatin 
(Shahbazian and Grunstein 2007).  Within specific euchromatic loci, histone acetylation 
colocalises with DNAseI hypersensitive sites (Hebbes et al. 1994), showing its potential 
ability to determine chromatin structure.  Additionally, nucleosomes with acetylated histones 
have decreased strength of interaction with the DNA (Hong et al. 1993), and increased 
accessibility of DNA to transcription factors and transcriptional machinery (Vettese-Dadey 
et al. 1996). 
Amongst the numerous potentially acetylated lysine residues, H4K16ac is specifically 
important for the process of chromatin decompaction.  In vitro, addition of H4K16ac must be 
removed prior to decompaction (Robinson et al. 2008).  Addition of H4K16ac to nucleosome 
arrays causes them to decompact from a 30nm fibre like structure and inhibits their ability 
for self-association (an in vitro approximation of chromatin fibre interactions) (Shogren-
Knaak et al. 2006; Allahverdi et al. 2010).  The interaction between H4K16 and H2A/H2B 
on the neighbouring nucleosome (Luger et al. 1997; Liu et al. 2011) is important for 
nucleosome-nucleosome interaction; acetylation of H4K16 abrogates this (whilst mutation of 
the lysine to an uncharged glutamine residue does not), demonstrating a direct effect of 
H4K16ac on nucleosome folding. 
I used the system of Retinoic Acid (RA) differentiation and the associated changes in 
H4K16ac to assay whether a change in H4K16ac state alone was a predicting factor for 
changes in chromatin compaction state in vivo.  I tested this using 2D Fluorescence In-Situ 
Hybridisation (FISH), which measures changes in interprobe distance between two points in 
a region, which can be inferred to be a result of changes in chromatin compaction state 
(Chambeyron and Bickmore 2004). 
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5.2 Detecting Changes in Chromatin Compaction using 2D 
FISH 
 
2D FISH gives a measure of chromatin compaction over specific genomic regions.  For 
example, between different regions in the same cell type (Fig 5.1A)(Yokota et al. 1997), the 
same regions between wild type and mutant cells (Eskeland et al. 2010).  Most relevant for 
this study, is measurement of changes during differentiation (Chambeyron and Bickmore 
2004). 
To measure chromatin compaction changes by FISH, fosmid pairs flanking the region of 
interest are selected using Ensembl (Ensembl61, NCBIM37, July 2007 genome assembly).  
The probes are labelled with DIG-11-dUTP or biotin-16-dUTP and hybridized to MAA fixed 
ES cells or D3 cells, then detected with fluorescein or Texas Red-conjugated antibodies to 
DIG and biotin respectively.  The physical distance between the two probes in the different 
cell types can then be measured.  Chromatin behaves according to a random walk model, 
meaning there is a linear relationship between the interphase interprobe distance2 and the 
genomic distance (Fig 5.1B) at distances from 100kbp to 1.5Mbp.  Therefore larger values at 
the same genomic distance suggest a less compacted chromatin state.  At greater genomic 
distances (1.5Mbp-200Mbp), chromatin behaviour deviates from the random walk model; 
physical interprobe distance does not increase at the same rate (as a function of genomic 
distance) as at smaller genomic distances.  This is explained with a “giant loop” model, of 
large loops on a flexible backbone (Sachs et al. 1995). 
Therefore, at genomic distances lower than 1Mbp, it is possible to use 2D FISH to measure 
compaction.  For example the  gene enriched Giemsa-negative bands of mitotic chromatin 
show greater interprobe distances/genomic distance than Giemsa-positive (less enriched in 




Figure 5.1: Mean physical interprobe distance2 is proportional to genomic interprobe distance 
A:  Relationship between interprobe distance and genomic distance in gene rich – band Xq28 (open circles) and gene poor – band Xp21.3 
(black circles) regions.  Adapted from (Yokota et al. 1997).  B:  Illustation of how mean interprobe distance2 is proportional to genomic 
distance.  Since small interprobe distances occur over regions with large genomic separation (due to random walk model behaviour of the 
chromatin fibre), raw interprobe distance mean is reduced.  Squaring the dataset means that large interprobe distances which occur only 
across regions with large genomic distances are high enough to increase the mean.  Across short genomic distances, squaring the 
interprobe distance has little effect on the mean.
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5.3 Loss of H4K16ac does not predict compaction of 
chromatin 
 
To analyse the relationship between H4K16ac and chromatin compaction in ES cells, I first 
looked for regions of the genome which showed large (>100kb) domains of H4K16ac in UD 
ES cells which were subsequently lost upon differentiation. I therefore centred my search 
around genes associated with pluripotency, starting with the core pluripotency factors, 
Pou5f1, Nanog, and Sox2.  I visualised the H4K16ac profile (along with MNase digested 
input DNA, to exclude regions with high background) in the Integrated Genome Browser 
(IGB) (Fig 5.2).  All the loci encoding core pluripotency factors had large domains of 
H4K16ac in their vicinity, which, as expected, were lost upon differentiation.  There was 
little background, evidenced by low amounts of input DNA in both samples.  I therefore 
selected Sox2 and Nanog for further investigation, and designed probes surrounding the 
H4K16ac domains at these loci for 2D FISH (Table 5.1). 
For initial analysis, I looked at raw interprobe distance squared (d2), and for both Nanog and 
Sox2, along with the control α-globin locus, and found no significant difference between UD 
and D3 cells (p>0.05, Wilcox test) (Fig 5.3).  Since nuclear area can alter with cell type, and 
can also be affected by humidity on the day of slide preparation, it is important to normalise 
to area (Fig 5.4), but this does not reveal any significant change in chromatin compaction 




Figure 5.2: Large domains of H4K16ac in UD ES cells 
Three locations in UD ES cells with a large (>100kb) domain of H4K16ac lost upon 
differentiation.  Normalised (RPM) wiggle tracks plotted against the mm9 mouse 
genome build using IGB programme in 200bp windows with 20bp step.  
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Table 5.1:  Statistics of d2 and d2/area for all datasets from 2D FISH. 
            
p-value 
            
 Wilcox 
test 
Region Probe 1 Probe 2 Separation (bp) 
Cell 









d, UD to 
D3 
Nanog WI1-2049I9  WI1-196C18  305863 UD  0.521 0.334 0.629 0.578 0.918 0.356 0.566 0.34 
    
D3 0.549 0.289 0.610 0.537 0.881 0.423 0.693 
 Sox2 WI1-1766B8 WI1-1185J11 142984 UD  0.222 0.109 0.394 0.330 0.837 0.260 0.660 0.06 
    
D3 0.155 0.076 0.331 0.275 0.832 0.215 0.650 
 α-
globin WI1-2837A17 WI1-2903N21 95495 UD  0.325 0.085 0.420 0.291 0.693 0.387 0.923 0.06 
    
D3 0.236 0.049 0.347 0.222 0.640 0.342 0.987 
  
       
p-value  











d2/r2, UD to 
D3 
Nanog WI1-2049I9  WI1-196C18  305863 
UD  0.004 0.003 






UD  0.002 0.001 







UD  0.003 0.001 






Figure 5.3 Loss of H4K16 acetylation does not correlate to decrease in interprobe distance 
Boxplots indicating the distribution of unnormalised squared interprobe distances (d2) for UD and D3 cells.  Boxes show the median and 
interquartile range of the data; circles indicate outliers.  n=50 nuclei.  Statistical significance of differences were examined by Mann-





Figure 5.4: Loss of H4K16 acetylation does not correlate to chromatin compaction in 
vivo. (Previous page)  
A: H4K16ac (RPM/bp in 200bp sliding window with 20bp step) across the Nanog, 
Sox2 loci and control (Hbq-Il9r) loci in undifferentiated ES cells (UN, top row) and in 
differentiated cells (D3, bottom row). The position of fosmid probes (green and red 
boxes) used in FISH is indicated below genomic maps from the mm9 assembly of 
the mouse genome.  B: Example FISH images of nuclei from undifferentiated (UN; 
left) and differentiated (D3; left) ES cells, hybridized with probe pairs cross the 
Nanog, Sox2 and Hbq-Il9r loci. Nuclei were counterstained with DAPI (blue).  Scale 
bar = 20μm.  C: Boxplots indicating the distribution of squared interprobe distances 
(d2) normalised to nuclear radius2 (r2) for UD and D3 cells.  Boxes show the median 
and interquartile range of the data; circles indicate outliers.  n=50 nuclei.  Statistical 




5.4 Summary of association with chromatin compaction 
 
Loss of a large domain of H4K16ac during ES cell differentiation does not lead to a change 
in chromatin compaction over that domain at a level which can be detected by FISH. These 
experiments do not rule out the possibility that chromatin decompaction occurs on a 
nucleosomal level which cannot be detected by FISH, or that removal of H4K16ac may be 




Chapter 6:  Preliminary investigation into the MOF complex 
in ES cells 
6.1 Introduction 
The interaction partners of MOF are extremely important for its activity.  Although on free 
histones, MOF alone displays the ability to acetylate H4K16, on nucleosome arrays it can 
only show HAT activity when its interaction partners are also present.  Even on free 
histones, the interaction partners increase HAT activity and are required for specificity 
(Morales et al., 2004).  
In Drosophila, MOF is vital for the process of dosage compensation in male flies, which 
carry only one copy of the X chromosome to the females’ two, but which require equal 
dosage of many of the genes contain therein.  However, MOF is also expressed in female 
flies, implying a division of function.  In males, MOF localisation to the X chromosome is 
mediated by binding to MSL1 in association with MSL3; this binding also increases HAT 
activity.  MOF is also found at the promoters of autosomal genes in both males and females.  
This binding is independent of the MSL complex and instead occurs with MOF in the 
context of the NSL, or Non-Specific Lethal complex (Raja et al., 2010; Feller et al., 2011). 
In mammalian cells, MOF has also been documented to be a member of several complexes, 
including the mammalian homolog of the MSL complex (Smith et al., 2005), potentially the 
MLL complex (Dou et al., 2005), and the mammalian homolog of the NSL complex.  As in 
Drosophila, the complexes are functionally distinct;  within the MSL complex, MOF has 
specific substrate specificity to H4K16ac, whilst when part of the NSL complex, MOF is 
reported to exhibit acetylation activity on H4K5 and H4K8 as well as H4K16 (Cai et al., 
2009). 
As shown in previous chapters, MOF is of particular importance in the context of 
undifferentiated embryonic stem cells (UD ES cells).  I therefore wanted to look at the 
binding profile of MOF (recently published by Li and colleagues, 2012) and its interaction 
partners in ES cells and by contrast, in Mouse Embryonic Fibroblasts (MEFs).  In addition, I 
wanted to examine the effect on UD ES cells, and upon differentiation, of changes in the 
level of MOF protein using overexpression.
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6.2 MOF over-expression in ES cells 
 
As in previous studies, I first opted to look at MOF complexes by adding a flag tag to enable 
a simple pull down unaffected by poor antibody specificity.  I first tried an approach which 
had previously been successfully used for the over-expression of Ring1B (Eskeland et al., 
2010) in ES cells, utilising the pTLC plasmid (Fig 6.1A).  I selected for ES colonies stably 
containing the construct, which results in expression of dsRed fluorescent protein and the 
gene for puromycin resistance.  To determine whether the population was pure, I used FACS 
to check levels of dsRed and subsequently introduced Cre, under control of a CAG promoter. 
pTLC contains two LoxP sites; excision at these sites should result in loss of dsRed and 
puromycin resistance, and gain of expression for Flag-MOF and GFP.  GFP (and therefore 
Flag-MOF) expressing cells can then be FACS sorted prior to use in downstream 
experiments.  
The initial transfection and stable cell line generation was successful, all selected colonies 
expressed dsRed as detected by FACS to a similar extent (an example is shown in Fig. 6.1B).  
However, after addition of Cre, only a very small proportion of the population was GFP 
positive.  Around 25% remained dsRed positive, but surprisingly, around 70% showed loss 
of dsRed, without an associated gain of GFP.  The low number of GFP positive cells was 
sorted, but a subsequent analysis 96 hours later showed that the majority of these had lost 
expression of GFP (the population going from 100% GFP positive to 6.7 % GFP positive) 
(Fig. 6.1C).  This suggests that MOF over-expression is detrimental to ES cells and made the 
construct impractical for experiments which required a large number of cells.  
As a different approach for MOF expression was needed, I then put flag-MOF into a 
construct allowing for direct expression in transfected cells (Fig. 6.2).  I first tested the 
construct for expression in the easily transfected Human Embryonic Kidney (HEK) 293T 
cell line.  This showed strong expression of flag-MOF, but not in control transfection with 
the empty vector, or in untransfected controls.  By contrast, the transient expression of the 
same construct in ES cells showed that no Flag could be detected by western blot. This 





Figure 6.1 Overexpression of Flag-MOF in ES cells using pTLC strategy 
A:  Illustration of system for Flag-MOF overexpression.  Schematic of pTLC plasmid 
as initially inserted.   LoxP sites are represented by scissors.  B:  FACS analysis for 
untransfected control (left), and stable, puromycin resistant colonies (right).  Cells 
exposed to a 561nm laser for excitation of RFP.  x-axis shows fluorescence 
intensity.  C:  Cre-loxed stable puromycin resistant cells, 5 days after Cre 
transfection, split harshly and allowed to form colonies.  Cells exposed to a 561nm 
laser and a 525nm laser for excitation of RFP and GFP respectively.  Results then 
plotted according to intensity; x-axis shows fluorescence intensity of GFP, y-axis 
shows fluorescence intensity for RFP.  D: As C, for Cre-loxed GFP sorted cells, 96 




Figure 6.2 Overexpression of Flag-MOF in ES cells using Zeocin resistance strategy 
A:  Schematic of pCAGxn plasmid.  B:  Immunoblot for anti-FLAG, of cells 
transiently transfected (72 hours post-transfection) with flag-p52 (flag western blot 
positive control), flag-MOF (fl-MOF), empty vector (e.v.) or non-transfected control.  
Position of molecular weight markers is indicated on the right (kD).  Cell type is 
indicated above.  C:  As B, for zeocin resistant stable ES cell lines, and transiently 
transfected flag-p52 in 293T cells (flag western blot positive control).
175 
 
6.3 Preliminary data for interaction partners of endogenous 
MOF 
Given the difficulties involved in overexpressing Flag-MOF, I decided to focus instead on 
isolating the complex of MOF using the endogenous protein.  Work by colleagues in the lab 
showed that after running nuclear extract of ES cells on a gel filtration column, MOF 
separates into a fraction corresponding to approximately 700kDa in size; interestingly, MLL 
is also found in this fraction (Ragnhild Eskeland, unpublished, Fig 6.3A).   
The interaction between MOF and MLL has been shown previously (Dou et al., 2005), but 
was not seen in subsequent work (Mendjan et al., 2006; Cai et al., 2009).  In addition, all 
previous work on mammalian MOF interactions has been undertaken in human cells (293T 
and HeLa) using overexpression.  To investigate this further, using an unbiased approach 
which did not rely on a large number of high-quality antibodies, I used the SILAC technique 
(Fig 6.3B).  Briefly, cells are labelled with either heavy or medium lysine/arginine; essential 
amino acids which the cell cannot produce.  They are then lysed and used in a traditional 
immunoprecipitation.  Pull down from IgG and proteins of interest are then pooled and 
washed, boiled, and separated by SDS-PAGE.  Ten gel slices per fraction were cut and 
digested in-gel with trypsin.  The purified peptides were then separated (Ultimate U3000, 
trap-enriched nanoflow LC-system, Dionex), and identified (LTQ Orbitrap XL, 
Thermoscientific, via nano ES ion source, Proxeon Biosystems).  Quantification (MaxQuant, 
based on 2D centroid of isotope clusters within each SILAC pair) can distinguish between 
the samples, to give a ratio of protein of interest to IgG.  Background proteins would be 
expected to have a ratio of 1:1 and can therefore be disregarded.  SDS-PAGE, LC-MS/MS 
and quantification were carried out by Dundee Cell Proteomics. 
I performed these experiments on MEFs and ES cells (Table 6.1).  In MEFs, the result falls 
in line with data previously seen in the literature, as MOF is found in a complex with the 
MSL complex homologues.  In ES cells, however the MSL proteins were not found.  A 
considerable amount of further work is needed to verify this result; for example antibodies 
for the MSL proteins must be acquired and optimised, and reciprocal IPs performed in both 
cell types.  Given the important role of MOF in ES cells it would be interesting if complexes 
differ between ES cells and other cell types.  I did not find MOF in complex with MLL in 




Figure 6.3 Determining interaction partners for MOF in ES cells 
A:  Immunoblot of a SDS-polyacrylamide gel for aliquots of fractions (input = I and 
numbered column fractions 12-40) derived from ES cell nuclear extract on a 
Superose 6 gel-filtration column (Ragnhild Eskeland, unpublished).  Arrows indicate 
approximate complex sizes.  Numbers above blot indicate fraction numbers (0.5mL) 
from start to finish.  B:  Work flow for labelling cells with heavy isotope containing 
amino acids.  Cells were seeded into DMEM containing “light” (R0K0), “medium” 
(R6K4), or “heavy” (R10K8) amino acids (Dundee Cell Products).  After at least four 
cell doublings, the cells are collected, lysed, and used in conventional IP for IgG, 
MOF, or p75.  The beads are then pooled and washed, and are then processed for 
LC-MS/MS by Dundee Cell Proteomics.  Identical pairs of peptides with different 
isotope compositions can be distinguished by the mass spectrometer based on 
mass differences, and the relative ratio of abundance can be calculated.
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Table 6.1 Results of SILAC experiment in MEF and ES cells.  








Clint1 67.73 clathrin interactor 1 52.001 17 
Msl1 67.319 Isoform 1 of Male-specific lethal 1 homolog 39.618 15 
Cltc 191.98 Clathrin, heavy polypeptide 27.552 93 
Ppp1r9b 89.519 Isoform 1 of Neurabin-2 26.828 25 
Ap2a1 107.66 Isoform A of AP-2 complex subunit alpha-1 22.1 34 
Kat8 52.573 Isoform 1 of Probable histone acetyltransferase MYST1 21.532 8 
Ap2b1 105.72 Isoform 2 of AP-2 complex subunit beta 19.69 34 
Msl3 60.291 Isoform 1 of Male-specific lethal 3 homolog 16.863 2 
Ap2a2 104.02 adaptor protein complex AP-2, alpha 2 subunit 11.893 25 
Msl2 62.537 Male-specific lethal 2 homolog 10.357 4 
Bmp2k 126.18 Isoform 1 of BMP-2-inducible protein kinase 10.139 3 
Reps1 86.518 Isoform 1 of RalBP1-associated Eps domain-containing protein 1 8.7978 4 
Actn4 104.98 Alpha-actinin-4 8.7417 67 
Ap2m1 49.654 AP-2 complex subunit mu 8.2163 5 
Spna2 285.34 spectrin alpha 2 6.9795 66 
C330027C09Ri
k 102.11 Protein CIP2A 6.3761 2 
Ppp1ca 37.54 Serine/threonine-protein phosphatase PP1-alpha catalytic subunit 6.3231 9 
Spnb2 274.22 Isoform 1 of Spectrin beta chain, brain 1 6.2025 42 
Pml 98.241 Isoform 1 of Probable transcription factor PML 5.6959 5 
Col5a2 145.02 Collagen alpha-2(V) chain 5.3838 3 
Col5a1 183.67 Collagen alpha-1(V) chain 5.3265 9 
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Lima1 84.059 LIM domain and actin binding 1 isoform a 5.1746 43 
Cenpj 153.05 Centromere protein J 4.39 2 
Actn1 103.07 Alpha-actinin-1 4.3391 61 
Ppp1cb 37.186 Serine/threonine-protein phosphatase PP1-beta catalytic subunit 3.8085 11 
Svil 243.16 Supervillin 2.6957 3 
Efhd2 26.8 EF hand domain containing 2 2.6809 11 
Cttn 61.249 Cortactin, isoform CRA_e 2.369 26 
Utrn 392.7 utrophin 2.069 3 
Rab30 23.058 Ras-related protein Rab-30 1.8759 2 
Iqgap1 188.75 Ras GTPase-activating-like protein IQGAP1 1.8611 12 
Flnb 277.75 Filamin-B 1.8565 51 
Cd44 85.837 CD44 antigen isoform a 1.8313 5 
Plec 534.18 plectin isoform 12alpha 1.8079 349 
Hspa5 72.421 78 kDa glucose-regulated protein 1.7475 24 
Flna 281.22 Filamin, alpha 1.7101 109 
Coro1b 53.912 Coronin-1B 1.6833 8 
Plec-1a 517.31 Isoform PLEC-1A of Plectin-1 1.6811 345 
Mfge8 51.268 Isoform 1 of Lactadherin 1.5989 5 
Lrrfip2 47.147 Isoform 1 of Leucine-rich repeat flightless-interacting protein 2 1.5866 10 
Hspa9 73.527 Stress-70 protein, mitochondrial 1.5806 12 
Rpl19 23.466 60S ribosomal protein L19 1.5507 2 
Dbn1 72.544 Isoform E2 of Drebrin 1.5479 41 
Mme 85.701 Neprilysin 1.4878 6 
Ppp1r12a 114.99 Isoform 1 of Protein phosphatase 1 regulatory subunit 12A 1.48 28 
Hspa8 70.87 Heat shock cognate 71 kDa protein 1.401 31 
G6pd2 59.125 Glucose-6-phosphate 1-dehydrogenase 2 1.3867 1 
Flii 144.8 Protein flightless-1 homolog 1.3312 31 
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Myo18a 233.98 Isoform 6 of Myosin-XVIIIa 1.2829 32 
Vim 53.687 Vimentin 1.2265 54 
Pik3c2a 190.76 Isoform 1 of Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing alpha polypeptide 1.2037 2 
Nes 207.12 Isoform 1 of Nestin 1.1324 53 
Coro1c 53.12 Coronin-1C 1.0771 27 
Arpc5l 16.98 Actin-related protein 2/3 complex subunit 5-like protein 1.0714 4 
Twf1 40.079 Twinfilin-1 1.0594 12 
Rbm14 69.448 Isoform 1 of RNA-binding protein 14 1.0437 5 
Flnc 292.34 Isoform 1 of Filamin-C 1.042 18 
Cd109 161.66 CD109 antigen 1.0224 5 
Arpc4 19.667 Actin-related protein 2/3 complex subunit 4 1.0128 7 
 





(kD) Description MOF/IgG 
Peptide
s 
Cltc 191.98 clathrin, heavy polypeptide (Hc) 8.3419 9 
Clint1 69.758 clathrin interactor 1 5.5724 6 
Kat8 52.573 K(lysine) acetyltransferase 8 5.1921 7 
H2afv 13.608 H2A histone family, member V 2.7119 4 
Pdcd11 207.78 programmed cell death 11 1.7509 4 
Wdr3 105.77 WD repeat-containing protein 3 1.2309 4 
 
Results are ordered according to ratio of MOF/IgG, for proteins above 1:1 background level.  Italics indicate frequent contaminants of 
SILAC experiments using Dynabeads (Trinkle-Mulcahy et al., 2008).  MOF is highlighted in red.  Green highlighting indicate proteins 
shared between MEF and ES cells.
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6.4 MOF chromodomain shows weak interactions with a 
variety of histone modifications 
 
The presence of a chromodomain in MOF is conserved from yeast to human.  Though the 
domain is very highly conserved in vertebrates it has much lower conservation between flies 
and mammals (Fig 6.4A) (Sievers et al., 2011).  Chromodomains are conserved protein 
domains, usually involved in chromatin remodelling (Yap and Zhou, 2011).  Some are 
known to recognise histone modifications; for example, the chromodomain of Drosophila 
HP1 binds to methylated H3K9, and this binding is necessary for HP1 dependent gene 
silencing. (Bannister et al., 2001)  The Drosophila Polycomb (Pc) protein similarly binds 
methylated lysine, but has a preference for H3K27 (Fischle et al., 2003).  
In Drosophila, the chromobarrel domain of MOF has been well studied, and is extremely 
important for the enzymatic activity.  Disruption of the domain leads to global loss of 
H4K16ac in both male and female flies, though MOF is still bound to chromatin in this 
instance (Conrad et al., 2012).  The chromodomain of MOF in mammals is less well studied, 
though the lack of conservation between flies and mammals implies that there may be some 
difference in function. 
To investigate this further, I cloned the chromodomain of mouse MOF (the domain is 
identical in humans) with the addition of a GST tag.  I expressed the protein in bacteria, then 
purified the protein for use in a MODified histone peptide array.  There was no single 
histone modification which was clearly bound by the chromodomain of MOF.  The top hits 
(Fig6.3D) were H3K36ac, H3K36me3, and H4R17me2a, though the top two modifications 
are found only once on the MODified peptide array (Fig 6.3C), whilst H4R17me2a is found 
on 8 spots on the array (giving a more robust estimation of specificity). 
By comparison to the analysis of the highly specific H4K16ac antibody (Fig 3.1C), or of 
specific histone modification binding domain from the literature (Pradeepa et al., 2012), the 
specificity of binding to both these marks is extremely low, and may be purely background.  
Further work (for example, peptide pull downs using these modifications) would be 
necessary to confirm whether the interaction takes place in vitro by a different experimental 
method, and also in vivo. 
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Figure 6.4 MOF chromodomain has weak interaction with multiple histone 
modifications (Previous page) 
A:  Sequence alignment (ClustalOmega) of chromodomains detected by SMART 
(Letunic et al., 2011)from full length MOF sequences from vertebrate (human, 
mouse, horse, frog, zebrafish), and invertebrate (honeybee, oyster, drosophila) 
species.  B:  Signal intensities for all spots on MODified Histone Peptide array.  
Orange line represents threshold for signal intensity designated as background.  C:  
Example of a-GST antibody signal after incubation of GST-MOF chromodomain on 
MOFified Histone Peptide array.  Spots containing top modification hits are circled 
as described above.  D:  Specificity factors calculated by Array Analyse software 
(Activ motif) given background designated in (B) for top 10 hits (n=2).
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6.5 Summary of MOF interactions 
 
From these results, multiple future directions present themselves.  The initial overexpression 
was unsuccessful, but the endogenous immunoprecipitation showed promising preliminary 
results which can be built on.  The chromodomain of Drosophila MOF has been shown to 
bind RNA, and this is necessary for its function.  The chromodomain of mammalian MOF, 
however, though highly conserved between vertebrates, is diverged from its homolog in 
Drosophila, and has not been shown to have the ability to bind RNA.  Neither has it been 
examined for ability to bind methylated amino groups, as many chromodomains can 
(Bannister et al., 2001; Jacobs and Khorasanizadeh, 2002; Nielsen et al., 2002).  My results 
showed a very low specificity binding to both acetyl and methyl H3K36, along with a 
number of other acetylations and methylations of Lysine (and one Arginine residue).  Further 
work is needed to determine whether this is biologically significant. 
I had previously intended to observe the effects of a shRNA mediated knock down of MOF 
in ES cells and upon differentiation.  A MOF knock out experiment was performed in ES 
cell by Li et al (2012), whose data showed that MOF is vital for ES cell renewal and correct 
gene expression, emphasising its particular relevance for pluripotency. 
MOF is expressed in a wide variety of cell types to a similar extent (Thomas et al., 2007), 
but seems to be of particular importance for ES cells and pluripotency.  As shown in 
previous chapters, H4K16ac may mark enhancers only in ES cells.  Therefore, determining 
the complex (or complexes) or which MOF is a part in ES cells could be an important clue as 







Chapter 7:  Discussion and Future Directions 
 
Acetylation of H4K16 has been widely studied in vitro for its effects on chromatin 
compaction, and in Drosophila for its role in the dosage compensation complex, but its 
genome wide profile in mammalian cells has been limited to only a few studies.  In spite of 
its importance in chromatin structure, H4K16ac was not one of the histone acetylations 
included as part of the ENCODE (Consortium, 2012) or Roadmap 
(http://www.roadmapepigenomics.org/complete_epigenomes/) projects to locate regulatory 
elements of the genome.  Though H4K16ac and MOF are known to be of particular 
importance to mammalian development, and knock out of MOF leads to loss of self-renewal 
in pluripotent stem cells, until this study, there had been no genome wide profile of H4K16ac 
in ES cells, or during differentiation. 
Therefore, the aim of this work was to generate a genome wide profile of H4K16 acetylation 
(H4K16ac) in mouse Embryonic Stem cells (ES cells), and to determine whether changes in 
H4K16ac over large domains could be used to predict changes in chromatin compaction and 
gene expression.  A further aim was to study the Histone Acetyl Transferase (HAT), MOF, 
which is specifically responsible for H4K16 acetylation, by looking at its complex or 
complexes in ES cells. 
I have shown that H4K16ac is increased on the promoters of active genes, and that the 
profile changes in a manner broadly correlated with expression upon differentiation.  
Surprisingly, in ES cells, H4K16ac is also present on a subset of genes connected with 
differentiation.  Secondly, I found that H4K16ac and MOF were located on active enhancers, 
sometimes independently of H3K27ac, which is also known to mark active enhancers. 
Unlike H3K27ac, however, acetylation of H4K16ac on enhancers is potentially ES cell 
specific.   
Thirdly, loss of H4K16ac upon differentiation over a large domain was not found to correlate 
with a change chromatin compaction when analysed by FISH.   
Finally, it was not possible to overexpress MOF in ES cells, and so further work is needed to 
elucidate the role of the MOF containing protein complexes in the mechanism of H4K16ac 
targeting.  However, the chromodomain of mammalian MOF was shown to have weak 
specificity for several lysine modifications of histone tails.   
185 
 
7.1 H4K16ac and global transcription 
The profile of H4K16ac has been examined globally in CD4+T cells (Wang et al., 2008), 
and, more recently, in immature and mature erythrocytes (Wong et al., 2011), and mouse day 
E14.1 mouse embryo brains (Badeaux et al., 2012).  The correlation of H4K16ac with 
transcriptional level was not tested in the study of mouse embryo brains, but in both 
developing erythrocytes and CD4+T cells, H4K16ac presence was highly correlated with 
transcriptional activation of genes. 
My data shows that this is also true in mouse ES cells; those genes upregulated in 
undifferentiated (UD) ES cells have higher levels of H4K16ac in UD cells than genes 
upregulated in differentiated cells, and vice versa.  Similarly, genes which move from low 
expression in UD ES cells to high expression in differentiated cells also gain H4K16ac upon 
differentiation.  Unsurprisingly given the correlation with increased expression, I also found 
that H4K16ac correlates well with presence of RNA polymerase II on promoters in UD ES 
cells. 
The effect of MOF and H4K16ac on transcription is not only correlative.  It is known that 
siRNA mediated knockdown of MOF leads to knockdown of a selection of genes in HeLa 
cells (Dou et al., 2005).  In Drosophila, twofold upregulation of genes on the male X 
chromosome depends on MOF (Hilfiker et al., 1997).  In vitro (and in vivo in yeast), 
targeting H4K16ac to the promoter of a gene can relieve repression (Akhtar and Becker, 
2000).   
How H4K16ac and MOF achieve activation/derepression of transcription is still not 
precisely known, but it has been linked to both the processes of transcriptional initiation and 
transcriptional elongation. 
H4K16ac and MOF are found around the 5’ end of active genes on the autosomes in both 
Drosophila and mammals.  This profile supports a role in transcriptional initiation.  Further 
evidence for this is found in the fact that the MOF-containing NSL complex is required for 
recruitment of RNA Polymerase II (Pol II) and the pre-initiation complex at housekeeping 
genes in Drosophila (though levels of H4K16ac at these promoters was not examined in this 
study) (Lam et al., 2012).  In addition, the MOF-containing MSL complex has been 
suggested to upregulate the  genes of the male X chromosome by enhancing transcriptional 
initiation via Pol II binding at these promoters (Conrad et al., 2012).  This study also 
suggested that the MSL complex may be involved in transcriptional elongation, since in the 
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genes of the male X chromosome, Pol II levels on gene bodies are increased compared to the 
female X chromosome.  Transcriptional elongation is another mechanism which H4K16ac 
has been suggested to positively influence in Drosophila, leading to upregulation of 
transcription.  Knockdown of components of the MSL complex leads to loss of Pol II 
throughout the body of the gene (Larschan et al., 2011). 
My data shows that, like in CD4+T cells, H4K16ac in ES cells is present broadly over the 
promoters of active genes (Chapter 3, Fig 3.10), but does extend into the body of the genes 
somewhat.  In Drosophila, there is evidence for segregation of the mechanisms by which 
MOF can enhance transcription depending on the function of the genes.  On the male-X 
linked promoters, transcriptional elongation has a larger role, evidenced by a broader profile 
of MOF and H4K16ac on these genes compared with autosomal genes where they are 
limited to the 5’ end and therefore may be more linked with transcriptional initiation (Kind et 
al., 2008). 
In mammals, the picture is more complicated, as MOF binding in ES cells has been split into 
two classes based on the binding profile (either 5’/promoter binding, or binding in the body 
of the gene), but as yet no functional relationship has been elucidated between MOF binding 
profile and gene type (Li et al., 2012).  It would be interesting to classify genes based on the 
presence of H4K16ac in a similar way, to determine whether the genes which emerge as 
marked on the 5’ with H4K16ac versus genes marked through the gene body correlate with 
those so bound by MOF.   
7.2 H4K16ac, pluripotency and development 
 
H4K16ac has a global correlation with active transcription, as expected from previous data, 
but it is also, specifically, important for maintenance of pluripotency in a manner which 
seems to be independent of its activity in differentiated cells.  Li et al (2012) showed that 
MOF was intrinsic to the pluripotency network, but that overexpression of Nanog could 
partially rescue the MOF-/- phenotype, implying that once Nanog expression has been 
achieved, MOF is at least somewhat dispensable.   
Consistent with that study’s report of a reduction in H4K16ac upon retinoic acid 
differentiation, the level of H4K16ac I detected by ChIP-sequencing was generally lower in 
the differentiated samples than the undifferentiated (Chapter 4). Although H4K16ac is 
reduced on the promoters of pluripotency genes in MOF-/- ES cells, it is not clear whether 
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their reduction in expression is due to hypoacetylation at H4K16.  MOF is also known to 
acetylate p53 when in the context of the NSL complex, and this acetylation leads to 
upregulation of a selection of p53 target genes (Li et al., 2009).  Nanog is silenced by p53 
upon retinoic acid differentiation (Lin et al., 2004), but it is not clear whether MOF is found 
within a complex which renders it capable of accepting K120 of p53 as a substrate in ES 
cells, or whether this acetylation would prevent p53 silencing Nanog in undifferentiated ES 
cells (Fig 7.1A).  Further work is therefore needed to separate the histone acetylation activity 
of MOF from the p53 acetylation activity to determine whether the H4K16ac I find on the 
pluripotency genes in ES cells is functionally important to their expression.   
In Drosophila, MOF is found on many of the active promoters, but not all (Kind et al., 2008), 
and the MOF containing NSL complex binds to a large number of housekeeping genes, but 
only activates a defined subset (Feller et al., 2011).  In mammals, it has been noted that MOF 
binds to differentiation associated genes in ES cells, even though these genes are not 
expressed in that cell type (Li et al., 2012).  The authors suggest that MOF has a priming 
activity on genes “poised” for later activation; similarly, I have shown that peaks of 
H4K16ac are found over the promoters of genes associated with differentiation (Chapter 4, 
Fig 4.9).  This is consistent with evidence from S. cerevisae, in which inducible genes are 
acetylated even in the non-inducible state  (Roh et al., 2004), notably, for the PHO5 gene, 
transcription in the induced state is dependent on prior acetylation (Nourani et al., 2004). 
Interestingly, H4K16ac is excluded from the early Hox genes in undifferentiated ES cells 
(Chapter 4, Fig 4.4), which are classic examples of poised developmental genes, bivalently 
marked by H3K27me3 and H3K4me3 (Bernstein et al., 2006).  MOF was also shown to have 
no significant enrichment on bivalent domains (Li et al., 2012).  This is in contrast with 
H3K9ac and H3K14ac which are both found alongside H3K27me3 and H3K4me3 at 
bivalent promoters (Karmodiya et al., 2012).  This, and my data supports the idea that 
histone acetylation can ‘prime’ genes for subsequent activation, and presents the possibility 
of another subset of poised developmental genes, separate from known bivalent promoters, 




Figure 7.1:  Potential models for action of MOF/H4K16ac on Nanog transcription 
A:  MOF, in the context of the NSL complex acetylates p53 on K120, which prevents 
p53 from silencing its target gene, Nanog.  Nanog is expressed and pluripotency is 
maintained.  Upon differentiation, MOF levels are reduced (the NSL complex may 
still assemble), and unacetylated p53 is free to silence Nanog, leading to 
differentiation.  B:  MOF, in the context of either the MSL or NSL complex acetylates 
histones on H4K16 at the promoter and regulatory region of Nanog, generating an 
open chromatin environment and leading to recruitment of transcription factors and 
chromatin remodellers, which then leads to transcription of Nanog and maintenance 
of pluripotency.   In the absence of MOF, the chromatin environment is non-
conducive to TF binding, and Nanog is silenced, leading to differentiation.
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7.3 H4K16ac and Long Range Control 
 
One of the most important findings of this study was the fact that H4K16ac is present on 
active enhancers in ES cells.  This was unexpected, since a previous study in CD4+T cells 
analysed regulatory regions for histone modifications, and H4K16ac was not significantly 
enriched on enhancers in that cell type (Wang et al., 2008).  However, previous studies have 
shown that H3 acetylation generally is enriched on regulatory regions (Roh et al., 2005; 
Wang et al., 2008).  In addition, H3K9ac and H3K14ac were recently noted to mark active 
enhancers in ES cells (Karmodiya et al., 2012); neither of these modifications was found to 
be enriched on regulatory regions in the earlier study by Wang et al.  Potentially, this is 
simply due to a low level of sequencing depth in the early experiment, but it could also be 
due to cell type specificity.  On examination of a well-known limb regulatory region in a 
limb cell line, I was unable to detect any H4K16ac (Chapter 4, Fig 4.14), whilst a modest 
amount of H3K27ac and H3K4me1 was present on the region in this cell type.    
Interestingly, I noticed that though there is a good correlation between H4K16ac and 
H3K27ac on active enhancers, there is a subset of enhancers marked by one of the two 
modifications (together with H3K4me1), but not both.  This is reminiscent of the ‘classes’ of 
enhancers which were defined by Zentner et al (2011) who used H3K27ac, H3K27me3, 
H3K36me3 and H3K4me1 to subclassify active enhancers.  It is possible that the post 
translational modification profile of individual enhancers are more variable than previously 
thought; though to confirm this it would be necessary to generate genome wide ChIP-seq 
datasets for all possible histone modifications in a variety of cell types.  The fact that 
H3K27ac, H3K14ac, H3K9ac and H4K16ac have been found on regulatory regions in ES 
cells suggests the possibility that histone acetylation is a general feature of active enhancers 
in this cell type.  Knockout and knockdown of a number of HATs has been shown to have an 
adverse effect on regulation of differentiation, which points to a more general role of histone 
acetylation, but MOF is the only HAT which targets the core pluripotency factors directly; 
the others function downstream – for example, depletion of Nanog causes reduction of 
Tip60-p400 binding to target promoters (Fazzio et al., 2008), but depletion of Gcn5, p300, or 
Tip60 does not lead to reduction in expression of the core pluripotency factors in ES cells 
(Lin et al., 2007; Fazzio et al., 2008; Zhong and Jin, 2009) as depletion of MOF does.  
Further work with MOF-/- ES cells would be necessary to determine whether ablation of 
H4K16ac has an effect on other histone acetylation modifications at regulatory regions. 
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What function could H4K16ac perform on enhancers, and is its presence there necessary?  
This is a question which is asked of all the histone modifications found on enhancers.  In the 
example of virally induced activation of the IFN-β enhancer, a group of induced 
transcription factors binds to a nucleosome free region, and recruits the HATs Gcn5 and 
CBP.  Acetylation induces binding of the SWI/SNF complex, leading to nucleosome 
remodelling, which is necessary for induction of IFN-β transcription (Agalioti et al., 2000).  
This is, however, an individual case, and further work is needed to determine whether 
histone acetylation has a general function on active enhancers genome wide. 
7.4 H4K16ac and chromatin compaction 
In vitro, H4K16 acetylation status directly affects the chromatin compaction state; H4K16ac 
of nucleosome arrays leads to their decompaction, and its presence prevents the compaction 
which would otherwise be induced by increasing salt concentration.  In this regard, it is one 
of the few histone modifications to be directly correlated with chromatin compaction state. 
In vivo, however, I was unable to use H4K16ac state to detect changes in chromatin 
compaction at a level that could be detected by FISH (Chapter 5). This suggests that FISH 
may measure a different level of chromatin structure than that measured in many in vitro 
assays.  
Firstly, H4K16ac has been shown to be very important for cation induced intramolecular 
association of nucleosome arrays (Fig 7.2).  Acetylation of H4K16 abolishes array folding 
(Shogren-Knaak et al., 2006; Robinson et al., 2008), and to a much greater extent than the 
charge abolishing H4K16→Q mutation, or acetylation of H4K5, H4K8 and H4K12 
(Allahverdi et al., 2010; Liu et al., 2011).  This is likely due to the role of H4K16 in the 
interaction between the H4 tail of one nucleosome and H2A/H2B of the following 
nucleosome (Fig 1.7).  By contrast, H4K16ac has a minimal effect on cation induced inter-
array self-association (Fig 7.2); acetylation of H4K5, K8, K12 and K16 or mutation of those 
lysine residues to uncharged glutamine has a much greater effect than acetylation or 
mutation of K16 alone.  This supports the idea that nucleosome array self-association occurs 
due to a non-specific electrostatic mechanism (Allahverdi et al., 2010; Liu et al., 2011).  
Potentially, this second mechanism of chromatin compaction can be detected by FISH, 
whilst the first cannot.  The acetylation state of the other H4 lysine residues in UD ES and 




Figure 7.2:  Illustration of cation induced nucleosome array folding. 
Upon addition of a cation, such as Ca2+, nucleosome arrays condense, both within 
the array itself (“Intramolecular association”), which can be measured by analytical 
ultracentrifugation, and between arrays (“Inter-array self-association”), which can be 
measured by precipitation assays.  H4K16ac is important for intramolecular 
association, but is less important for inter-array self-association.
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Alternatively, my failure to detect a change in chromatin compaction state around the Nanog 
and Sox2 loci upon differentiation may be because deacetylation of H4K16ac is only one 
step in the process of chromatin compaction; indeed, chromatin compaction in vitro requires 
both hypoacetylaton of H4K16 and removal of the H1 linker histone.  The presence of the 
H1 histone has not been examined in this work.  It would be interesting to increase the length 
of cellular exposure to retinoic acid to determine whether any of the loci undergo 
compaction at a later stage in differentiation. 
Finally, the effect on chromatin compaction of a gain of H4K16ac over a large locus was not 
examined in this work, due to a difficulty in locating large regions which gain H4K16ac 
upon differentiation (as opposed to small, localised gains over promoters of expressed 
genes), potentially due to an overall loss of H4K16ac upon retinoic acid differentiation (Li et 
al., 2012).  Therefore, to look at chromatin compaction after a gain of H4K16ac, it may be 
necessary to use another system of differentiation where this does not occur. 
7.5 MOF 
 
My preliminary investigation into MOF function showed that overexpression of MOF in ES 
cells was potentially detrimental to cell survival, as ES cells quickly silenced flag-MOF 
overexpression, and even under antibiotic selection, expression was extremely 
low/undetectable by western blot.  This implies that dosage of MOF in ES cells may be 
important.  Previous studies have overexpressed MOF in HeLa cells (Dou et al., 2005; 
Mendjan et al., 2006; Cai et al., 2009), indicating that this sensitivity may be cell type 
specific.  This would be in line with the specific role of MOF in ES cells. 
Since I was unable to overexpress flag-MOF in ES cells, isolating the complex in ES cells 
became more complicated.  To perform an unbiased screen of MOF interaction partners, I 
used an antibody against endogenous MOF to perform an IP in conjunction with SILAC 
mass spectrometry in Mouse Embryonic Fibroblasts (MEFs) and ES cells.  In MEFs, as 
expected from previous studies which used overexpressed tagged proteins, MOF was 
partnered with MSL1, 2, and 3, though I did not detect interaction with any members of the 
NSL complex.  In ES cells, I was unable to isolate MOF in conjunction with any of the MSL 
or NSL proteins, which may be due to technical problems.  Further work is needed to 
determine whether the complex differs between MEFs and ES cells.  Size separation of 
protein complexes found in ES cell nuclei confirm that MOF is found in a complex of size 
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~700kDa in ES cells (Fig 6.3A).  This experiment could be repeated for MEF nuclei to look 
for differences in complex size. 
In addition to looking at the protein interactions of MOF, I also investigated the similarity of 
mammalian MOF chromodomain with the domain in fish, frogs, and invertebrates.  I also 
examined the binding specificity of its chromodomain for modified histones, which could 
potentially explain how MOF and H4K16ac are targeted to specific loci.  The results showed 
that the chromodomain binds weakly to a variety of lysine or arginine residues.  The 
strongest specificity was to H3K36ac, followed by H3K36me3 and H4R17me2a.  There is so 
far no data to connect H3K36ac to MOF binding or H4K16ac, with the exception that both 
are found on active promoters, and show higher levels on inducible genes upon stimulation 
of lymphocytes (Wang et al., 2008; Lim et al., 2009). 
Interestingly, however, H3K36me3 has been shown to have an antagonistic cross talk with 
H4K16ac.  Reduction in levels of H3K36me3 (but not H3K36me2) leads to increase of 
H4K16ac across the gene body of examined genes (Bell et al., 2007).  Potentially, this could 
mean that binding of MOF chromodomain to H3K36me3 leads to a reduction in MOF HAT 
activity.   Binding specificity and other functions of the MOF chromodomain have not been 
examined in mammals before.  However, in Drosophila it is required for MOF binding to the 
dosage compensation linked non-coding RNA roX, and for global H4K16ac, via an 
interaction with DNA which influences the HAT activity of MOF.  The chromodomain of 
MOF is extremely well conserved in vertebrates, but there is significantly more divergence 
between mammals and flies.  This indicates that there may be differences in mechanism 
and/or binding capabilities.  Further work is needed to determine whether MOF binds to 
DNA in vivo in mammalian cells, and whether the weak binding to modified lysine/arginine 
residues is physiologically significant. 
7.6 Future Directions 
 
The work presented in this thesis provides new insight into the role of H4K16ac during 
pluripotency and differentiation.  Whilst examination of data in three cell types suggests that 
H4K16ac presence on enhancers is ES cell specific, this is by no means a comprehensive 
analysis, and more cell types must be examined before this conclusion can be drawn. 
To show that H4K16ac presence on ES cell enhancers has a role in gene regulation, it would 
be necessary to show that induced hypoacetylation of H4K16ac at these enhancers would 
194 
 
negatively regulate gene expression. Targeted recruitment of a SIR family deacetylase to one 
of these enhancers via zinc fingers or TALEN fusion proteins might be an interesting avenue 
for further investigation. However, whilst SirT2 shows a preference for H4K16ac in vivo, it 
has not been tested fully for specificity to loci of interest (Vaquero et al., 2006).  Since 
targeting SirT2 to pluripotency promoters or enhancers would not affect the ability of MOF 
to acetylate p53, this method could provide a way of decoupling the effect of MOF 
acetyltransferase activity on histones and on p53. 
In addition, it will be interesting to determine whether hypoacetylation of H4K16ac has a 
different downstream effect than hypoacetylation of H3K27ac, or other acetylations which 
are known to mark enhancers.  
Building on the SILAC results presented in Chapter 4 would help be to determine whether 
H4K16ac presence on enhancers is dependent on a particular complex.  If this is the case, the 
complex could be targeted (for example by RNAi), and the downstream effects on 
transcription analysed.  Finally, the problem of mechanism could be approached from 
another angle, by investigating whether H4K16ac is necessary for protein binding at 
enhancers or promoters.  This could be performed using sequential re-ChIP for H4K16ac, 
then H3K4me1 or H3K4me3.  Candidate proteins could be identified by immunoblot or 
mass spectrometry, then analysed for presence of a bromodomain, indicating potential to 
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Appendix1:  Loci covered by NimbleGen tiling arrays 
Table Appendix 1.1:  Genomic Regions covered by custom Hox Nimblegen tiling array.  




Aard 8426 chr15:51,869,406-51,877,831 
Actb 5414 chr5:143,663,892-143,669,305 
Adssl1 31878 chr12:113,852,987-113,884,864 
Ankhd1 6329 chr18:36,715,293-36,721,621 
Asl1 6000 chr10:86,953,114-86,959,113 
Aurkb 9030 chr11:68,856,737-68,865,766 
Brachyury 150001 chr17:8,554,691-8,704,691 
Brd3 41055 chr2:27,296,495:27,337,549 
Cdx2 12700 chr5:148,110,571-148,123,270 
Chchd7 10373 chr4:3,862,488-3,872,860 
Chmp4b 56637 chr2:154,473,323-154,529,959 
c-myc 15063 chr15:61,811,875-61,826,937 
Crabp1 12453 chr9:54,610,540-54,622,992 
Ctnnal1 81381 chr4:56,810,244-56,891,624 
Ddx6 48314 chr9:44,404,928-44,453,241 
Dlk1 136468 chr12:110,693,533-110,830,000 
Dnmt3b 16799 chr2:153,470,702-153,487,500 
Emilin2 88185 chr17:71,586,819-71,675,003 
Eno1 8210 chr4:149,609,995-149,618,204 
Fgf10 115623 chr13:119,484,571-119,600,193 
Fus 21830 chr7:135,107,354-135,129,183 
Gata1 17112 chrX:7,532,108-7,549,219 
Gata4 13904 chr14:63,855,878-63,869,781 
Gnas 69619 chr2:174,105,382-174,175,000 
Grem1 990000 chr2:112,862,000-113,856,000 
Gsc 50001 chr12:105,687,160-105,737,160 
Gypa 25112 chr8:83,013,758-83,038,869 
H19 137587 chr7:149,730,414-149,868,000 
Hand2 900000 chr8:59,050,000-59,951,000 
Hba 237547 chr11:32,087,454-32,325,000 
Hbb 197639 chr7:110,861,362-111,059,000 
Hebp1 46046 chr6:135,079,862-135,125,907 
Hemgn 15293 chr4:46,404,312-46,419,604 
Hhex 40001 chr19:37,489,346-37,529,346 
Hnrpa1 8303 chr15:103,068,649-103,076,951 
HoxA 818585 chr6:51,781,416-52,600,000 
HoxB 755001 chr11:95,845,224-96,600,224 
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HoxC 702398 chr15:102,400,000-103,102,397 
HoxD 668990 chr2:74,241,352-74,910,341 
Jarid1b 8076 chr1:136,453,744-136,461,819 
Kcnq1 394001 chr7:150,256,000-150,650,000 
Klf4 13200 chr4:55,536,078-55,549,277 
Lin28 27001 chr4:133,553,000-133,580,000 
Ly6a 6777 chr15:74,823,425-74,830,201 
Ly6c1 5724 chr15:74,874,491-74,880,214 
Magea3 8801 chrX:151,379,200-151,388,000 
Mapk1ip1l 37167 chr14:47,911,795-47,948,961 
Mest 225001 chr6:30,685,000-30,910,000 
mirlet7-d 14164 chr13:48,630,830-48,644,993 
Mlkl 39156 chr8:113,829,174-113,868,329 
Myf5 6262 chr10:106,919,672-106,925,933 
Nanog 10001 chr6:122,656,000-122,666,000 
Nestin 28077 chr3:87,765,656-87,793,732 
Nkx2-9 6000 chr12:57,709,722-57,715,721 
Npm3 5490 chr19:45,820,805-45,826,294 
Nrn1 13244 chr13:36,815,287-36,828,530 
Olig2 7038 chr16:91,223,137-91,230,174 
Pax6 35000 chr2:105,505,001-105,540,000 
Pcdha 1012030 chr18:36,996,988-38,009,017 
Pdlim2 20183 chr14:70,560,661-70,580,843 
Pou5f1 9401 chr17:35,640,600-35,650,000 
Ppm1b 5838 chr17:85,352,959-85,358,796 
Ppp1cc 5664 chr5:122,604,605-122,610,268 
Pramel4 15290 chr4:143,646,480-143,661,769 
Prf1 9716 chr10:60,757,991-60,767,706 
Psip1 36768 chr4:83,097,979-83,134,746 
Rpl19 6164 chr11:97,886,000-97,892,163 
Shh 1221001 chr5:28,489,000-29,710,000 
Shmt2 11919 chr10:126,950,487-126,962,405 
Sif1 13637 chr16:18,262,780-18,276,416 
Slc7a3 9198 chrX:98,273,946-98,283,143 
Snx17 12596 chr5:31,492,177-31,504,772 
Sox2 23606 chr3:34,540,712-34,564,317 
Srebf2 86538 chr15:81,963,276-82,049,813 
Tcfap2a 27278 chr13:40,807,558-40,834,835 
Tex19.1 8770 chr11:121,004,657-121,013,426 
Tle1 4134 chr4:71,858,971-71,863,104 
Tnik 6790 chr3:28,159,250-28,166,039 
Xist 34292 chrX:100,649,996-100,684,287 
Xlr4a 12245 chrX:70,317,643-70,329,887 
Zbtb2 31535 chr10:5,953,177-5,984,711 
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Table Appendix 1.2:    Genomic Regions covered by custom Limb Regulatory region 
Nimblegen tiling array.  Coordinates used from UCSC genome browser, Mouse NCBI37, 





ZRS 1.66 chr5:28,398,000-30,058,000 
HoxD 1.76 chr2:73,733,000-75,498,000 
Gremlin 0.99 chr2:112,862,000-113,856,000 
Gli1 0.053 chr10:126,746,000-126,799,000 
Gli2 0.99 chr1:120,420,000-121,408,000 
Gli3 1.39 chr13:14,720,000-16,118,000 
dHAND(Hand2) 0.9 chr8:59,050,000-59,951,000 
Lmx1b 0.48 chr2:33,291,000-33,770,000 
Tbx3/Tbx5 0.43 chr5:119,158,000-120,596,000 
Sal1 1.53 chr8:91,251,000-92,780,000 
Fgf10 1.55 chr13:118,650,000-120,200,000 
HoxA 1.08 chr6:51,525,000-52,600,000 
Etv4/Meox1 0.33 chr11:101,520,000-101,850,000 
Etv5 0.26 chr16:22,245,000-22,500,000 
Ets1 2.65 chr9:32,212,00-34,860,000 
Alx4 0.425 chr2:93,250,000-93,675,000 
Fgfr2 0.965 chr7:136,730,000-137,695,000 
Sulf1 1.37 chr1:11,535,000-12,900,000 
Ptch1 0.6 chr13:63,400,000-64,000,000 
Twist1 1.24 chr12:34,000,000-35,240,000 
Bapx1(Nkx3-2) 2.18 chr5:40,100,000-42,280,000 
 
 
